
<html lang="en"     class="pb-page"  data-request-id="b49ffe4b-1c5c-4d18-8cd8-33be16040fcc"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-13;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b00433;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery" /></meta><meta name="dc.Creator" content="Jing  Ma" /></meta><meta name="dc.Creator" content="Qingpeng  Wang" /></meta><meta name="dc.Creator" content="Zhonglv  Huang" /></meta><meta name="dc.Creator" content="Xiande  Yang" /></meta><meta name="dc.Creator" content="Quandeng  Nie" /></meta><meta name="dc.Creator" content="Wenpei  Hao" /></meta><meta name="dc.Creator" content="Peng George  Wang" /></meta><meta name="dc.Creator" content="Xin  Wang" /></meta><meta name="dc.Description" content="Glycosylated platinum(IV) complexes were synthesized as substrates for GLUTs and OCTs for the first time, and the cytotoxicity and detailed mechanism were determined in vitro and in vivo. Galactosi..." /></meta><meta name="Description" content="Glycosylated platinum(IV) complexes were synthesized as substrates for GLUTs and OCTs for the first time, and the cytotoxicity and detailed mechanism were determined in vitro and in vivo. Galactosi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 27, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00433" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00433" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00433" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00433" /></link>
        
    
    

<title>Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00433" /></meta><meta property="og:title" content="Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0010.jpeg" /></meta><meta property="og:description" content="Glycosylated platinum(IV) complexes were synthesized as substrates for GLUTs and OCTs for the first time, and the cytotoxicity and detailed mechanism were determined in vitro and in vivo. Galactoside Pt(IV), glucoside Pt(IV), and mannoside Pt(IV) were highly cytotoxic and showed specific cancer-targeting properties in vitro and in vivo. Glycosylated platinum(IV) complexes 5, 6, 7, and 8 (IC50 0.24–3.97 μM) had better antitumor activity of nearly 166-fold higher than the positive controls cisplatin (1a), oxaliplatin (3a), and satraplatin (5a). The presence of a hexadecanoic chain allowed binding with human serum albumin (HSA) for drug delivery, which not only enhanced the stability of the inert platinum(IV) prodrugs but also decreased their reduction by reductants present in human whole blood. Their preferential accumulation in cancer cells compared to noncancerous cells (293T and 3T3 cells) suggested that they were potentially safe for clinical therapeutic use." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00433"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00433">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00433&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00433&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00433&amp;href=/doi/10.1021/acs.jmedchem.7b00433" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 5736-5748</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00425" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00428" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Ma">Jing Ma</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qingpeng++Wang">Qingpeng Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhonglv++Huang">Zhonglv Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiande++Yang">Xiande Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Quandeng++Nie">Quandeng Nie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenpei++Hao">Wenpei Hao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peng+George++Wang">Peng George Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Wang">Xin Wang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-6641-3041" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, State Key Laboratory of Elemento-organic Chemistry, Nankai University, Tianjin 300071 P. R. China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Pharmaceutical College, Henan University, Kaifeng 475004, Henan P. R. China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, P. R. China</span></div><div class="corresp-info"><strong>*</strong>Phone: (86) 022-23501642. Fax: (86) 022-23501642. E-mail: <a href="/cdn-cgi/l/email-protection#91e6f0fff6e9f8fffffad1fff0fffaf0f8bff4f5e4bff2ff"><span class="__cf_email__" data-cfemail="5a2d3b343d22333434311a343b34313b33743f3e2f743934">[email protected]</span></a>; <a href="/cdn-cgi/l/email-protection#ff8f889e9198bf919e91949e96d19a9b8ad19c91"><span class="__cf_email__" data-cfemail="7c0c0b1d121b3c121d12171d1552191809521f12">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00433&amp;href=/doi/10.1021%2Facs.jmedchem.7b00433" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 5736–5748</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 12, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 March 2017</li><li><span class="item_label"><b>Published</b> online</span>27 June 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 July 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00433" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00433</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5736%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJing%2BMa%252C%2BQingpeng%2BWang%252C%2BZhonglv%2BHuang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D13%26contentID%3Dacs.jmedchem.7b00433%26title%3DGlycosylated%2BPlatinum%2528IV%2529%2BComplexes%2Bas%2BSubstrates%2Bfor%2BGlucose%2BTransporters%2B%2528GLUTs%2529%2Band%2BOrganic%2BCation%2BTransporters%2B%2528OCTs%2529%2BExhibited%2BCancer%2BTargeting%2Band%2BHuman%2BSerum%2BAlbumin%2BBinding%2BProperties%2Bfor%2BDrug%2BDelivery%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5748%26publicationDate%3DJuly%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00433"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2063</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">53</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00433" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Ma&quot;},{&quot;first_name&quot;:&quot;Qingpeng&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Zhonglv&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Xiande&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Quandeng&quot;,&quot;last_name&quot;:&quot;Nie&quot;},{&quot;first_name&quot;:&quot;Wenpei&quot;,&quot;last_name&quot;:&quot;Hao&quot;},{&quot;first_name&quot;:&quot;Peng&quot;,&quot;last_name&quot;:&quot;George Wang&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Wang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;5736-5748&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00433&quot;},&quot;abstract&quot;:&quot;Glycosylated platinum(IV) complexes were synthesized as substrates for GLUTs and OCTs for the first time, and the cytotoxicity and detailed mechanism were determined in vitro and in vivo. Galactoside Pt(IV), glucoside Pt(IV), and mannoside Pt(IV) were highly cytotoxic and showed specific cancer-targeting properties in vitro and in vivo. Glycosylated platinum(IV) complexes 5, 6, 7, and 8 (IC50 0.24–3.97 μM) had better antitumor activity of nearly 166-fold higher than the positive controls cisplatin (1a), oxaliplatin (3a), and satraplatin (5a). The presence of a hexadecanoic chain allowed binding with human serum albumin (HSA) for drug delivery, which not only enhanced the stability of the inert platinum(IV) prodrugs but also decreased their reduction by reductants present in human whole blood. Their preferential accumulation in cancer cells compared to noncancerous cells (293T and 3T3 cells) suggested that they were potentially safe for clinical therapeutic use.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00433&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00433" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00433&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00433" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00433&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00433" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00433&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00433&amp;href=/doi/10.1021/acs.jmedchem.7b00433" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00433" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00433" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00433%26sid%3Dliteratum%253Aachs%26pmid%3D28603992%26genre%3Darticle%26aulast%3DMa%26date%3D2017%26atitle%3DGlycosylated%2BPlatinum%2528IV%2529%2BComplexes%2Bas%2BSubstrates%2Bfor%2BGlucose%2BTransporters%2B%2528GLUTs%2529%2Band%2BOrganic%2BCation%2BTransporters%2B%2528OCTs%2529%2BExhibited%2BCancer%2BTargeting%2Band%2BHuman%2BSerum%2BAlbumin%2BBinding%2BProperties%2Bfor%2BDrug%2BDelivery%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D13%26spage%3D5736%26epage%3D5748%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292098" title="Platinum">Platinum</a>,</li><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/jmcmar.2017.60.issue-13/20170713/jmcmar.2017.60.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Glycosylated platinum(IV) complexes were synthesized as substrates for GLUTs and OCTs for the first time, and the cytotoxicity and detailed mechanism were determined in vitro and in vivo. Galactoside Pt(IV), glucoside Pt(IV), and mannoside Pt(IV) were highly cytotoxic and showed specific cancer-targeting properties in vitro and in vivo. Glycosylated platinum(IV) complexes <b>5</b>, <b>6</b>, <b>7</b>, and <b>8</b> (IC<sub>50</sub> 0.24–3.97 μM) had better antitumor activity of nearly 166-fold higher than the positive controls cisplatin (<b>1a</b>), oxaliplatin (<b>3a</b>), and satraplatin (<b>5a</b>). The presence of a hexadecanoic chain allowed binding with human serum albumin (HSA) for drug delivery, which not only enhanced the stability of the inert platinum(IV) prodrugs but also decreased their reduction by reductants present in human whole blood. Their preferential accumulation in cancer cells compared to noncancerous cells (293T and 3T3 cells) suggested that they were potentially safe for clinical therapeutic use.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The FDA-approved platinum(II) drugs, such as cisplatin, carboplatin, and oxaliplatin, are widely used in all first-line clinical cancer treatments, including ovarian, lung, head, neck, and colorectal cancer. They induce apoptosis in cancer cells primarily via DNA damage.<a onclick="showRef(event, 'cit1a cit1b'); return false;" href="javascript:void(0);" class="ref cit1a cit1b">(1a, 1b)</a> However, their drawbacks, such as toxicity, tumor recurrence, and deactivation, remain deadly and problematic and originate from a lack of tumor selectivity and poor stability.<a onclick="showRef(event, 'ref2 cit3a cit3b'); return false;" href="javascript:void(0);" class="ref ref2 cit3a cit3b">(2, 3a, 3b)</a> Recently, platinum anticancer drug candidates were designed as inert platinum(IV) prodrugs that can be activated by intracellular reduction following cellular uptake.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Reductants such as ascorbic acid and glutathione occur at higher concentrations in tumor cells than in the blood and normal tissues, which makes them good targets. Satraplatin, the most promising platinum(IV) prodrug, is orally absorbed via passive diffusion and has greater potential because of its better stability, lower toxicity, and higher blood circulation time than cisplatin. The two functional “axial ligands” of platinum(IV) prodrugs can be used to tune the physical and chemical properties of the complex and impart targeting and additional biological activity without altering the structure of the active pharmacophore.<a onclick="showRef(event, 'cit5a cit5b cit5c cit5d cit5e cit5f cit5g cit5h cit5i'); return false;" href="javascript:void(0);" class="ref cit5a cit5b cit5c cit5d cit5e cit5f cit5g cit5h cit5i">(5a-5i)</a></div><div class="NLM_p">The potential of glycoconjugation for diagnosis and therapy has been realized, and it has become an appealing strategy for the targeted delivery of anticancer drugs.<a onclick="showRef(event, 'cit6a cit6b cit6c'); return false;" href="javascript:void(0);" class="ref cit6a cit6b cit6c">(6a-6c)</a> On the basis of the “the Warburg effect”, glucose transporters (GLUTs) and sodium-dependent glucose transporters (SGLTs) are widely overexpressed in many human cancers.<a onclick="showRef(event, 'cit7a cit7b cit7c'); return false;" href="javascript:void(0);" class="ref cit7a cit7b cit7c">(7a-7c)</a> Our group and others recently developed glycoconjugation by platinum(II).<a onclick="showRef(event, 'cit8a cit8b cit8c cit8d cit8e cit8f cit8g'); return false;" href="javascript:void(0);" class="ref cit8a cit8b cit8c cit8d cit8e cit8f cit8g">(8a-8g)</a> Our group also first designed and synthesized a series of glycosylated Pt(IV) complexes protected by acetyl groups.<a onclick="showRef(event, 'cit8h cit8i'); return false;" href="javascript:void(0);" class="ref cit8h cit8i">(8h, 8i)</a> To explore whether the transformation of glycosylated Pt(IV) complexes was associated with GLUTs, phlorizin was employed in the present study as a GLUT inhibitor to study its impact on their antitumor activities. Unfortunately, GLUT inhibition did not affect the IC<sub>50</sub> values of the tested complexes, indicating that the tested glycosylated platinum(IV) complexes were not transferred by glucose transporters. However, the unprotected glycosylated platinum(II) conjugates not only exploited both GLUTs and OCTs, but compared with normal epithelial cells in vitro, the conjugates also accumulated in and killed the cancer cells, demonstrating the potential of glycoconjugation for the selective destruction of cancer cells by platinum compounds.<a onclick="showRef(event, 'cit8f'); return false;" href="javascript:void(0);" class="ref cit8f">(8f)</a> In addition, the cellular uptake, cytotoxicity profile and glucose transporter 1 (GLUT1) specificity can be affected by variation in the position of <span class="smallcaps smallerCapital">d</span>-glucose substitution in the unprotected glycosylated platinum(II) conjugates.<a onclick="showRef(event, 'cit8g'); return false;" href="javascript:void(0);" class="ref cit8g">(8g)</a> However, the labile platinum(II) prodrugs would react with nucleophiles in human whole blood and never reach the tumor, which limits their bioavailability and precludes oral administration.<a onclick="showRef(event, 'cit9a cit9b'); return false;" href="javascript:void(0);" class="ref cit9a cit9b">(9a, 9b)</a> The reasons that the bioavailability is limited are its reactivity and lack of selectivity. The design of platinum(IV) prodrugs is predicated on the assumption that the low spin octahedral d<sup>6</sup> Pt(IV) complexes will not undergo hydrolysis or ligand substitutions in the blood but will be activated in cells by reductive elimination, releasing the cytotoxic square-planar Pt(II) drug. Consequently, a series of cancer-targeting unprotected glycosylated Pt(IV) complexes were designed and synthesized.</div><div class="NLM_p">Liposomes,<a onclick="showRef(event, 'cit10a'); return false;" href="javascript:void(0);" class="ref cit10a">(10a)</a> polymers,<a onclick="showRef(event, 'cit10b'); return false;" href="javascript:void(0);" class="ref cit10b">(10b)</a> inorganic nanomaterials,<a onclick="showRef(event, 'cit10c cit10d cit10e cit10f'); return false;" href="javascript:void(0);" class="ref cit10c cit10d cit10e cit10f">(10c-10f)</a> metal–organic frameworks,<a onclick="showRef(event, 'cit10g'); return false;" href="javascript:void(0);" class="ref cit10g">(10g)</a> and calcium phosphate (CaP) nanoparticles<a onclick="showRef(event, 'cit10h'); return false;" href="javascript:void(0);" class="ref cit10h">(10h)</a> have been recently used to synthesize platinum(IV) prodrugs for drug delivery. It was also reported that the platinum(IV) prodrugs that contain a hexadecyl chain can interact with HSA to form a platinum–protein complex for drug delivery and that the interaction was noncovalent. Extraction with octanol can completely remove the prodrug from an aqueous solution of HSA.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> As an extension of our study on novel potent antitumor agents, it was of great interest for us to design and synthesize a series of glycosylated Pt(IV) analogues that contain a hexadecanoic chain to produce a dual-targeting mechanism. In addition to interaction with HSA during drug delivery, the hexadecanoic chain can also enhance the lipophilicity of the molecule, which can affect the ability of a platinum(IV) prodrug to enter a tumor cell.</div><div class="NLM_p">We designed, synthesized, and biologically evaluated a novel series of dual-functionalized glycosylated platinum(IV) complexes as antitumor agents for the first time. The details of the mechanism of glycosylated platinum(IV) complexes <b>1</b>–<b>8</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>a) were also studied. It was revealed that the targeting and activity can be improved by the incorporation of glycuronic acid into an antitumor agent.<a onclick="showRef(event, 'cit12a'); return false;" href="javascript:void(0);" class="ref cit12a">(12a)</a> Therefore, we designed the Pt(IV) compounds <b>1</b>–<b>3</b>. Then, we also designed the glycoside compounds <b>4</b>–<b>8</b>, which incorporated variable aliphatic chains of different lengths to determine whether varying the substitution position or the chain length could alter the cellular uptake, cytotoxicity profile, and the specificity. We selected the clinically widely used oxaliplatin as the platinum core. These serial complexes contained different glycosyl moieties, including glucose, galactose, and mannose, and their impact on the antitumor potency could be evaluated in vitro and in vivo.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Structures of <b>1</b>–<b>8</b> and <b>1a</b>–<b>5a</b> as positive control. Docking studies of <b>6</b> with HSA and GLUT1. (b) <b>6</b> interacting with a variety of amino acid residues of GLUT1 (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PYP">4PYP</a>). (c) The lowest energy structure and <b>6</b> buried beneath the protein surface (HSA pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E7H">1E7H</a>). (d) <b>6</b> interacting with a variety of amino acid residues of HSA (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E7H">1E7H</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64114" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64114" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis of Target Compounds</h3><div class="NLM_p">To the best of our knowledge, the synthetic route of <b>1</b>–<b>8</b> given in detail in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf" class="ext-link">Supporting Information</a> has not been previously reported. The oxidation of cisplatin and oxaliplatin by hydrogen peroxide in water afforded <b>2a</b> and <b>4a</b>. The synthetic route of the target compounds <b>1</b> and <b>4</b> is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Compounds <b>2</b> and <b>3</b> were prepared according to the procedure described for compound <b>1</b> and <b>5</b>–<b>8</b> according to the procedure described for compound <b>4</b>. The asymmetrically functionalized Pt(IV) compounds <b>1</b>–<b>8</b> can be obtained by the reaction of a solution of <b>10b</b>, <b>12b</b>, <b>14b</b>, <b>27</b><b>b</b>, <b>29b</b>, <b>31b</b>, <b>33b</b>, and <b>35b</b> in anhydrous DCM. BCl<sub>3</sub> (1 M) was added at −78 °C for 2 h. Then, the DCM was removed and purified by column chromatography.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route of Target Compounds <b>1</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions and reagents: (a) BnOH, CH<sub>3</sub>COCl 50 °C, 2 h; (b) TrtCl, DMAP Py, 50 °C; (c) BnBr, NaH, DMF, rt, overnight; (d) HBr/AcOH 10 °C; (e) K<sub>2</sub>Cr<sub>2</sub>O<sub>7</sub>, H<sub>2</sub>SO<sub>4</sub>, acetone, 55 °C, 2 h; (f) C<sub>2</sub>O<sub>2</sub>Cl<sub>2</sub> DMF(cat.); (g) Dry acetone rt, 2 d; (h) BCl<sub>3</sub>, DCM −78 °C, 2 h; (i) Ac<sub>2</sub>O, AcONa 80 °C, 6 h; (j) <i>p</i>-toluenethiol BF<sub>3</sub> Et<sub>2</sub>O, DCM; (k) MeONa, MeOH rt, overnight; (l) BnBr, NaH, DMF, overnight; (m) TMSOTf, NIS, CH<sub>3</sub>CN, 2 h; (n) NaOH (1 M), 24 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Characterization</h3><div class="NLM_p last">The Pt(IV) compounds <b>1</b>–<b>8</b> were fully characterized by (<sup>1</sup>H and <sup>13</sup>C) NMR spectroscopy and electrospray ionization mass spectrometry (ESI-MS). The [M + NH<sub>4</sub>]<sup>+</sup> parent ions of compounds <b>1</b>, <b>2</b>, and <b>3</b> and the [M + H]<sup>+</sup> parent ions of compounds <b>4</b>, <b>5</b>, <b>6</b>, <b>7</b>, and <b>8</b> were readily observed using ESI-MS. Characteristic resonances could be observed at approximately 1.18 ppm and −1.30 ppm (CH<sub>2</sub>) and 0.79 ppm and −0.92 ppm (CH<sub>3</sub>) in <sup>1</sup>H NMR and were assigned to the hexadecanoic acid ligand. Resonances at 3.01 ppm and −2.65 ppm (<b>1</b>), 2.95 and 2.79 ppm (<b>2</b>), 2.94 ppm −2.65 (<b>3</b>), 2.78 ppm (<b>4</b>), 2.80 ppm (<b>5</b>), 2.89 ppm −2.66 ppm (<b>6</b>), 2.71 and 1.18 ppm (<b>7</b>), and 2.78 ppm (<b>8</b>) of (CH)<sub>2</sub> in <sup>1</sup>H NMR were assigned to the oxaliplatin core. We could observe characteristic resonances by <sup>13</sup>C NMR at approximately 183.11, 178.11, 176.63, and 165.69 ppm (<b>1</b>), 182.78 ppm, 178.31, 166.07, and 129.46 ppm (<b>2</b>), 183.17, 178.05, and 165.50 ppm (<b>3</b>), 183.21 ppm, 182.66, 165.43, and 128.02 ppm (<b>4</b>), 183.18, 182.61, and 165.44 ppm (<b>5</b>), 183.19, 182.63, and 165.40 ppm (<b>6</b>), 183.10, 182.81, and 165.38 ppm (7), and 183.19, 183.06, and 165.27 ppm (<b>8</b>) were assigned to the carbonyl group.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Docking Studies of the Dual Targets of Platinum(IV) Pro-Drugs</h3><div class="NLM_p">First, we conducted docking studies of the dual targets of the platinum(IV) prodrugs to investigate the interaction between HSA-<b>6</b><a onclick="showRef(event, 'cit12b'); return false;" href="javascript:void(0);" class="ref cit12b">(12b)</a> (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E7H">1E7H</a>) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>b,c) and GLUT1-<b>6</b><a onclick="showRef(event, 'cit12c'); return false;" href="javascript:void(0);" class="ref cit12c">(12c)</a> (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PYP">4PYP</a>) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>d). <b>6</b> can noncovalently interact with both HSA and GLUT1. Hydrogen-bonding interactions occurred with ASN-415, ASN-288, TYR-292, THR-30, and GLN-282 by ligand exchange to form glycosylated acid moieties because it occurred in the interaction between GLUT1 (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PYP">4PYP</a>) and <b>6</b>. TRP-388 could noncovalently interact with the carboxylate platinum ligand center.</div><div class="NLM_p">Hydrogen-bonding interactions of <b>6</b> with HSA (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E7H">1E7H</a>) were observed in the pocket, located in the subdomain IIA (known as Sudlow’s site I) with a model of the lowest energy structure. ARG-222 and LYS-199 of HSA were found to noncovalently interact with a platinum ligand. Hydrogen bonding interactions of glycosylated acid moieties occurred with PRO-447, ASP-451, GLU-292, and ASN-295 of HSA using noncovalent bonds. The lipophilic C16 tail of fatty acid moieties of <b>6</b> is coiled into a hydophobic channel lined by Tyr150, Leu238, Leu219, Leu234, Phe223, Ile264, Ala261, Ile290, and Tyr150 using noncovalent bonds.</div><div class="NLM_p last">The above results indicated stable and low-energy interactions of HSA-<b>6</b> and GLUT1-<b>6</b>, which contributed greatly to the dual target of a pyranoside-conjugated platinum(IV) complex. We can also deduce that once the target compound entered the human blood, it would bind with HSA during drug delivery, target the tumor tissue, and then preferentially accumulate in the cancer cells because of “the Warburg effect”.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Antitumor Activities in Vitro</h3><div class="NLM_p">The cytotoxicity of compounds <b>1</b>–<b>8</b> and the positive controls <b>1a</b>–<b>5a</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) were evaluated in seven human cancer cell lines using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The inhibitory effects (IC<sub>50</sub> in μM) are summarized in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Cytotoxicity Profiles of Glycosylated Pt(IV) Complexes (IC<sub>50</sub> in μM) in Seven Human Carcinoma Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">HeLa</th><th class="colsep0 rowsep0" align="center">MCF-7</th><th class="colsep0 rowsep0" align="center">LNCaP</th><th class="colsep0 rowsep0" align="center">PC3</th><th class="colsep0 rowsep0" align="center">HepG-2</th><th class="colsep0 rowsep0" align="center">A549</th><th class="colsep0 rowsep0" align="center">A549R</th><th class="colsep0 rowsep0" align="center" char=".">RF<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">1.09 ± 1.89</td><td class="colsep0 rowsep0" align="center">6.36 ± 1.44</td><td class="colsep0 rowsep0" align="center">8.81 ± 0.38</td><td class="colsep0 rowsep0" align="center">6.33 ± 1.45</td><td class="colsep0 rowsep0" align="center">1.22 ± 1.58</td><td class="colsep0 rowsep0" align="center">1.63 ± 0.39</td><td class="colsep0 rowsep0" align="center">1.07 ± 1.90</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±">2.27 ± 1.87</td><td class="colsep0 rowsep0" align="center">0.88 ± 1.87</td><td class="colsep0 rowsep0" align="center">12.87 ± 0.89</td><td class="colsep0 rowsep0" align="center">2.77 ± 0.49</td><td class="colsep0 rowsep0" align="center">3.47 ± 0.49</td><td class="colsep0 rowsep0" align="center">24.51 ± 1.78</td><td class="colsep0 rowsep0" align="center">10.91 ± 0.48</td><td class="colsep0 rowsep0" align="char" char=".">0.45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="±">1.59 ± 0.67</td><td class="colsep0 rowsep0" align="center">13.33 ± 1.67</td><td class="colsep0 rowsep0" align="center">38.10 ± 0.78</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">14.83 ± 1.67</td><td class="colsep0 rowsep0" align="center">10.55 ± 1.49</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char="±">12.74 ± 0.78</td><td class="colsep0 rowsep0" align="center">15.62 ± 0.98</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">63.69 ± 0.78</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">12.05 ± 0.48</td><td class="colsep0 rowsep0" align="center">48.45 ± 1.76</td><td class="colsep0 rowsep0" align="char" char=".">4.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char="±">0.89 ± 0.56</td><td class="colsep0 rowsep0" align="center">0.25 ± 0.44</td><td class="colsep0 rowsep0" align="center">3.03 ± 0.12</td><td class="colsep0 rowsep0" align="center">0.43 ± 1.56</td><td class="colsep0 rowsep0" align="center">0.72 ± 0.79</td><td class="colsep0 rowsep0" align="center">0.98 ± 0.89</td><td class="colsep0 rowsep0" align="center">3.52 ± 0.67</td><td class="colsep0 rowsep0" align="char" char=".">3.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="±">0.44 ± 0.45</td><td class="colsep0 rowsep0" align="center">0.19 ± 0.47</td><td class="colsep0 rowsep0" align="center">2.31 ± 1.67</td><td class="colsep0 rowsep0" align="center">0.24 ± 0.56</td><td class="colsep0 rowsep0" align="center">0.79 ± 1.79</td><td class="colsep0 rowsep0" align="center">0.44 ± 0.78</td><td class="colsep0 rowsep0" align="center">1.10 ± 1.69</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="±">1.57 ± 0.78</td><td class="colsep0 rowsep0" align="center">0.31 ± 0.45</td><td class="colsep0 rowsep0" align="center">3.97 ± 0.45</td><td class="colsep0 rowsep0" align="center">0.53 ± 1.89</td><td class="colsep0 rowsep0" align="center">1.70 ± 1.46</td><td class="colsep0 rowsep0" align="center">0.40 ± 1.31</td><td class="colsep0 rowsep0" align="center">0.76 ± 1.69</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char="±">0.74 ± 0.65</td><td class="colsep0 rowsep0" align="center">0.22 ± 0.78</td><td class="colsep0 rowsep0" align="center">2.94 ± 0.45</td><td class="colsep0 rowsep0" align="center">0.24 ± 1.56</td><td class="colsep0 rowsep0" align="center">1.68 ± 1.79</td><td class="colsep0 rowsep0" align="center">0.31 ± 1.98</td><td class="colsep0 rowsep0" align="center">0.65 ± 0.69</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="char" char="±">0.80 ± 0.93</td><td class="colsep0 rowsep0" align="center">2.28 ± 0.56</td><td class="colsep0 rowsep0" align="center">23.83 ± 0.89</td><td class="colsep0 rowsep0" align="center">22.85 ± 1.45</td><td class="colsep0 rowsep0" align="center">3.94 ± 0.39</td><td class="colsep0 rowsep0" align="center">10.85 ± 1.98</td><td class="colsep0 rowsep0" align="center">35.78 ± 1.69</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="char" char="±">11.36 ± 1.56</td><td class="colsep0 rowsep0" align="center">27.01 ± 0.34</td><td class="colsep0 rowsep0" align="center">50.78 ± 0.79</td><td class="colsep0 rowsep0" align="center">61.42 ± 0.67</td><td class="colsep0 rowsep0" align="center">50.00 ± 1.79</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">13.40 ± 2.57</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="char" char="±">3.96 ± 0.75</td><td class="colsep0 rowsep0" align="center">5.22 ± 2.78</td><td class="colsep0 rowsep0" align="center">16.78 ± 0.34</td><td class="colsep0 rowsep0" align="center">39.74 ± 0.76</td><td class="colsep0 rowsep0" align="center">6.64 ± 1.79</td><td class="colsep0 rowsep0" align="center">10.06 ± 1.20</td><td class="colsep0 rowsep0" align="center">39.67 ± 0.69</td><td class="colsep0 rowsep0" align="char" char=".">3.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="char" char="±">15.78 ± 0.34</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">22.97 ± 0.89</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">29.67 ± 0.64</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="char" char="±">3.10 ± 0.89</td><td class="colsep0 rowsep0" align="center">8.01 ± 0.56</td><td class="colsep0 rowsep0" align="center">5.23 ± 1.77</td><td class="colsep0 rowsep0" align="center">16.77 ± 1.56</td><td class="colsep0 rowsep0" align="center">6.70 ± 1.89</td><td class="colsep0 rowsep0" align="center">2.17 ± 1.68</td><td class="colsep0 rowsep0" align="center">9.96 ± 0.57</td><td class="colsep0 rowsep0" align="char" char=".">4.59</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">(RF: Resistant factor = IC<sub>50</sub>(A549R)/IC<sub>50</sub>(A549).)</p></div></div></div><div class="NLM_p">The cytotoxicity of compounds <b>1</b>–<b>8</b> show a rather broad antitumor spectrum and are greater than that of cisplatin, oxaliplatin, and satraplatin. Furthermore, the introduction of the pyranoside to Pt(IV) complexes prominently enhances the activity, in contrast to the oxoplatins <b>2a</b> and <b>4a</b> precursors. The HeLa (IC<sub>50</sub> = 0.44–12.74 μM) and MCF-7 (IC<sub>50</sub> = 0.22–15.62 μM) cell lines are more sensitive to compounds <b>1</b>–<b>8</b> than the others. We can see that different structural carbohydrates, different linkers, and different pyranoside positions also have a great effect on the bioactivity of the target compounds. Except for compound <b>4</b>, the C1-modified glycoside compounds (<b>5</b>–<b>8</b>) are more potent than the C6-modified pyranoside acids (<b>1</b>–<b>3</b>). In addition, the glycosylated Pt(IV) compounds almost fully overcome the drug resistance of A549R cells, especially the compounds <b>1</b> and <b>2</b> with RF 0.66 and 0.45, respectively.</div><div class="NLM_p">Of the C6-modified pyranoside acids derivatives (<b>1</b>–<b>3</b>), compound <b>1</b> effectively inhibits the growth of all the tested cell lines with IC<sub>50</sub> values of 1.07–8.81 μM. The introduction of glucose and mannose is more potent than of galactose (<b>1</b> > <b>2</b> > <b>3</b>). It is worth mentioning that galactoside derivative <b>3</b> shows better inhibition effects in HeLa cells than in the other cancer cell lines, indicating the targeting properties to HeLa. Additionally, prostatic carcinoma (LNCaP and PC3) shows more sensitivity to compounds <b>1</b> and <b>2</b>.</div><div class="NLM_p">At the same time, for the C1-substituted glycoside compounds (<b>4</b>–<b>8</b>), when the lengths of the linkage change from 5 (<b>8</b>), to 4 (<b>7</b>), to 3 (<b>4</b>), the antitumor activities dramatically decrease, which is opposite to the result with the glucoside platinum(II) prodrugs.<a onclick="showRef(event, 'cit8f cit8g'); return false;" href="javascript:void(0);" class="ref cit8f cit8g">(8f, 8g)</a> This may result from the significant different spatial structure of Pt(II) and Pt(IV) or the combination of transport and EPR effects. Compared with compound <b>4</b>, the glucoside (<b>6</b>) and galactoside (<b>5</b>) Pt(IV) complexes show better cytotoxicity to a panel of cancer cells, which is also different from the C6-substituted pyranoside acid derivatives (<b>1</b>–<b>3</b>).</div><div class="NLM_p">Above all, compounds <b>5</b>, <b>6</b>, <b>7</b>, and <b>8</b> show an especially better antitumor activity with an IC<sub>50</sub> of 0.24 to 3.97 μM, which is almost 166-fold higher than cisplatin, oxaliplatin, and satraplatin especially to A549R, LNCaP, and PC3 cells, which have been reported to be resistant to cisplatin and oxaliplatin.</div><div class="NLM_p last">All of the above results indicate that Pt(IV) prodrugs containing different sugars such as glucose, mannose, and galactose show significant cytotoxicity to cancer cells. It is also worth mentioning that they show different cytotoxicity profiles for different cancer cells. The chain length and positional isomers also have effects. These properties suggest that these compounds show great potential for further investigation.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> The Effect of Incubation Time of Compounds <b>6</b>, <b>7</b>, <b>8</b>, and <b>5a</b> on the IC<sub>50</sub> Values for HeLa and MCF-7 Cells</h3><div class="NLM_p">On the basis of previous reports, if compounds <b>1</b>–<b>8</b> exhibit cancer-targeting abilities based on protein-mediated transport, which become saturated at longer time scales, the initial rate of accumulation of compounds <b>1</b>–<b>8</b> in cells would be more rapid than that for compound <b>5a</b> with passive uptake, which is slower but does not become saturated. We subsequently investigated the effect of the incubation time on the outcomes of these assays. We incubation the MTT assay for 8, 24, 30, and 48 h with HeLa or MCF-7 cells.</div><div class="NLM_p last">The results revealed that the initial rate of accumulation of compounds <b>6</b>, <b>7</b>, and <b>8</b> was faster than that for compound <b>5a</b> (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf" class="ext-link">Figure S1a,b</a>). Almost all of the compounds were observed intracellularly after 8 h incubation in the MTT assay for compounds <b>6</b>, <b>7</b>, and <b>8</b>. The rapid rate of accumulation in the cell indicates the possibility that the glycosylated Pt(IV) compounds are transported by the targeted transporters.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Effects of EDG (1), Phloretin (2), Ctd (3), and the Mixture of EDG and Ctd (4) on the IC<sub>50</sub> Values of MCF-7 Cells</h3><div class="NLM_p">To understand whether the targeted transporters worked, we investigated the mechanism of compounds <b>1</b> and <b>6</b> in MCF-7 cells, which were coincubated with the GLUT1 inhibitors 4,6-oethylidene-α-<span class="smallcaps smallerCapital">d</span>-glucose (EDG) (1) and phloretin (2), the OCT2 inhibitor Ctd (3), and a combination of EDG and Ctd (4). Both the GLUT1 and OCT2 are overexpressed in MCF-7 cells.<a onclick="showRef(event, 'cit8f'); return false;" href="javascript:void(0);" class="ref cit8f">(8f)</a> These results suggested that the cytotoxicity of <b>6</b> (IC<sub>50</sub> = 0.57 and 0.68 μM) with EDG and phloretin were regulated via the glucose transporters because IC<sub>50</sub> values were elevated compared with the 48 h IC<sub>50</sub> of <b>6</b> (IC<sub>50</sub> = 0.19 μM)) with no inhibitor. However, the glucuronic acid-modified compound <b>1</b> with an IC<sub>50</sub> of 6.36 μM had respective cytotoxicity values of 5.98 and 5.89 μM with EDG and phloretin, but it showed no relationship with GLUT1. The magnitude of the cytotoxicity in the presence of EDG and phloretin was in the order <b>6</b> > <b>1</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>a), which was also observed for the inhibition of cellular uptake (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>c) in a breast carcinoma cell line (MCF-7) that had a high level of GLUT1 expression. The results remind us that when we design sugar–platinum(IV) complexes, the C1-modified prodrugs can show a close relationship with the tranporters. EDG and phloretin do not affect compounds <b>1a</b> and <b>3a</b>, as evidenced by their IC<sub>50</sub> values, which were not greatly different.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Effects of EDG (1), phloretin (2), Ctd (3), and a mixture of EDG and Ctd (4) on the IC<sub>50</sub> values of compounds <b>1</b>, <b>6</b>, and <b>1a</b> in MCF-7 cells. (b) Effects of Ctd (3) on the IC<sub>50</sub> values of on the compounds <b>5</b>, <b>7</b>, <b>8</b>, and <b>3a</b> in MCF-7 cells. (c) Effects of EDG on the cellular uptake of compounds <b>1</b>, <b>6</b>, and <b>3a</b> in MCF-7 cells. (d) Effect of Ctd on the cellular uptake of compounds <b>1</b>, <b>6</b>, and <b>3a</b> in MCF-7 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, in the presence of Ctd and a combination of EDG and Ctd, if IC<sub>50</sub> and cellular uptake were greatly different, the energy-dependent organic cation transporters (OCTs) contributed. <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>a shows that the IC<sub>50</sub> value of <b>6</b> (IC<sub>50</sub> = 5.95 μM) in the presence of a combination of EDG and Ctd was 31-fold higher than that in the 48 h incubation (IC<sub>50</sub> = 0.19 μM) in the cytotoxicity assay and demonstrated greater sensitivity to the OCTs than the C6-substituted pyranoside acids compound (<b>1</b>). The same results in the cellular uptake inhibition also occurred with Ctd (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>d). It has been reported that the organic cation transporter 2 (OCT2), which is a primary factor responsible for the sensitivity of colorectal cancer to oxaliplatin, plays a considerable role in the cellular accumulation and consequent cytotoxicity of platinum complexes containing the ((1<i>R</i>,2<i>R</i>)-cyclohexane-1,2-diamine (DACH) ligand.<a onclick="showRef(event, 'cit13a cit13b'); return false;" href="javascript:void(0);" class="ref cit13a cit13b">(13a, 13b)</a> In our study, the IC<sub>50</sub> values for oxaliplatin with Ctd (IC<sub>50</sub> = 10.89 μM) are 2.09-fold higher than that without Ctd (IC<sub>50</sub> = 5.22 μM) and cellular uptake are 1.38-fold higher than that with Ctd, indicating that OCT2 also affects the consequent cytotoxicity and cellular uptake of oxaliplatin (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b,d). However, OCT2 did not contribute to compounds <b>5</b>, <b>7</b>, and <b>8</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b). The reason may be that OCT2 had a close relationship with the glucoside Pt(IV) prodrugs but not with the mannoside and galactoside complexes. As a result, compound <b>6</b> significantly exploits both glucose and organic cation transporters, both of which are widely overexpressed in cancer cells. Different sensitivities of Glc-Pt(IV), Gal-Pt(IV), and Man-Pt(IV) to the OCTs also occur.</div><div class="NLM_p last">The above observations indicate that the C1-modified glycoside compounds are superior to the C6-modified pyranoside acids derivatives for targeting transport. This phenomenon may be because of the differences in the spatial structure of the square-planar platinum(II) and the octahedral platinum(IV). The above results also suggest that the pyranoside conjugated platinum(IV) complexes have important cancer-targeting properties and provide new insight into the potential of the glycosylated Pt(IV) anticancer prodrugs.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Whole Cell Uptake Studies and DNA Platination for HeLa and MCF-7 Cells</h3><div class="NLM_p">Subsequently, the intracellular distribution of compounds <b>5</b>, <b>6</b>, <b>8</b>, <b>3a</b>, and <b>5a</b> that have potent cytotoxicity in HeLa and MCF-7 cells was quantified by inductively coupled plasma mass spectrometry (ICP-MS) using <sup>196</sup>Pt detection as shown in Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf" class="ext-link">Figure S2</a>.</div><div class="NLM_p">After incubation with compounds <b>5</b>, <b>6</b>, and <b>8</b>, the accumulation of platinum in MCF-7 cells was 5.11–17.39-fold and 1.41–4.79-fold higher than that of <b>3a</b> and <b>5a</b>, respectively. In HeLa cells, the accumulation was 7.25–30.96-fold and 1.41–6.07-fold higher than that of <b>3a</b> and <b>5a</b>. Platinum in the DNA isolated from HeLa and MCF-7 cells was also measured and was 1.91–8.34-fold and 1.99–8.69-fold higher than that with <b>3a</b> and <b>5a</b>, respectively.</div><div class="NLM_p last">Nuclear DNA was considered as a potential subcellular target and a correlation between the intracellular platinum accumulation and antitumor activity was confirmed. An annexin V/PI coupled flow cytometric analysis (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf" class="ext-link">Figures S4</a>) clearly indicated that compounds <b>6</b> and <b>7</b> effectively induced cell damage in A549 cells.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Viability of the Cancer Cells Such as Breast Cancer MCF-7, Breast Cancer HeLa, and Normal Cells Such as 293T and 3T3 in a 48 h Incubation Assay</h3><div class="NLM_p">An ideal anticancer compound should be selective for cancer cells over normal healthy cells, thereby mitigating undesired toxic side effects associated with chemotherapy. Platinum(IV) itself always shows less toxicity to normal cells than platinum(II) drugs.</div><div class="NLM_p">Therefore, we determined the viability of breast cancer MCF-7 cells, breast cancer HeLa cells, normal kidney epithelial 293Tcells, and mouse embryo 3T3 fibroblasts in a 48 h incubation assay to evaluate their selectivity for cancer cells to mitigate undesired toxic side effects associated with chemotherapy. The pyranoside conjugated platinum(IV) complexes <b>5</b>–<b>8</b> show less cytotoxicity to 3T3 and 293T cells compared with the more sensitive HeLa and MCF-7 cells (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> and Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf" class="ext-link">Figure S3</a>). For example, the cytotoxicity of 6 for 3T3 cells (IC<sub>50</sub> = 2.54 μM) was 13.37-fold higher than that for MCF-7 cells (IC<sub>50</sub> = 0.19 μM). Compared to <b>1a</b> and <b>3a</b> in the clinic, they are also even safer for normal cells.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Viability of MCF-7 cells, HeLa cells, 293T cells, and 3T3 cells in a 48 h incubation assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We can deduce that this phenomenon may contribute to the part of pyranoside with cancer-targeting properties and the platinum(IV) itself regaining its cytotoxicity via reductants such as ascorbic acid and glutathione, presenting higher concentrations in the tumor cells than in the blood and normal tissues. It is worth mentioning that these properties cannot be realized by Pt(II) drugs.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Stability of <b>6</b> in RPMI 1640 and the Whole Human Blood</h3><div class="NLM_p">One of most important advantages of inert Pt(IV) complexes is that they are more stable than Pt(II) prodrugs. This is also a key point for the facilitated intravenous-to-oral switch of satraplatin. As previously reported for the activation of structurally similar platinum compounds by nucleophiles, the stability of <b>6</b> in RPMI 1640 medium and human whole blood was evaluated. The results are shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Stability of <b>6</b> in whole human blood (a) and RPMI 1640 (b).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In RPMI medium, no significant decomposition of compound <b>6</b> was up to 12 h, and 66% of <b>6</b> remained unchanged even after 48 h, and a half-life (<i>t</i><sub>1/2</sub>) of up to 170 h in RPMI 1640 medium suggested that it was highly stable in biological media, which makes it superior to platinum(II) drugs (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a and Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf" class="ext-link">Figure S5</a>). Compound <b>6</b> was more stable in human whole blood, with a <i>t</i><sub>1/2</sub> of nearly 20 h, compared with 21.6 and 6.3 min for cisplatin and satraplatin, respectively. This suggested a significant potential for a facilitated intravenous to oral switch of glycosylated platinum(IV) prodrugs with cancer-targeting properties.</div><div class="NLM_p last">The stability of glycosylated platinum(IV) complexes <b>6</b> is more advantageous than the platinum(II) prodrugs, which may contribute greatly to the development of platinum(IV) prodrugs for an intravenous to oral switch.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Binding Studies of <b>6</b> with Albumin Using RP-HPLC</h3><div class="NLM_p">We previously assumed that the significant stability of compound <b>6</b> in human blood may have resulted from the HSA binding properties of the hexadecanoic chain. On the basis of these observations, we also determined the HSA binding properties of <b>6</b>. The results showed that the pyranoside conjugated platinum(IV) complex <b>6</b> containing a hexadecanoic acid chain as an axial ligand preferably interacted with HSA (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a). Conversely, oxaliplatin did not bind HSA (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf" class="ext-link">Figure S7</a>). Docking studies have shown that the interaction is the combination of noncovalent interactions of the hexadecyl chain and hydrogen-bond interactions of the pyranoside, suggesting that the prodrug is buried below the surface of the protein.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Binding studies of <b>6</b> with HSA after 0, 24, 48, and 196 h. (b) Reduction of <b>6</b> by ascorbate with and without HSA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We can also presume from the results that the rate of reduction of <b>6</b> by ascorbate can be reduced as a result of the interaction with HSA during drug delivery. Consequently, the reduction and DNA binding properties of <b>6</b> with and without HSA was studied as shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b. At 24, 48, 96, and 144 h, the remaining compound <b>6</b> for the groups that contained HSA was always less than those without HSA. In addition, the remaining HSA also gradually decreased. The smaller reduction of 6 by ascorbate in human blood as the result of the interaction with HSA during drug delivery can further enhance the stability of platinum(IV) prodrugs and their accumulation in cancer cells.</div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Reduction and DNA Binding Properties of <b>6</b> and Oxaliplatin with and without Ascorbic Acid</h3><div class="NLM_p last">We also investigated the reduction and DNA binding properties of <b>6</b> and <b>3a</b> with and without ascorbic acid for the inherent proficiency of the Pt prodrugs to bind at the N7 position of guanine bases, thus leading to DNA damage and inducing cell death.<a onclick="showRef(event, 'cit14a cit14b cit14c'); return false;" href="javascript:void(0);" class="ref cit14a cit14b cit14c">(14a-14c)</a> 5′-dGMP was used as a model for DNA. Adducts can only be observed in the presence of the reductant ascorbic acid for RP-HPLC analysis at 37 °C in Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf" class="ext-link">Figure S6</a>. The fractions that contained unknown peaks were separated and identified by ESI-MS analysis observing the same products with <b>3a</b>. The results showed that the bis-substituted products of <b>6</b> originating from the combination with 5′-dGMP of <b>3a</b>, were generated after the reduction by a reductant such as ascorbic acid.</div></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Biodistribution of <b>5</b>, <b>6</b>, <b>8</b>, and <b>5a</b> in Vivo</h3><div class="NLM_p">To determine whether pyranoside conjugated platinum(IV) complexes can exhibit cancer-targeting in vivo, the biodistribution of <b>5</b>, <b>6</b>, <b>8</b>, and <b>5a</b>, a nontargeted platinum complex used as the positive control in MCF-7 bearing animals, was assessed by ICP-MS at 9 h, and 24 h post administration (iv).</div><div class="NLM_p">The in vitro IC<sub>50</sub> values of <b>5</b>, <b>6</b>, <b>8</b>, and <b>5a</b> were respectively 0.25, 0.19, 0.22, and 8.01 μM, which were not greatly different. Surprisingly, the accumulation Pt of <b>6</b> in the tumor tissue after 24 h was approximately 6.2-, 7.9-, and 2.2-fold higher than <b>5</b>, <b>8</b>, and <b>5a</b> as shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A–D and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>F, which were considerably different from the in vitro results. Additionally, the accumulation of <b>5</b> was higher in tumors and the heart, liver, spleen, and lungs than <b>5a</b> after 9 h. However, <b>5a</b> and <b>8</b> did not show in vivo cancer-targeting properties (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A,D).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A–D) Biodistribution of <b>5</b>, <b>6</b>, <b>8</b>, and <b>5a</b>, as the positive control in MCF-7 bearing animals was assessed by ICP-MS at 9 and 24 h post administration (iv). (E,F) Biodistribution of <b>5</b>, <b>6</b>, <b>8</b>, and <b>5a</b> at 9 and 24 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The results in vivo indicated that <b>6</b> exhibited enhanced cancer-targeting abilities and decreased toxicity for MCF-7-bearing animals compared with <b>5</b>, <b>8</b>, and the positive control <b>5a</b>. The encouraging selectivity of <b>6</b> to MCF-7 cells after 24 h in vivo prompted the adventurous assumption that different cancer cells might have different sensitivities to different glycosylated platinum(IV) prodrugs.</div></div><div id="sec2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Effects of EDG (1), Phloretin (2), Ctd (3), and a Mixture of EDG and Ctd (4) on the IC<sub>50</sub> Values of the Madine–Darby Canine Kidney (MDCK) Cells</h3><div class="NLM_p">It is well-known that MDCK cells are widely used to establish an intestinal epithelial model for the evaluation of the oral administration of a drug and can also be used to screen substrates and inhibitors in vitro. The most important goal regarding Pt(IV) prodrugs is to find a prodrug with an enhanced potential for oral administration. To determine whether targeted transport works in MDCK cells, we also investigated the mechanism of compounds <b>6</b> and <b>5a</b>, which were also coincubated with the GLUT1 inhibitor 4, 6-<i>o</i>-ethylidene-α-<span class="smallcaps smallerCapital">d</span>-glucose (EDG) and phloretin, the OCT2 inhibitor Ctd, and a combination of EDG and Ctd as shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of EDG (1), phloretin (2), Ctd (3), and the mixture of EDG and Ctd (4) on the IC<sub>50</sub> values of compounds <b>6</b> and <b>5a</b> in MDCK cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The results show that IC<sub>50</sub> with inhibitors are higher than in the 48 h MTT assays, indicating a close relationships of <b>6</b> with the transporters in MDCK cells. As GLUT and OCT substrates in MDCK cells, compound <b>6</b> would contribute greatly to the intravenous to oral switch for Pt(IV) prodrugs.</div></div><div id="sec2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> In Vivo Efficacy of <b>6</b> and <b>3a</b></h3><div class="NLM_p">To further investigate the antitumor potential of the glycosylated Pt(IV) complexes, compounds with potent in vitro activity were selected for further evaluation in vivo, using a mouse model of GLUT1 expressing breast cancer (MCF-7) in Balb/c mice. Intraperitoneal injections of 5 mg Pt/kg of <b>6</b> or <b>3a</b> were begun when the tumors reached ∼80–150 mm<sup>3</sup> for three successive treatments in 1 week. Treatment groups included <b>6</b>, <b>3a</b>, and a control group. The antitumor efficacy was evaluated by measuring the tumor volume over a period of 14 days. The toxic side effects of the platinum agents under investigation were assessed daily by a thorough examination of physical condition of the animals, including body weight, lethargy, loss of appetite, and general behavior.</div><div class="NLM_p">The tumor treatment revealed that <b>6</b> effectively reduced the disease burden by significantly delaying the tumor growth (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>A). Moreover, <b>3a</b> treatment showed no statistically significant difference compared to the <b>6</b>-treated group. Notably, tumors treated with <b>6</b>, or <b>3a</b> were 2-fold smaller compared to control group tumors, indicating excellent efficacy. Importantly, the bodyweight of mice in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>B indicates that the glycosylated Pt(IV) compounds <b>6</b> exhibited reduced toxicity compared with <b>3a</b>. Images of the tumors at the end of the experiment are shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>C. The results reveal that the glycosylated Pt(IV) complexes had lower toxicity and higher dose tolerance in vivo with comparative tumor control rates to platinum(II) drugs such as <b>3a</b>.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. In vivo antitumor activities of compounds Glc-Pt(IV) <b>6</b> and oxaliplatin in MCF-7. (A) Tumor growth as a function of time. (B) The bodyweight of mice during the treatments. (C) Images of tumors at the end of the experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34450" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34450" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Platinum anticancer drug candidates are designed as inert platinum(IV) prodrugs that can be activated following cellular uptake by intracellular reducing agents that are abundant in cancer cells. For the first time, we synthesized and determined the cytotoxicity and the detailed mechanism of pyranoside conjugated platinum(IV) complexes in vitro and in vivo. Pyranoside-conjugated platinum(IV) complexes are GLUT and OCT substrates and contributed greatly to the targeted therapy. Previously reported glycosylated Pt(IV) complexes protected by acetyl groups<a onclick="showRef(event, 'cit8h cit8i'); return false;" href="javascript:void(0);" class="ref cit8h cit8i">(8h, 8i)</a> did not have such properties. The cellular uptake and target engagement among these glycosylated Pt(IV) complexes is variable. A major reason is off-target effects due to the presence of glucose.</div><div class="NLM_p">Overall, compounds <b>4</b>–<b>8,</b> which were C1-substituted glycoside compounds, were more effective than compounds <b>1</b>–<b>3</b>, which were C6-substituted pyranoside acids. However, compounds <b>1</b>–<b>3</b> that contained different pyranosides such as glucose, galactose, and mannose also showed specific tumor targeting properties in vitro. Different chain lengths of between the sugar and the platinum also made a great difference, possibly because of a combination of effects of EPR and transporters. In a MTT assay after 8 h incubation, most of compounds <b>6</b>, <b>7</b>, and <b>8</b> were intracellular, indicating that they would rapidly accumulate in cancer cells. They also demonstrated the potential to exploit the two transporters GLUT1 and OCT2, both of which are overexpressed on the surface of tumor cells. Their preferential accumulation kills more cancer cells than noncancerous cells (293T and 3T3 cells) in vitro and indicates a low toxicity for the antineoplastic chemotherapy of platinum drugs. Binding with HSA during drug delivery also enhanced the stability of the dual targeted Pt(IV) compounds in human whole blood. A half-life of <b>6</b> of up to 170 h in RPMI 1640 medium suggested that this compound was highly stable in biological media, more so than platinum(II) drugs. The biodistribution of <b>5</b>, <b>6</b>, and <b>8</b> in vivo made a great difference with the in vitro results. The encouraging selectivity of <b>6</b> in vivo in MCF-7 tumor cells may contribute to the assumption that different cancer cells would have different sensitivities to different glycosylated platinum prodrugs in vivo. Compound <b>6</b> is a substrate of GLUT and OCT in MDCK cells, and it would contribute greatly to the intravenous to oral switch for Pt(IV) prodrugs. However, previously reported glycosylated Pt(IV) complexes protected by acetyl groups<a onclick="showRef(event, 'cit8h cit8i'); return false;" href="javascript:void(0);" class="ref cit8h cit8i">(8h, 8i)</a> also did not have similar properties. The in vivo antitumor activities revealed that the glycosylated Pt(IV) complexes exhibited important antitumor activities and reduced toxicity in vivo with a tumor control rate similar to that of the platinum(II) drug oxaliplatin.</div><div class="NLM_p last">All the results above show great differences with the glucose–platinum(II) prodrugs and enhanced of cancer-targeting effects, which will contribute to the design of platinum(IV) prodrugs that will facilitate an intravenous to oral switch. Eventually, the desirable biological performance of the glycosylated Pt(IV) complexes mentioned above could prove to be of prime importance in the future development of platinum antitumor drugs.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15752" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15752" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> HPLC Studies</h3><div class="NLM_p">The purities of all target compounds were determined by HPLC. The HPLC analyses were also performed as on a Waters E2695-2998 equipped with a Venusil MP C18 column (150 mm × 4.6 mm, 5 μM). The purity of the platinum complexes (<b>1</b>–<b>8</b>) was confirmed to be ≥95% by analytical HPLC (in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf" class="ext-link">Supporting Information</a>). The linear gradient was as follows (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Methods of the HPLC Analyses for the Purities of All Target Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">time (min)</th><th class="colsep0 rowsep0" align="center" char=".">A (water)</th><th class="colsep0 rowsep0" align="center" char=".">B (methol)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr></tbody></table></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure for the Synthesis of Compound <b>1</b></h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Preparation of <b>6b</b></h4><div class="NLM_p last">To a stirred solution of <b>5b</b> (1.6 g) in 40 mL of acetone, K<sub>2</sub>Cr<sub>2</sub>O<sub>7</sub> (1.49 g) dissolved in H<sub>2</sub>SO<sub>4</sub> (18 mL, 6 mol/L) was added in a dropwise manner at 0 °C under an N<sub>2</sub> atmosphere and the resulting solution was stirred at 55 °C for an additional 2 h. After evaporation under reduced pressure, the precipitate was then washed with 100 mL (×3) of DCM and dried. The residue obtained was purified by flash column chromatography to give the desired compound <b>S6</b> as a white solid (yield: 1.2 g, 71%).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Preparation of <b>10b</b></h4><div class="NLM_p last">To <b>6b</b> (200 mg, 0.36 mmol) under N<sub>2</sub> atmosphere, C<sub>2</sub>O<sub>2</sub>Cl<sub>2</sub> (4 mL) was added with catalytic DMF at 0 °C. White smoke was observed, and then the reaction was stirred for another 30 min at 0 °C. The resulting solution was stirred at room temperature for 2 h. The C<sub>2</sub>O<sub>2</sub>Cl<sub>2</sub> was removed to obtain <b>9b</b> as a slightly yellow solid. Pt(IV) compounds combined with <b>4a</b> and hexadecanoic acid as axial ligands (200 mg, 0.30 mmol) was added along with acetone (20 mL) under an N<sub>2</sub> atmosphere. After 2 days, the liquid was evaporated and purified by column chromatography to give the desired compound <b>10b</b> as a yellow solid (yield: 166 mg, 46%).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Preparation of <b>1</b></h4><div class="NLM_p last">To a solution of <b>10b</b> (120 mg, 0.10 mmol) in anhydrous DCM, BCl<sub>3</sub> (1 M) 0.80 mL, 0.80 mmol) was added at −78 °C for 2 h. Then, the DCM was removed and purified by column chromatography to get the white solid <b>1</b> (41 mg, 48%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 5.14 (s, 1H), 4.60–4.35 (m, 1H), 4.03–3.66 (m, 1H), 3.62–3.38 (m, 2H), 3.01–2.65 (m, 2H), 2.45–2.20 (m, 4H), 1.72–1.51 (m, 6H), 1.30 (s, 26H), 0.92 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 183.11, 178.11, 176.63, 165.69, 97.09, 92.95, 75.99, 75.89, 74.54, 73.09, 72.75, 72.43, 71.95, 71.50, 61.92, 61.29, 35.92, 31.71, 31.14, 29.46, 29.31, 29.18, 29.12, 28.92, 25.61, 23.75, 23.61, 22.37, 13.13. HRMS: calcd for C<sub>30</sub>H<sub>54</sub>N<sub>2</sub>O<sub>13</sub>Pt (M + NH<sub>4</sub>)<sup>+</sup>, 863.3612; found, 863.3594.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedure for the Synthesis of <b>2</b></h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Preparation of <b>7b</b>, <b>11b</b>, and <b>12b</b></h4><div class="NLM_p last">Compounds <b>7b</b>, <b>11b</b>, and <b>12b</b> were prepared according to the procedure described for compounds <b>6b</b>, <b>9b</b>, and <b>10b</b>, respectively.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Preparation of <b>2</b></h4><div class="NLM_p last">To a solution of <b>12b</b> (120 mg, 0.10 mmol) in anhydrous DCM, BCl<sub>3</sub> (1 M) (0.80 mL, 0.80 mmol) was added at −78 °C for 2 h. The DCM was removed and purified by column chromatography to get the white solid <b>2</b> (46 mg, 54%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 5.24 (s, 1H), 4.42–4.26 (m, 1H), 3.97–3.76 (m, 1H), 3.54–3.43 (m, 2H), 2.95 (s, 1H), 2.79 (s, 1H), 2.43–2.22 (d, <i>J</i> = 20.7 Hz, 4H), 1.70–1.52 (m, 6H), 1.30 (s, 26H), 0.92 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 182.78, 178.31, 166.07, 129.46, 96.77, 92.98, 81.72, 72.77, 71.62, 71.01, 70.50, 70.38, 69.11, 68.25, 61.78, 61.67, 35.78, 31.68, 31.15, 31.01, 29.41, 29.26, 29.12, 29.09, 28.88, 26.71, 25.49, 23.75, 23.57, 22.35, 22.27, 13.09. HRMS: calcd for C<sub>30</sub>H<sub>54</sub>N<sub>2</sub>O<sub>13</sub>Pt (M + NH<sub>4</sub>)<sup>+</sup>, 863.3612; found, 863.3593.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure for the Synthesis of <b>3</b></h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Preparation of <b>8b</b>, <b>13b</b>, and <b>14b</b></h4><div class="NLM_p last">Compounds <b>8b</b>, <b>13b</b>, and <b>14b</b> were prepared according to the procedure described for compounds <b>6b</b>, <b>9b</b>, and <b>10b</b>, respectively.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Preparation of <b>3</b></h4><div class="NLM_p last">To a solution of <b>14b</b> (120 mg, 0.10 mmol) in anhydrous DCM, BCl<sub>3</sub> (1 M) (0.80 mL, 0.80 mmol) was added at −78 °C for 2 h. The DCM was removed and purified by column chromatography to get the white solid <b>3</b> (87 mg, 48%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 5.15 (s, 1H), 4.27 (d, <i>J</i> = 7.9 Hz, 1H), 3.92 (s, 1H), 3.85–3.69 (d, <i>J</i> = 14.3 Hz, 2H), 2.94–2.83 (m, 1H), 2.83–2.65 (m, 1H), 2.43–2.20 (m, 4H), 1.70–1.46 (m, 6H), 1.28 (s, 26H), 0.90 (t, <i>J</i> = 6.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 183.17, 178.05, 165.50, 94.55, 73.18, 70.95, 70.69, 69.73, 62.01, 61.23, 35.93, 31.71, 31.18, 29.45, 29.41, 29.30, 29.17, 29.12, 28.91, 25.62, 23.76, 23.57, 22.37, 13.11. HRMS: calcd for C<sub>30</sub>H<sub>54</sub>N<sub>2</sub>O<sub>13</sub>Pt (M + NH<sub>4</sub>)<sup>+</sup>, 863.3612; found, 863.3606.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> General Procedure for the Synthesis of <b>4</b></h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Preparation of <b>21b</b></h4><div class="NLM_p last">NaOH (1 M) (17 mmol) was added to a solution of <b>20b</b> (1.1 g, 1.7 mmol) dissolved in 17 mL of dioxane and stirred for 12 h at room temperature. The product <b>21b</b> was finally purified by column chromatography as a slightly yellow liquid with a yield of 84% (0.9 g).</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Preparation of <b>26b</b> and <b>27b</b></h4><div class="NLM_p last">To <b>21b</b> (113 mg, 0.18 mmol) under an N<sub>2</sub> atmosphere, C<sub>2</sub>O<sub>2</sub>Cl<sub>2</sub> (2 mL) was added with catalytic DMF at 0 °C. White smoke was observed, and then the reaction was stirred for another 30 min at 0 °C. The resulting solution was stirred at room temperature for 2 h. The C<sub>2</sub>O<sub>2</sub>Cl<sub>2</sub> was removed to obtain <b>26b</b> as slightly yellow solid. Pt(IV) compounds combined with <b>4a</b> and a hexadecanoic acid as an axial ligand (100 mg, 0.15 mmol) was added along with acetone (10 mL) under an N<sub>2</sub> atmosphere. After 2 days, the reaction was evaporated and purified by column chromatography to give the desired compound <b>27b</b> as a yellow solid (yield: 120 mg, 63%).</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Preparation of <b>4</b></h4><div class="NLM_p last">To a solution of <b>27b</b> (120 mg, 0.10 mmol) in anhydrous DCM, BCl<sub>3</sub> (1 M) (0.80 mL, 0.80 mmol) was added at −78 °C for 2 h. The DCM was removed and purified by column chromatography to get the white solid <b>4</b> (36 mg, 41%). Data for compound <b>4</b>. <sup>1</sup>H NMR (400 MHz, MeOD) δ 5.01 (d, <i>J</i> = 3.6 Hz, 1H), 4.02–3.63 (m, 3H), 3.54 (t, <i>J</i> = 6.2 Hz, 2H), 2.91 (s, 1H), 2.78 (t, <i>J</i> = 9.3 Hz, 2H), 2.51–2.40 (m, 2H), 2.39–2.23 (m, 4H), 1.86–1.71 (m, 3H), 1.69–1.62 (d, <i>J</i> = 8.4 Hz, 2H), 1.60–1.46 (m, 5H), 1.28 (s, 26H), 0.89 (t, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (100 MHz, MeOD) δ 183.21, 182.66, 165.43, 128.02, 100.06, 73.23, 71.18, 70.74, 67.29, 66.11, 61.82, 61.49, 60.85, 35.98, 32.58, 31.72, 31.19, 29.46, 29.42, 29.31, 29.17, 29.13, 28.92, 28.28, 25.62, 23.73, 23.67, 22.38, 13.13. HRMS: calcd for C<sub>34</sub>H<sub>62</sub>N<sub>2</sub>O<sub>14</sub>Pt (M + H)<sup>+</sup>, 918.3922; found, 918.3879.</div></div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> General Procedure for the Synthesis of <b>5</b></h3><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Preparation of <b>22b</b></h4><div class="NLM_p last">Compound <b>22b</b> obtained as a slightly yellow solid was prepared according to the procedure described for compound <b>21b</b>.</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Preparation of <b>28b</b> and <b>29b</b></h4><div class="NLM_p last">To <b>22b</b> (226 mg, 0.36 mmol) under an N<sub>2</sub> atmosphere, C<sub>2</sub>O<sub>2</sub>Cl<sub>2</sub> (4 mL) was added with catalytic DMF at 0 °C. White smoke was observed, and then the reaction was stirred for another 30 min at 0 °C. The resulting solution was stirred at room temperature for 2 h. The C<sub>2</sub>O<sub>2</sub>Cl<sub>2</sub> was removed to obtain <b>28b</b> as slightly yellow solid. Pt(IV) compounds combined with <b>4a</b> and a hexadecanoic acid as an axial ligand (200 mg, 0.30 mmol) along with acetone (20 mL) was added under an N<sub>2</sub> atmosphere. After 2 days, the liquid was evaporated and purified by column chromatography to give the desired compound <b>29b</b> as a yellow solid (yield: 196 mg, 51%).</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Preparation of <b>5</b></h4><div class="NLM_p last">To a solution of <b>29b</b> (120 mg, 0.10 mmol) in anhydrous DCM, BCl<sub>3</sub> (1 M) (0.80 mL, 0.80 mmol) was added at −78 °C for 2 h. The DCM was removed and purified by column chromatography to get the white solid <b>5a</b> (25 mg, 28%). Data for compound <b>5a</b>. <sup>1</sup>H NMR (400 MHz, MeOD) δ 4.02–3.82 (m, 1H), 3.80–3.60 (m, 2H), 3.58–3.42 (m, 2H), 2.80 (s, 2H), 2.58–2.40 (m, 2H), 2.38–2.22 (m, 4H), 1.99–1.73 (m, 2H), 1.72–1.48 (m, 6H), 1.30 (s, 28H), 0.92 (s, 3H). <sup>13</sup>C NMR (100 MHz, MeOD) δ 183.18, 182.61, 165.44, 103.68, 75.23, 73.52, 71.18, 68.92, 68.56, 61.79, 61.46, 61.12, 60.84, 35.97, 32.56, 31.73, 31.18, 29.47, 29.43, 29.32, 29.19, 29.14, 28.92, 28.27, 25.62, 23.72, 22.39, 13.14. HRMS: calcd for C<sub>34</sub>H<sub>62</sub>N<sub>2</sub>O<sub>14</sub>Pt (M + H)<sup>+</sup>, 918.3922; found, 918.3854.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> General Procedure for the Synthesis of <b>6</b></h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Preparation of <b>23b</b></h4><div class="NLM_p last">Compound <b>23b</b> was obtained as a slightly yellow solid and was prepared according to the procedure described for compound <b>21b</b>, respectively.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Preparation of <b>30b</b> and <b>31b</b></h4><div class="NLM_p last">To <b>23b</b> (226 mg, 0.36 mmol) under an N<sub>2</sub> atmosphere, C<sub>2</sub>O<sub>2</sub>Cl<sub>2</sub> (4 mL) added with catalytic DMF at 0 °C. White smoke was observed and then the reaction was stirred for another 30 min at 0 °C. The resulting solution was stirred at room temperature for 2 h. The C<sub>2</sub>O<sub>2</sub>Cl<sub>2</sub> was removed to obtain <b>30b</b> as a slightly yellow solid. The Pt(IV) compounds combined with <b>4a</b> and a hexadecanoic acid as an axial ligand (200 mg, 0.30 mmol) along with acetone (20 mL) was added under an N<sub>2</sub> atmosphere. After 2 days, the liquid was evaporated and purified by column chromatography to give the desired compound <b>31b</b> as a yellow solid (yield: 250 mg, 66%).</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Preparation of <b>6</b></h4><div class="NLM_p last">To a solution of <b>31b</b> (120 mg, 0.10 mmol) in anhydrous DCM, BCl<sub>3</sub> (1 M) (0.80 mL, 0.80 mmol) was added at −78 °C for 2 h. The DCM was removed and purified by column chromatography to get the white solid <b>6</b> (31 mg, 35%). Data for compound <b>6</b>. <sup>1</sup>H NMR (400 MHz, MeOD) δ 4.24–3.83 (m, 1H), 3.75–3.50 (m, 2H), 3.39–3.32 (m, 1H), 3.28–3.20 (m, 1H), 2.89–2.66 (m, 2H), 2.57–2.38 (m, 2H), 2.39–2.21 (m, 4H), 1.97–1.70 (m, 2H), 1.68–1.48 (m, 6H), 1.28 (s, 28H), 0.89 (t, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (100 MHz, MeOD) δ 183.19, 182.63, 165.40, 103.01, 76.61, 76.48, 73.69, 70.20, 68.52, 61.82, 61.49, 61.30, 60.85, 48.30, 35.98, 32.57, 31.73, 31.19, 29.48, 29.44, 29.33, 29.20, 29.15, 28.94, 28.28, 25.63, 23.73, 22.40, 13.16. HRMS: calcd for C<sub>34</sub>H<sub>62</sub>N<sub>2</sub>O<sub>14</sub>Pt (M + H)<sup>+</sup>, 918.3922; found, 918.3887.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> General Procedure for the Synthesis of <b>7</b></h3><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Preparation of <b>24b</b></h4><div class="NLM_p last">Compound <b>24b</b> was obtained as a slightly yellow solid and was prepared according to the procedure described for compound <b>21b</b>.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Preparation of <b>32b</b> and <b>33b</b></h4><div class="NLM_p last">To <b>24b</b> (232 mg, 0.36 mmol) under a N<sub>2</sub> atmosphere, C<sub>2</sub>O<sub>2</sub>Cl<sub>2</sub> (4 mL) added with catalytic DMF at 0 °C. White smoke was observed, and the reaction was stirred for another 30 min at 0 °C. Then, the resulting solution was stirred at room temperature for 2 h. The C<sub>2</sub>O<sub>2</sub>Cl<sub>2</sub> was removed to obtain <b>32b</b> as a slightly yellow solid. The Pt(IV) compounds combined with <b>4a</b> and a hexadecanoic acid an axial ligand (200 mg, 0.30 mmol) along with acetone (20 mL) was added under an N<sub>2</sub> atmosphere. After 2 days, the liquid was evaporated and purified by column chromatography to give the desired compound <b>33b</b> as a yellow solid (yield: 220 mg, 57%).</div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Preparation of <b>7</b></h4><div class="NLM_p last">To a solution of <b>33b</b> (120 mg, 0.09 mmol) in anhydrous DCM, BCl<sub>3</sub> (1 M) (0.80 mL, 0.80 mmol) was added at −78 °C for 2 h. The DCM was removed and purified by column chromatography to get the white solid <b>7</b> (38 mg, 43%). Data for compound <b>7</b>. <sup>1</sup>H NMR (400 MHz, MeOD) δ 3.78–3.67 (m, 1H), 3.65–3.59 (m, 1H), 3.57–3.47 (m, 1H), 3.44 (s, 1H), 3.28–3.17 (m, 1H), 2.71 (s, 2H), 2.42–2.09 (m, 6H), 1.61–1.38 (m, 10H), 1.18 (s, 28H), 0.79 (t, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (100 MHz, MeOD) δ 183.10, 182.81, 165.38, 100.07, 73.18, 71.21, 70.82, 67.31, 66.68, 61.78, 61.67, 61.52, 61.07, 36.00, 35.63, 31.76, 31.59, 31.20, 29.52, 29.47, 29.38, 29.25, 29.18, 28.98, 28.59, 25.65, 23.76, 22.43, 21.90, 13.23. HRMS: calcd for C<sub>35</sub>H<sub>64</sub>N<sub>2</sub>O<sub>14</sub>Pt (M + H)<sup>+</sup>, 932.4078; found, 932.4058.</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> General Procedure for the Synthesis of <b>8</b></h3><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Preparation of <b>25b</b></h4><div class="NLM_p last">Compound <b>25b</b> was obtained as a slightly yellow solid and was prepared according to the procedure described for compound <b>21b</b>.</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Preparation of <b>34b</b> and <b>35b</b></h4><div class="NLM_p last">To <b>25b</b> (232 mg, 0.36 mmol) under an N<sub>2</sub> atmosphere, C<sub>2</sub>O<sub>2</sub>Cl<sub>2</sub> (4 mL) added with catalytic DMF at 0 °C. White smoke was observed, and the reaction was stirred for another 30 min at 0 °C. The resulting solution was stirred at room temperature for 2 h. The C<sub>2</sub>O<sub>2</sub>Cl<sub>2</sub> was removed to obtain <b>34b</b> as slightly yellow solid. The Pt(IV) compounds combined with <b>4a</b> and a hexadecanoic acid an axial ligands (200 mg, 0.30 mmol) along with acetone (20 mL) was added under an N<sub>2</sub> atmosphere. After 2 days, the liquid was evaporated and purified by column chromatography to give the desired compound <b>35b</b> as a yellow solid (yield: 180 mg, 46%).</div></div><div id="sec4_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Preparation of <b>8</b></h4><div class="NLM_p last">To a solution of <b>35b</b> (120 mg, 0.09 mmol) in anhydrous DCM, BCl<sub>3</sub> (1 M) (0.80 mL, 0.80 mmol) was added at −78 °C for 2 h. The DCM was removed and purified by column chromatography to get the white solid <b>8</b> (29 mg, 33%). Data for compound <b>8</b>. <sup>1</sup>H NMR (400 MHz, MeOD) δ 4.74 (s, 1H), 3.99–3.21 (m, 5H), 2.78 (s, 2H), 2.31 (d, <i>J</i> = 29.4 Hz, 6H), 1.60 (d, <i>J</i> = 38.5 Hz, 10H), 1.28 (s, 26H), 0.90 (s, 3H). <sup>13</sup>C NMR (100 MHz, MeOD) δ 183.19, 183.06, 165.27, 100.12, 73.15, 71.23, 70.85, 67.29, 66.96, 61.74, 61.55, 61.37, 35.97, 35.93, 31.93, 31.72, 31.21, 29.47, 29.43, 29.32, 29.19, 29.14, 28.93, 28.85, 25.62, 25.47, 25.37, 25.32, 25.06, 23.72, 22.39, 13.15. HRMS: calcd for C<sub>36</sub>H<sub>66</sub>N<sub>2</sub>O<sub>14</sub>Pt (M + H)<sup>+</sup>, 946.4235; found, 946.4197.</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> DNA and HSA Binding Properties of Oxaliplatin and <b>6</b> Using RP-HPLC</h3><div class="NLM_p">To investigate the binding properties of DNA with Pt(II) complexes, 5′-GMP was used as model of DNA. The DNA binding properties of oxaliplatin (1 mM) and 5′-GMP (1 mM) at 37 °C after 2, 24, 48, 96, and 144 h were determined using RP-HPLC (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf" class="ext-link">Figure S6A</a>). The results revealed new peaks of Oxp-Pt(II)-GMP (the conjugated complexes of oxaliplatin with 5′-GMP) generated by the mixture and demonstrated the potency of 5′-GMP to combine with Pt(II) complexes.</div><div class="NLM_p">Further experiments were designed to test the reduction potential of the Pt(IV) complexes. The reduction and DNA binding properties of <b>6</b> (1 mM) and 5′-GMP (3 mM) with and without ascorbic acid (5 mM) at 37 °C after 0, 24, 48, 96, and 144 h were measured using RP-HPLC (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf" class="ext-link">Figure S6B,C</a>). The results proved that the glycosylated platinum(IV) complexes could be reduced by ascorbic acid and release Pt(II) complexes. Then the Pt(II) compounds combined with 5′-GMP to form OxpPt(II)-GMP, which was confirmed by HRMS.</div><div class="NLM_p last">The reduction of compound <b>6</b> and its DNA binding properties by ascorbic acid with and without HSA were also studied at 37 °C after 24, 48, 96, and 144 h as shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b. The results showed that the rate of reduction of <b>6</b> by ascorbic acid can be reduced as the result of the interaction with HSA during drug delivery, which can further enhance its stability in human blood and its accumulation in cancer cells. Binding studies with compound <b>6</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A) and oxaliplatin (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf" class="ext-link">Figure S7</a>) with HSA at 37 °C after 0, 24, 48, and 196 h indicated that compound <b>6</b> with a chain of hexadecanoic acid showed a preferable interaction with HSA. Oxaliplatin did not bind HSA. HPLC analyses were performed as on a Waters E2695-2998 equipped with a Venusil MP C18 column (150 mm × 4.6 mm, 5 μm).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00433">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62165" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62165" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00433" class="ext-link">10.1021/acs.jmedchem.7b00433</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Full experimental details, NMR data, and bioassay information (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings(<a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Docking of <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E7H">1E7H</a> (HSA) (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Docking of <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PYP">4PYP</a> (GLUT1) (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_003.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_001.csv">jm7b00433_si_001.csv (1.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_002.pdb">jm7b00433_si_002.pdb (420.98 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_003.pdb">jm7b00433_si_003.pdb (591.6 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf">jm7b00433_si_004.pdf (2.36 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00433" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peng George Wang</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy,
Tianjin Key Laboratory of Molecular Drug Research, State Key Laboratory
of Elemento-organic Chemistry, Nankai University, Tianjin 300071 P. R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Wang</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy,
Tianjin Key Laboratory of Molecular Drug Research, State Key Laboratory
of Elemento-organic Chemistry, Nankai University, Tianjin 300071 P. R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, P. R. China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6641-3041" title="Orcid link">http://orcid.org/0000-0001-6641-3041</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dfa8beb1b8a7b6b1b1b49fb1beb1b4beb6f1babbaaf1bcb1ffafa8beb1b89fb1beb1b4beb6f1babbaaf1bcb1"><span class="__cf_email__" data-cfemail="d5a2b4bbb2adbcbbbbbe95bbb4bbbeb4bcfbb0b1a0fbb6bb">[email protected]</span> <span class="__cf_email__" data-cfemail="99e9eef8f7fed9f7f8f7f2f8f0b7fcfdecb7faf7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Ma</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy,
Tianjin Key Laboratory of Molecular Drug Research, State Key Laboratory
of Elemento-organic Chemistry, Nankai University, Tianjin 300071 P. R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Pharmaceutical College, Henan University, Kaifeng 475004, Henan P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qingpeng Wang</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy,
Tianjin Key Laboratory of Molecular Drug Research, State Key Laboratory
of Elemento-organic Chemistry, Nankai University, Tianjin 300071 P. R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhonglv Huang</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy,
Tianjin Key Laboratory of Molecular Drug Research, State Key Laboratory
of Elemento-organic Chemistry, Nankai University, Tianjin 300071 P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiande Yang</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy,
Tianjin Key Laboratory of Molecular Drug Research, State Key Laboratory
of Elemento-organic Chemistry, Nankai University, Tianjin 300071 P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Quandeng Nie</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy,
Tianjin Key Laboratory of Molecular Drug Research, State Key Laboratory
of Elemento-organic Chemistry, Nankai University, Tianjin 300071 P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenpei Hao</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy,
Tianjin Key Laboratory of Molecular Drug Research, State Key Laboratory
of Elemento-organic Chemistry, Nankai University, Tianjin 300071 P. R. China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The authors contribute equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d89e3193-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78185" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78185" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by the National Natural Science Foundation of China (grants 21102076, 91013013, 31100587, and 21572106) and the Natural Science Foundation of Tianjin (grant 10JCYBJC04100).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i57" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i57"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i58" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i58"> Abbreviations Used</h2><tr><td class="NLM_term">5′-GMP</td><td class="NLM_def"><p class="first last">5′-guanosine monophosphate</p></td></tr><tr><td class="NLM_term">GLUTs</td><td class="NLM_def"><p class="first last">glucose transporters</p></td></tr><tr><td class="NLM_term">OCTs</td><td class="NLM_def"><p class="first last">organic cation transporters</p></td></tr><tr><td class="NLM_term">HSA</td><td class="NLM_def"><p class="first last">human serum albumin</p></td></tr><tr><td class="NLM_term">SGLTs</td><td class="NLM_def"><p class="first last">sodium dependent glucose transporter</p></td></tr><tr><td class="NLM_term">EDG</td><td class="NLM_def"><p class="first last">4,6-<i>O</i>-ethylidene-a-<span class="smallcaps smallerCapital">d</span>-glucose</p></td></tr><tr><td class="NLM_term">Ctd</td><td class="NLM_def"><p class="first last">cimetidine</p></td></tr><tr><td class="NLM_term">GLUT 1</td><td class="NLM_def"><p class="first last">glucose transporter 1</p></td></tr><tr><td class="NLM_term">OCT2</td><td class="NLM_def"><p class="first last">organic cation transporter 2</p></td></tr><tr><td class="NLM_term">DACH</td><td class="NLM_def"><p class="first last">(1<i>R</i>,2<i>R</i>)-cyclohexane-1,2-diamine</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madine–Darby canine kidney</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">RPMI 1640</td><td class="NLM_def"><p class="first last">Roswell Park Memorial Institute 1640</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77678" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77678" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 14 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Cellular processing of platinum anticancer drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span><span class="refDoi"> DOI: 10.1038/nrd1691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1038%2Fnrd1691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=15789122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVart7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=307-320&author=D.+Wangauthor=S.+J.+Lippard&title=Cellular+processing+of+platinum+anticancer+drugs&doi=10.1038%2Fnrd1691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular processing of platinum anticancer drugs</span></div><div class="casAuthors">Wang, Dong; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-320</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cisplatin, carboplatin and oxaliplatin are platinum-based drugs that are widely used in cancer chemotherapy.  Platinum-DNA adducts, which are formed following uptake of the drug into the nucleus of cells, activate several cellular processes that mediate the cytotoxicity of these platinum drugs.  This review focuses on recently discovered cellular pathways that are activated in response to cisplatin, including those involved in regulating drug uptake, the signaling of DNA damage, cell-cycle checkpoints and arrest, DNA repair and cell death.  Such knowledge of the cellular processing of cisplatin adducts with DNA provides valuable clues for the rational design of more efficient platinum-based drugs as well as the development of new therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHJfZNaqwy67Vg90H21EOLACvtfcHk0ljN4niSqLXxPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVart7c%253D&md5=e44a8e87683ba5cfe3e165f9f4229fee</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1691%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DCellular%2520processing%2520of%2520platinum%2520anticancer%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D307%26epage%3D320%26doi%3D10.1038%2Fnrd1691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wheate, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oun, R.</span><span> </span><span class="NLM_article-title">The status of platinum anticancer drugs in the clinic and in clinical trials</span> <span class="citation_source-journal">Dalton Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">8113</span><span class="NLM_x">–</span> <span class="NLM_lpage">8127</span><span class="refDoi"> DOI: 10.1039/c0dt00292e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1039%2Fc0dt00292e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=20593091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVOhsrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=8113-8127&author=N.+J.+Wheateauthor=S.+Walkerauthor=G.+E.+Craigauthor=R.+Oun&title=The+status+of+platinum+anticancer+drugs+in+the+clinic+and+in+clinical+trials&doi=10.1039%2Fc0dt00292e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The status of platinum anticancer drugs in the clinic and in clinical trials</span></div><div class="casAuthors">Wheate, Nial J.; Walker, Shonagh; Craig, Gemma E.; Oun, Rabbab</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">8113-8127</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Since its approval in 1979 cisplatin has become an important component in chemotherapy regimes for the treatment of ovarian, testicular, lung and bladder cancers, as well as lymphomas, myelomas and melanoma.  Unfortunately its continued use is greatly limited by severe dose limiting side effects and intrinsic or acquired drug resistance.  Over the last 30 years, 23 other platinum-based drugs have entered clin. trials with only two (carboplatin and oxaliplatin) of these gaining international marketing approval, and another three (nedaplatin, lobaplatin and heptaplatin) gaining approval in individual nations.  During this time there have been more failures than successes with the development of 14 drugs being halted during clin. trials.  Currently there are four drugs in the various phases of clin. trial (satraplatin, picoplatin, Lipoplatin and ProLindac).  No new small mol. platinum drug has entered clin. trials since 1999 which is representative of a shift in focus away from drug design and towards drug delivery in the last decade.  In this perspective article we update the status of platinum anticancer drugs currently approved for use, those undergoing clin. trials and those discontinued during clin. trials, and discuss the results in the context of where we believe the field will develop over the next decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqSuqxBzUTjbVg90H21EOLACvtfcHk0ljN4niSqLXxPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVOhsrnO&md5=bfa2fef3a7c3c4a3122a0fa60e45f804</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1039%2Fc0dt00292e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0dt00292e%26sid%3Dliteratum%253Aachs%26aulast%3DWheate%26aufirst%3DN.%2BJ.%26aulast%3DWalker%26aufirst%3DS.%26aulast%3DCraig%26aufirst%3DG.%2BE.%26aulast%3DOun%26aufirst%3DR.%26atitle%3DThe%2520status%2520of%2520platinum%2520anticancer%2520drugs%2520in%2520the%2520clinic%2520and%2520in%2520clinical%2520trials%26jtitle%3DDalton%2520Trans.%26date%3D2010%26volume%3D39%26spage%3D8113%26epage%3D8127%26doi%3D10.1039%2Fc0dt00292e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Siddik, Z. H.</span><span> </span><span class="NLM_article-title">Cisplatin: mode of cytotoxic action and molecular basis of resistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7265</span><span class="NLM_x">–</span> <span class="NLM_lpage">7279</span><span class="refDoi"> DOI: 10.1038/sj.onc.1206933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1038%2Fsj.onc.1206933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=14576837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotlajtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7265-7279&author=Z.+H.+Siddik&title=Cisplatin%3A+mode+of+cytotoxic+action+and+molecular+basis+of+resistance&doi=10.1038%2Fsj.onc.1206933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cisplatin: mode of cytotoxic action and molecular basis of resistance</span></div><div class="casAuthors">Siddik, Zahid H.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">7265-7279</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cisplatin is one of the most potent antitumor agents known, displaying clin. activity against a wide variety of solid tumors.  Its cytotoxic mode of action is mediated by its interaction with DNA to form DNA adducts, primarily intrastrand crosslink adducts, which activate several signal transduction pathways, including those involving ATR, p53, p73, and MAPK, and culminate in the activation of apoptosis.  DNA damage-mediated apoptotic signals, however, can be attenuated, and the resistance that ensues is a major limitation of cisplatin-based chemotherapy.  The mechanisms responsible for cisplatin resistance are several, and contribute to the multifactorial nature of the problem.  Resistance mechanisms that limit the extent of DNA damage include reduced drug uptake, increased drug inactivation, and increased DNA adduct repair.  Origins of these pharmacol.-based mechanisms, however, are at the mol. level.  Mechanisms that inhibit propagation of the DNA damage signal to the apoptotic machinery include loss of damage recognition, overexpression of HER-2/neu, activation of the PI3-K/Akt (also known as PI3-K/PKB) pathway, loss of p53 function, overexpression of antiapoptotic bcl-2, and interference in caspase activation.  The mol. signature defining the resistant phenotype varies between tumors, and the no. of resistance mechanisms activated in response to selection pressures dictates the overall extent of cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3k2Fki_ax2rVg90H21EOLACvtfcHk0lgjX6PYYI9hXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotlajtbY%253D&md5=8520a82f029717c4352d23e4bd7166fe</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206933%26sid%3Dliteratum%253Aachs%26aulast%3DSiddik%26aufirst%3DZ.%2BH.%26atitle%3DCisplatin%253A%2520mode%2520of%2520cytotoxic%2520action%2520and%2520molecular%2520basis%2520of%2520resistance%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D7265%26epage%3D7279%26doi%3D10.1038%2Fsj.onc.1206933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kelland, L.</span><span> </span><span class="NLM_article-title">The resurgence of platinum-based cancer chemotherapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">584</span><span class="refDoi"> DOI: 10.1038/nrc2167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1038%2Fnrc2167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=17625587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVKru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=573-584&author=L.+Kelland&title=The+resurgence+of+platinum-based+cancer+chemotherapy&doi=10.1038%2Fnrc2167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of platinum-based cancer chemotherapy</span></div><div class="casAuthors">Kelland, Lloyd</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">573-584</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The accidental discovery of the anticancer properties of cisplatin and its clin. introduction in the 1970s represent a major landmark in the history of successful anticancer drugs.  Although carboplatin - a second-generation analog that is safer but shows a similar spectrum of activity to cisplatin - was introduced in the 1980s, the pace of further improvements slowed for many years.  However, in the past several years interest in platinum drugs has increased.  Key developments include the elucidation of mechanisms of tumor resistance to these drugs, the introduction of new platinum-based agents (oxaliplatin, satraplatin and picoplatin), and clin. combination studies using platinum drugs with resistance modulators or new molecularly targeted drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTEI4HRCjxQrVg90H21EOLACvtfcHk0lgjX6PYYI9hXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVKru7c%253D&md5=9d55f600a83a19d7836a2524de20efbf</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2167%26sid%3Dliteratum%253Aachs%26aulast%3DKelland%26aufirst%3DL.%26atitle%3DThe%2520resurgence%2520of%2520platinum-based%2520cancer%2520chemotherapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D573%26epage%3D584%26doi%3D10.1038%2Fnrc2167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Miller, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadagavadi, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, W. B.</span><span> </span><span class="NLM_article-title">Mechanisms of cisplatin nephrotoxicity</span> <span class="citation_source-journal">Toxins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2518</span><span class="refDoi"> DOI: 10.3390/toxins2112490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.3390%2Ftoxins2112490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=22069563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSht7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=2490-2518&author=R.+P.+Millerauthor=R.+K.+Tadagavadiauthor=G.+Rameshauthor=W.+B.+Reeves&title=Mechanisms+of+cisplatin+nephrotoxicity&doi=10.3390%2Ftoxins2112490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of cisplatin nephrotoxicity</span></div><div class="casAuthors">Miller, Ronald P.; Tadagavadi, Raghu K.; Ramesh, Ganesan; Reeves, William Brian</div><div class="citationInfo"><span class="NLM_cas:title">Toxins</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2490-2518</span>CODEN:
                <span class="NLM_cas:coden">TOXIB7</span>;
        ISSN:<span class="NLM_cas:issn">2072-6651</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Cisplatin is a widely used and highly effective cancer chemotherapeutic agent.  One of the limiting side effects of cisplatin use is nephrotoxicity.  Research over the past 10 years has uncovered many of the cellular mechanisms which underlie cisplatin-induced renal cell death.  It has also become apparent that inflammation provoked by injury to renal epithelial cells serves to amplify kidney injury and dysfunction in vivo.  This review summarizes recent advances in our understanding of cisplatin nephrotoxicity and discusses how these advances might lead to more effective prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquPxscC-wQ87Vg90H21EOLACvtfcHk0ljOWdF-rLyDJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSht7vJ&md5=7fd6f1103c5e8185eeae1b2d9e9f3969</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.3390%2Ftoxins2112490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Ftoxins2112490%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DR.%2BP.%26aulast%3DTadagavadi%26aufirst%3DR.%2BK.%26aulast%3DRamesh%26aufirst%3DG.%26aulast%3DReeves%26aufirst%3DW.%2BB.%26atitle%3DMechanisms%2520of%2520cisplatin%2520nephrotoxicity%26jtitle%3DToxins%26date%3D2010%26volume%3D2%26spage%3D2490%26epage%3D2518%26doi%3D10.3390%2Ftoxins2112490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Graf, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Adxcv. Redox activation of metal-based prodrugs as a strategy for drug delivery</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span><span class="refDoi"> DOI: 10.1016/j.addr.2012.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.addr.2012.01.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=993-1004&author=N.+Grafauthor=S.+J.+Lippard&title=Adxcv.+Redox+activation+of+metal-based+prodrugs+as+a+strategy+for+drug+delivery&doi=10.1016%2Fj.addr.2012.01.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2012.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2012.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DGraf%26aufirst%3DN.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DAdxcv.%2520Redox%2520activation%2520of%2520metal-based%2520prodrugs%2520as%2520a%2520strategy%2520for%2520drug%2520delivery%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2012%26volume%3D64%26spage%3D993%26epage%3D1004%26doi%3D10.1016%2Fj.addr.2012.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shamsuddin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santillan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitmire, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddik, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khokhar, A. R.</span><span> </span><span class="NLM_article-title">Synthesis, characterization, and antitumor activity of new platinum(IV) trans-carboxylate complexes: crystal structure of [Pt(cis-1,4-DACH)trans-(acetate)<sub>2</sub>Cl<sub>2</sub>]</span> <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1016/S0162-0134(98)10029-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2FS0162-0134%2898%2910029-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=9755489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVKhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1998&pages=29-35&author=S.+Shamsuddinauthor=C.+C.+Santillanauthor=J.+L.+Starkauthor=K.+H.+Whitmireauthor=Z.+H.+Siddikauthor=A.+R.+Khokhar&title=Synthesis%2C+characterization%2C+and+antitumor+activity+of+new+platinum%28IV%29+trans-carboxylate+complexes%3A+crystal+structure+of+%5BPt%28cis-1%2C4-DACH%29trans-%28acetate%292Cl2%5D&doi=10.1016%2FS0162-0134%2898%2910029-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization, and antitumor activity of new platinum(IV) trans-carboxylate complexes: crystal structure of [Pt(cis-1,4-DACH)trans-(acetate)2Cl2]</span></div><div class="casAuthors">Shamsuddin, Shaikh; Santillan, Claudia C.; Stark, Joseph L.; Whitmire, Kenton H.; Siddik, Zahid H.; Khokhar, Abdul R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">29-35</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Novel platinum(IV) cisplatin analogs [Pt(cis-1,4-DACH)trans-(L)2Cl2] (cis-1,4-DACH = cis-1,4-diaminocyclohexane and L = acetate, propionate, butyrate, valerate, hexanoate, heptanoate, octanoate, nonanoate, or decanoate) was synthesized and characterized by elemental anal., IR, 13C-NMR, and 195Pt-NMR spectroscopy.  The structure of [Pt(cis-1,4-DACH)trans-(acetate)2Cl2] (1) was detd. by x-ray crystallog.  The crystals were monoclinic, space group P21/n with a 10.193(2), b 10.687(2), c 14.265(3) Å, β 99.67(3)°, Z = 4.  The total reflections collected were 2556.  The structure refinement converged to R1 = 0.0539 and wR2 = 0.1531.  In this complex, platinum has a distorted octahedral geometry, and cis-1,4-DACH is in a unique twist-boat configuration.  Cis-1,4-DACH forms a seven-member chelating ring with platinum, leading to considerable strain in bidentate DACH binding.  The strain is evidenced by a large 126.5(9)° C-N-Pt angle.  The N-Pt-N angle is expanded to 97.4(5)° owing to geometric constraints of the cis-1,4-DACH geometry.  Three lower homologs of the cis-1,4-DACH-Pt(IV) series were tested in the murine L1210/0 leukemia model for antitumor activity.  Activity decreases in ascending the homologous series, and the activity of two of the complexes is substantially better than that of cisplatin with respect to increase in life span and cures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOWfrPyFBr97Vg90H21EOLACvtfcHk0ljOWdF-rLyDJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVKhtLs%253D&md5=8da564a8e2aa07d8c64012c0652fceaa</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2FS0162-0134%2898%2910029-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0162-0134%252898%252910029-6%26sid%3Dliteratum%253Aachs%26aulast%3DShamsuddin%26aufirst%3DS.%26aulast%3DSantillan%26aufirst%3DC.%2BC.%26aulast%3DStark%26aufirst%3DJ.%2BL.%26aulast%3DWhitmire%26aufirst%3DK.%2BH.%26aulast%3DSiddik%26aufirst%3DZ.%2BH.%26aulast%3DKhokhar%26aufirst%3DA.%2BR.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520antitumor%2520activity%2520of%2520new%2520platinum%2528IV%2529%2520trans-carboxylate%2520complexes%253A%2520crystal%2520structure%2520of%2520%255BPt%2528cis-1%252C4-DACH%2529trans-%2528acetate%25292Cl2%255D%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D1998%26volume%3D71%26spage%3D29%26epage%3D35%26doi%3D10.1016%2FS0162-0134%2898%2910029-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hambley, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battle, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrenz, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fallon, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatehouse, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainone, S.</span><span> </span><span class="NLM_article-title">Modifying the properties of platinum (IV) complexes in order to increase biological effectiveness</span> <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/S0162-0134(99)00133-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2FS0162-0134%2899%2900133-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1999&pages=3-12&author=T.+W.+Hambleyauthor=A.+R.+Battleauthor=G.+B.+Deaconauthor=E.+T.+Lawrenzauthor=G.+D.+Fallonauthor=B.+M.+Gatehouseauthor=L.+K.+Websterauthor=S.+Rainone&title=Modifying+the+properties+of+platinum+%28IV%29+complexes+in+order+to+increase+biological+effectiveness&doi=10.1016%2FS0162-0134%2899%2900133-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2FS0162-0134%2899%2900133-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0162-0134%252899%252900133-6%26sid%3Dliteratum%253Aachs%26aulast%3DHambley%26aufirst%3DT.%2BW.%26aulast%3DBattle%26aufirst%3DA.%2BR.%26aulast%3DDeacon%26aufirst%3DG.%2BB.%26aulast%3DLawrenz%26aufirst%3DE.%2BT.%26aulast%3DFallon%26aufirst%3DG.%2BD.%26aulast%3DGatehouse%26aufirst%3DB.%2BM.%26aulast%3DWebster%26aufirst%3DL.%2BK.%26aulast%3DRainone%26aufirst%3DS.%26atitle%3DModifying%2520the%2520properties%2520of%2520platinum%2520%2528IV%2529%2520complexes%2520in%2520order%2520to%2520increase%2520biological%2520effectiveness%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D1999%26volume%3D77%26spage%3D3%26epage%3D12%26doi%3D10.1016%2FS0162-0134%2899%2900133-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mukho-padhyay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haskel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Short, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span><span class="refDoi"> DOI: 10.1021/bc070031k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc070031k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=39-49&author=S.+Mukho-padhyayauthor=C.+M.+Barnesauthor=A.+Haskelauthor=S.+M.+Shortauthor=K.+R.+Barnesauthor=S.+J.+Lippard&title=Conjugated+platinum%28IV%29-peptide+complexes+for+targeting+angiogenic+tumor+vasculature&doi=10.1021%2Fbc070031k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1021%2Fbc070031k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc070031k%26sid%3Dliteratum%253Aachs%26aulast%3DMukho-padhyay%26aufirst%3DS.%26aulast%3DBarnes%26aufirst%3DC.%2BM.%26aulast%3DHaskel%26aufirst%3DA.%26aulast%3DShort%26aufirst%3DS.%2BM.%26aulast%3DBarnes%26aufirst%3DK.%2BR.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DConjugated%2520platinum%2528IV%2529-peptide%2520complexes%2520for%2520targeting%2520angiogenic%2520tumor%2520vasculature%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D39%26epage%3D49%26doi%3D10.1021%2Fbc070031k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Graf, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokhtari, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papayannopoulos, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells</span> <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1016/j.jinorgbio.2012.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.jinorgbio.2012.02.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2012&pages=58-63&author=N.+Grafauthor=T.+E.+Mokhtariauthor=I.+A.+Papayannopoulosauthor=S.+J.+Lippard&title=Platinum%28IV%29-chlorotoxin+%28CTX%29+conjugates+for+targeting+cancer+cells&doi=10.1016%2Fj.jinorgbio.2012.02.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2012.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2012.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DGraf%26aufirst%3DN.%26aulast%3DMokhtari%26aufirst%3DT.%2BE.%26aulast%3DPapayannopoulos%26aufirst%3DI.%2BA.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DPlatinum%2528IV%2529-chlorotoxin%2520%2528CTX%2529%2520conjugates%2520for%2520targeting%2520cancer%2520cells%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2012%26volume%3D110%26spage%3D58%26epage%3D63%26doi%3D10.1016%2Fj.jinorgbio.2012.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Barnes, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2004.03.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.chembiol.2004.03.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=15123250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1Cms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=557-564&author=K.+R.+Barnesauthor=A.+Kutikovauthor=S.+J.+Lippard&title=Synthesis%2C+characterization%2C+and+cytotoxicity+of+a+series+of+estrogen-tethered+platinum%28IV%29+complexes&doi=10.1016%2Fj.chembiol.2004.03.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Characterization, and Cytotoxicity of a Series of Estrogen-Tethered Platinum(IV) Complexes</span></div><div class="casAuthors">Barnes, Katie R.; Kutikov, Alexander; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">557-564</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Several estrogen-tethered platinum(IV) complexes were prepd. and characterized by ESI-MS and 1H NMR spectroscopy.  Their design was inspired by the observation that estrogen receptor-pos. cells exposed to the hormone are sensitized to cisplatin.  Intracellular redn. of bis-estrogen-cis-diamminedichloroplatinum(IV), BEPn (where n = 1-5 methylene groups between Pt and estrogen), occurs to afford cisplatin and two equiv. of the linker-modified estrogen.  The ability of BEPn to induce overexpression of HMGB1 was established by immunofluorescence microscopy.  The cytotoxicity of the compds. was evaluated in ER(+) MCF-7 and ER(-) HCC-1937 human breast cancer cell lines.  BEP3 selectively induces overexpression of HMGB1 in MCF-7 cells, compared to HCC-1937 cells, and enhances their sensitivity (IC50 = 2.1±0.4 μM vs. 3.7±0.9 μM, resp.) to the compd.  The difference in compd. activities and the potential of compds. of this class for treating breast and ovarian cancer are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3dZz7v_qRUbVg90H21EOLACvtfcHk0lil1UTeOe1lsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1Cms70%253D&md5=871e7ef7a62018dc13df36b0be3a9a0a</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.03.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.03.024%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DK.%2BR.%26aulast%3DKutikov%26aufirst%3DA.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520cytotoxicity%2520of%2520a%2520series%2520of%2520estrogen-tethered%2520platinum%2528IV%2529%2520complexes%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D557%26epage%3D564%26doi%3D10.1016%2Fj.chembiol.2004.03.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Ang, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khalaila, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allardyce, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyson, P. J.</span><span> </span><span class="NLM_article-title">Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">1382</span><span class="NLM_x">–</span> <span class="NLM_lpage">1383</span><span class="refDoi"> DOI: 10.1021/ja0432618</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0432618" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=1382-1383&author=W.+H.+Angauthor=I.+Khalailaauthor=C.+S.+Allardyceauthor=L.+Juillerat-Jeanneretauthor=P.+J.+Dyson&title=Rational+design+of+platinum%28IV%29+compounds+to+overcome+glutathione-S-transferase+mediated+drug+resistance&doi=10.1021%2Fja0432618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5fR"><div class="casContent"><span class="casTitleNuber">5f</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Platinum(IV) Compounds to Overcome Glutathione-S-Transferase Mediated Drug Resistance</span></div><div class="casAuthors">Ang, Wee Han; Khalaila, Isam; Allardyce, Claire S.; Juillerat-Jeanneret, Lucienne; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1382-1383</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A rationally designed Pt(IV) anticancer compd. is described, employing the novel concept of tethering an inhibitor of glutathione-S-transferase, an enzyme assocd. with Pt-based drug-resistance, to cisplatin.  Its enzyme inhibition activity, investigated using spectrophotometric and mass spectrometry-based techniques, and cytotoxic profile in resistant cancer cells are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7VgXIgOAQKLVg90H21EOLACvtfcHk0lil1UTeOe1lsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFGmsA%253D%253D&md5=814c125e4c704b8b1a3811f1e01eedfd</span></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=10.1021%2Fja0432618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0432618%26sid%3Dliteratum%253Aachs%26aulast%3DAng%26aufirst%3DW.%2BH.%26aulast%3DKhalaila%26aufirst%3DI.%26aulast%3DAllardyce%26aufirst%3DC.%2BS.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DRational%2520design%2520of%2520platinum%2528IV%2529%2520compounds%2520to%2520overcome%2520glutathione-S-transferase%2520mediated%2520drug%2520resistance%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D1382%26epage%3D1383%26doi%3D10.1021%2Fja0432618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Dhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">22199</span><span class="NLM_x">–</span> <span class="NLM_lpage">22204</span><span class="refDoi"> DOI: 10.1073/pnas.0912276106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1073%2Fpnas.0912276106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=20007777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=22199-22204&author=S.+Dharauthor=S.+J.+Lippard&title=Mitaplatin%2C+a+potent+fusion+of+cisplatin+and+the+orphan+drug+dichloroacetate&doi=10.1073%2Fpnas.0912276106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5gR"><div class="casContent"><span class="casTitleNuber">5g</span><div class="casTitle"><span class="NLM_cas:atitle">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span></div><div class="casAuthors">Dhar, Shanta; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">22199-22204, S22199/1-S22199/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The unique glycolytic metab. of most solid tumors, known as the Warburg effect, is assocd. with resistance to apoptosis that enables cancer cells to survive.  Dichloroacetate (DCA) is an anticancer agent that can reverse the Warburg effect by inhibiting a key enzyme in cancer cells, pyruvate dehydrogenase kinase (PDK), that is required for the process.  DCA is currently not approved for cancer treatment in the USA.  Here, we present the synthesis, characterization, and anticancer properties of c,t,c-[Pt(NH3)2(02CHCl2)2Cl2], mitaplatin, in which two DCA units are appended to the axial positions of a six-coordinate Pt(IV) center.  The neg. intracellular redox potential reduces the platinum to release cisplatin, a Pt(II) compd., and two equiv. of DCA.  By a unique mechanism, mitaplatin thereby attacks both nuclear DNA with cisplatin and mitochondria with DCA selectively in cancer cells.  The cytotoxicity of mitaplatin in a variety of cancer cell lines equals or exceeds that of all known Pt(IV) compds. and is comparable to that of cisplatin.  Mitaplatin alters the mitochondrial membrane potential gradient (Δψm) of cancer cells, promoting apoptosis by releasing cytochrome c and translocating apoptosis inducing factor from mitochondria to the nucleus.  Cisplatin formed upon cellular redn. of mitaplatin enters the nucleus and targets DNA to form 1,2-intrastrand d(GpG) cross-links characteristic of its own potency as an anticancer drug.  These properties of mitaplatin are manifest in its ability to selectively kill cancer cells cocultured with normal fibroblasts and to partially overcome cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Dar40eUqpLVg90H21EOLACvtfcHk0lhh65qLm2TnGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D&md5=7d8f3946238537b33ff15a49a4b13d3d</span></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0912276106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0912276106%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DS.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DMitaplatin%252C%2520a%2520potent%2520fusion%2520of%2520cisplatin%2520and%2520the%2520orphan%2520drug%2520dichloroacetate%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D22199%26epage%3D22204%26doi%3D10.1073%2Fpnas.0912276106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span> </span><span class="NLM_article-title">Conjugate of Pt(IV)-histone deacetylase inhibitor as a prodrug for cancer chemotherapy</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2793</span><span class="NLM_x">–</span> <span class="NLM_lpage">2800</span><span class="refDoi"> DOI: 10.1021/mp200597r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp200597r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=2793-2800&author=J.+Yangauthor=X.+Sunauthor=W.+Maoauthor=M.+Suiauthor=J.+Tangauthor=Y.+Shen&title=Conjugate+of+Pt%28IV%29-histone+deacetylase+inhibitor+as+a+prodrug+for+cancer+chemotherapy&doi=10.1021%2Fmp200597r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5hR"><div class="casContent"><span class="casTitleNuber">5h</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugate of Pt(IV)-Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy</span></div><div class="casAuthors">Yang, Jun; Sun, Xuanrong; Mao, Weiwei; Sui, Meihua; Tang, Jianbin; Shen, Youqing</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2793-2800</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Platinum(IV) prodrug diaminedichlorodihydroxyplatinum (ACHP) conjugated with a histone deacetylase (HDAC) inhibitor valproic acid (VA), VAAP, exhibited strong synergistic cytotoxicity, about 50-100 times more cytotoxic than ACHP or its simple mixt. with VA, against various human carcinoma cell lines.  VAAP could be quickly absorbed in the cell membrane and diffused into the cytosol.  VAAP loaded in polyethylene glycol-polycaprolactone micelles (PEG-PCL) was taken up via endocytosis.  The cytosolic VAAP was intracellular reduced to Pt(II) and released VA eliciting a HDAC inhibitory effect and subsequently induced cell cycle arrest at the S phase in 24 h and cell apoptosis in a time-dependent manner.  The in vivo antitumor expt. on A549-xenograft tumor model showed that VAAP dispersed in Tween 80 or loaded in PEG-PCL nanoparticles had long blood circulation times and thereby high accumulation in tumors and exerted a significant in vivo inhibitory effect on tumor growth with low systemic toxicity.  Therefore, this novel conjugate is very promising for cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeW1MFD6bedbVg90H21EOLACvtfcHk0lhh65qLm2TnGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrrK&md5=838e90dcb852b4dddeb424832f46ab15</span></div><a href="/servlet/linkout?suffix=cit5h&amp;dbid=16384&amp;doi=10.1021%2Fmp200597r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp200597r%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DSui%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DConjugate%2520of%2520Pt%2528IV%2529-histone%2520deacetylase%2520inhibitor%2520as%2520a%2520prodrug%2520for%2520cancer%2520chemotherapy%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D2793%26epage%3D2800%26doi%3D10.1021%2Fmp200597r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Suntharalingam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Conjugation of vitamin E analog a-TOS to Pt(IV) complexes for dual-targeting anticancer therapy</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2465</span><span class="NLM_x">–</span> <span class="NLM_lpage">2468</span><span class="refDoi"> DOI: 10.1039/c3cc48740g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1039%2Fc3cc48740g" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=2465-2468&author=K.+Suntharalingamauthor=Y.+Songauthor=S.+J.+Lippard&title=Conjugation+of+vitamin+E+analog+a-TOS+to+Pt%28IV%29+complexes+for+dual-targeting+anticancer+therapy&doi=10.1039%2Fc3cc48740g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5i&amp;dbid=16384&amp;doi=10.1039%2Fc3cc48740g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cc48740g%26sid%3Dliteratum%253Aachs%26aulast%3DSuntharalingam%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DConjugation%2520of%2520vitamin%2520E%2520analog%2520a-TOS%2520to%2520Pt%2528IV%2529%2520complexes%2520for%2520dual-targeting%2520anticancer%2520therapy%26jtitle%3DChem.%2520Commun.%26date%3D2014%26volume%3D50%26spage%3D2465%26epage%3D2468%26doi%3D10.1039%2Fc3cc48740g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Calvaresi, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hergenrother, P. J.</span><span> </span><span class="NLM_article-title">Glucose conjugation for the specific targeting and treatment of cancer</span> <span class="citation_source-journal">Chem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2319</span><span class="NLM_x">–</span> <span class="NLM_lpage">2333</span><span class="refDoi"> DOI: 10.1039/c3sc22205e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1039%2Fc3sc22205e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=24077675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntV2jsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2319-2333&author=E.+C.+Calvaresiauthor=P.+J.+Hergenrother&title=Glucose+conjugation+for+the+specific+targeting+and+treatment+of+cancer&doi=10.1039%2Fc3sc22205e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose conjugation for the specific targeting and treatment of cancer</span></div><div class="casAuthors">Calvaresi, Emilia C.; Hergenrother, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2319-2333</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Cancers of diverse origins exhibit marked glucose avidity and high rates of aerobic glycolysis.  Increased understanding of this dysfunctional metab. known as the Warburg effect has led to an interest in targeting it for cancer therapy.  One promising strategy for such targeting is glycoconjugation, the linking of a drug to glucose or another sugar.  This review summarizes the most salient examples of glycoconjugates, in which known cytotoxins or anticancer therapeutics were linked to glucose (or another glucose transporter substrate sugar) for improved cancer targeting and selectivity.  Building on these examples, this review also provides a series of guidelines for the design and mechanistic evaluation of future glycoconjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRBb0dfq_1NrVg90H21EOLACvtfcHk0lhh65qLm2TnGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntV2jsrY%253D&md5=3ede88f390b141479c271a220fae56d2</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1039%2Fc3sc22205e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3sc22205e%26sid%3Dliteratum%253Aachs%26aulast%3DCalvaresi%26aufirst%3DE.%2BC.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DGlucose%2520conjugation%2520for%2520the%2520specific%2520targeting%2520and%2520treatment%2520of%2520cancer%26jtitle%3DChem.%2520Sci.%26date%3D2013%26volume%3D4%26spage%3D2319%26epage%3D2333%26doi%3D10.1039%2Fc3sc22205e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ben-Haim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ell, P.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-FDG PET and PET/CT in the evaluation of cancer treatment response</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.2967/jnumed.108.054205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.2967%2Fjnumed.108.054205" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=88-99&author=S.+Ben-Haimauthor=P.+Ell&title=18F-FDG+PET+and+PET%2FCT+in+the+evaluation+of+cancer+treatment+response&doi=10.2967%2Fjnumed.108.054205"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.108.054205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.108.054205%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Haim%26aufirst%3DS.%26aulast%3DEll%26aufirst%3DP.%26atitle%3D18F-FDG%2520PET%2520and%2520PET%252FCT%2520in%2520the%2520evaluation%2520of%2520cancer%2520treatment%2520response%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2009%26volume%3D50%26spage%3D88%26epage%3D99%26doi%3D10.2967%2Fjnumed.108.054205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">He, Q.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. O.</span><span> </span><span class="NLM_article-title">Targeted delivery and sustained antitumor activity of triptolide through glucose conjugation</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">12035</span><span class="NLM_x">–</span> <span class="NLM_lpage">12039</span><span class="refDoi"> DOI: 10.1002/anie.201606121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2Fanie.201606121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=12035-12039&author=Q.-L.+Heauthor=I.+Minnauthor=Q.+Wangauthor=P.+Xuauthor=S.+A.+Headauthor=E.+Datanauthor=B.+Yuauthor=M.+G.+Pomperauthor=J.+O.+Liu&title=Targeted+delivery+and+sustained+antitumor+activity+of+triptolide+through+glucose+conjugation&doi=10.1002%2Fanie.201606121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1002%2Fanie.201606121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201606121%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DQ.-L.%26aulast%3DMinn%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DHead%26aufirst%3DS.%2BA.%26aulast%3DDatan%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26atitle%3DTargeted%2520delivery%2520and%2520sustained%2520antitumor%2520activity%2520of%2520triptolide%2520through%2520glucose%2520conjugation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D12035%26epage%3D12039%26doi%3D10.1002%2Fanie.201606121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vander Heiden, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">Understanding the warburg effect: the metabolic requirements of cell proliferation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1033</span><span class="refDoi"> DOI: 10.1126/science.1160809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1126%2Fscience.1160809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=19460998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=1029-1033&author=M.+G.+Vander+Heidenauthor=L.+C.+Cantleyauthor=C.+B.+Thompson&title=Understanding+the+warburg+effect%3A+the+metabolic+requirements+of+cell+proliferation&doi=10.1126%2Fscience.1160809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation</span></div><div class="casAuthors">Vander Heiden, Matthew G.; Cantley, Lewis C.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5930</span>),
    <span class="NLM_cas:pages">1029-1033</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes, most cancer cells instead rely on aerobic glycolysis, a phenomenon termed "the Warburg effect".  Aerobic glycolysis is an inefficient way to generate ATP, however, and the advantage it confers to cancer cells has been unclear.  Here we propose that the metab. of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass (e.g., nucleotides, amino acids, and lipids) needed to produce a new cell.  Supporting this idea are recent studies showing that (i) several signaling pathways implicated in cell proliferation also regulate metabolic pathways that incorporate nutrients into biomass; and that (ii) certain cancer-assocd. mutations enable cancer cells to acquire and metabolize nutrients in a manner conducive to proliferation rather than efficient ATP prodn.  A better understanding of the mechanistic links between cellular metab. and growth control may ultimately lead to better treatments for human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGvLHGQ9TX77Vg90H21EOLACvtfcHk0ljQbbFjvr-_YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D&md5=f927402a43cdca471c3f4874dcbeb943</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1160809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1160809%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DUnderstanding%2520the%2520warburg%2520effect%253A%2520the%2520metabolic%2520requirements%2520of%2520cell%2520proliferation%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D1029%26epage%3D1033%26doi%3D10.1126%2Fscience.1160809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Warburg, O.</span><span> </span><span class="NLM_article-title">On the origin of cancer cells</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1956</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span><span class="refDoi"> DOI: 10.1126/science.123.3191.309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1126%2Fscience.123.3191.309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=13298683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1956&pages=309-314&author=O.+Warburg&title=On+the+origin+of+cancer+cells&doi=10.1126%2Fscience.123.3191.309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">On the origin of cancer cells</span></div><div class="casAuthors">WARBURG O</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">3191</span>),
    <span class="NLM_cas:pages">309-14</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDsp1coYpQW669lAbTj9rGfW6udTcc2eYL_NhQNDOdQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D&md5=860d5ce9456831968fcc897b37d6d9c2</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1126%2Fscience.123.3191.309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.123.3191.309%26sid%3Dliteratum%253Aachs%26aulast%3DWarburg%26aufirst%3DO.%26atitle%3DOn%2520the%2520origin%2520of%2520cancer%2520cells%26jtitle%3DScience%26date%3D1956%26volume%3D123%26spage%3D309%26epage%3D314%26doi%3D10.1126%2Fscience.123.3191.309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Szablewski, L.</span><span> </span><span class="NLM_article-title">Biochim. Biophys. Expression of glucose transporters in cancers</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1835</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span><span class="refDoi"> DOI: 10.1016/j.bbcan.2012.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.bbcan.2012.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=23266512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVeksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1835&publication_year=2013&pages=164-169&author=L.+Szablewski&title=Biochim.+Biophys.+Expression+of+glucose+transporters+in+cancers&doi=10.1016%2Fj.bbcan.2012.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of glucose transporters in cancers</span></div><div class="casAuthors">Szablewski, Leszek</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1835</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-169</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  It has been known for 80 years that cancer cell growth in an energy-related process supported by an increased glucose metab.  This phenomenon suggests a need for a corresponding increased uptake of glucose across the plasma membrane through an enhancement in the glucose transporter proteins, SGLT proteins as well as GLUT proteins.  The results of many studies have demonstrated that the expression of glucose transporters, esp. GLUT1, is increased in a variety of malignancies.  GLUT1 overexpression has been found to be assocd. with tumor progression.  It was found that GLUT1 overexpression is assocd. with poor overall survival in various malignant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg5-w4WRFRJLVg90H21EOLACvtfcHk0ljQbbFjvr-_YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVeksLo%253D&md5=10875eb2ffba33f6890befed65fa21d3</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2012.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2012.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DSzablewski%26aufirst%3DL.%26atitle%3DBiochim.%2520Biophys.%2520Expression%2520of%2520glucose%2520transporters%2520in%2520cancers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2013%26volume%3D1835%26spage%3D164%26epage%3D169%26doi%3D10.1016%2Fj.bbcan.2012.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braunschweiger, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span> </span><span class="NLM_article-title">A carbohydrate-linked cisplatin analogue having antitumor activity</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1768</span><span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19990614)38:12<1768::AID-ANIE1768>3.0.CO;2-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1768%3A%3AAID-ANIE1768%3E3.0.CO%3B2-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADyaK1MXktVCntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1768&author=Y.+Chenauthor=M.+J.+Heegauthor=P.+G.+Braunschweigerauthor=W.+Xieauthor=P.+G.+Wang&title=A+carbohydrate-linked+cisplatin+analogue+having+antitumor+activity&doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1768%3A%3AAID-ANIE1768%3E3.0.CO%3B2-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">A carbohydrate-linked cisplatin analogue having antitumor activity</span></div><div class="casAuthors">Chen, Yongsheng; Heeg, Mary J.; Braunschweiger, Paul G.; Xie, Wenhua; Wang, Peng G.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1768-1769</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The authors report on the synthesis, characterization, and cytotoxicity of a novel carbohydrate-linked cisplatin analog, cis-dichloro[(2-3-D-glucopyranosidyl)propane-l,3-diamine]platinum (I).  I was characterized by 1H and 13C NMR spectroscopy which confirms complex formation in water.  The x-ray crystal structure anal. of I reveals that there are two independent mols. in the crystal.  In both mols., the intact and unprotected β-D-glucopyranose moiety is connected to platinum through the 2-propane-1,3-diamine linker group, which acts as a neutral bidendate ligand and coordinates through the two amino groups.  The coordination about platinum is roughly square planar as expected, and the six-membered chelate ring is in a chair conformation as is the glucopyranose ring.  The in vitro antitumor activity of I shows that it is as active as cisplatin against human ovarian cancer cell A278OS and human melanoma cancer cell MeWo, but less active against human ovarian cancer cell A2780cP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo54HRm2aRFI7Vg90H21EOLACvtfcHk0ljfQYjlWKJphQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVCntLg%253D&md5=c480614723cccb5078b2a6a808a6c1a6</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1768%3A%3AAID-ANIE1768%3E3.0.CO%3B2-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819990614%252938%253A12%253C1768%253A%253AAID-ANIE1768%253E3.0.CO%253B2-6%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHeeg%26aufirst%3DM.%2BJ.%26aulast%3DBraunschweiger%26aufirst%3DP.%2BG.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DP.%2BG.%26atitle%3DA%2520carbohydrate-linked%2520cisplatin%2520analogue%2520having%2520antitumor%2520activity%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D1768%26doi%3D10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1768%3A%3AAID-ANIE1768%3E3.0.CO%3B2-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang-Negrerie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span> </span><span class="NLM_article-title">Highly water-soluble platinum(II) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2421</span><span class="NLM_x">–</span> <span class="NLM_lpage">2423</span><span class="refDoi"> DOI: 10.1039/c3cc38589b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1039%2Fc3cc38589b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=23420130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVClt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=2421-2423&author=P.+Liuauthor=Y.+Luauthor=X.+Gaoauthor=R.+Liuauthor=D.+Zhang-Negrerieauthor=Y.+Shiauthor=Y.+Wangauthor=S.+Wangauthor=Q.+Gao&title=Highly+water-soluble+platinum%28II%29+complexes+as+GLUT+substrates+for+targeted+therapy%3A+improved+anticancer+efficacy+and+transporter-mediated+cytotoxic+properties&doi=10.1039%2Fc3cc38589b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Highly water-soluble platinum(II) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties</span></div><div class="casAuthors">Liu, Pengxing; Lu, Yanhui; Gao, Xiangqian; Liu, Ran; Zhang-Negrerie, Daisy; Shi, Ying; Wang, Yiqiang; Wang, Songqing; Gao, Qingzhi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2421-2423</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Glucose-conjugated malonato Pt(II) R,R-cyclohexanediamine complexes are designed and synthesized to target tumor-specific active transporters, namely, glucose transporters (GLUTs).  The complexes exhibit much higher aq. soly. by 150 times, improved potency in cytotoxicities by 10 times, and increased therapeutic index by over 30 fold compared to the newest generation of clin. drugs oxaliplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGbUs-f_ZR-LVg90H21EOLACvtfcHk0ljfQYjlWKJphQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVClt7w%253D&md5=dc9b30b67047b8b9797965e40eff516f</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1039%2Fc3cc38589b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cc38589b%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DZhang-Negrerie%26aufirst%3DD.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DQ.%26atitle%3DHighly%2520water-soluble%2520platinum%2528II%2529%2520complexes%2520as%2520GLUT%2520substrates%2520for%2520targeted%2520therapy%253A%2520improved%2520anticancer%2520efficacy%2520and%2520transporter-mediated%2520cytotoxic%2520properties%26jtitle%3DChem.%2520Commun.%26date%3D2013%26volume%3D49%26spage%3D2421%26epage%3D2423%26doi%3D10.1039%2Fc3cc38589b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span> </span><span class="NLM_article-title">Glucose conjugated platinum(II) complex: antitumor superiority to oxaliplatin, combination effect and mechanism of action</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.ejmech.2015.07.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2015&pages=400-408&author=H.+Liauthor=X.+Gaoauthor=R.+Liuauthor=Y.+Wangauthor=M.+Zhangauthor=Z.+Fuauthor=Y.+Miauthor=Y.+Wangauthor=Z.+Yaoauthor=Q.+Gao&title=Glucose+conjugated+platinum%28II%29+complex%3A+antitumor+superiority+to+oxaliplatin%2C+combination+effect+and+mechanism+of+action&doi=10.1016%2Fj.ejmech.2015.07.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DZ.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DQ.%26atitle%3DGlucose%2520conjugated%2520platinum%2528II%2529%2520complex%253A%2520antitumor%2520superiority%2520to%2520oxaliplatin%252C%2520combination%2520effect%2520and%2520mechanism%2520of%2520action%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D101%26spage%3D400%26epage%3D408%26doi%3D10.1016%2Fj.ejmech.2015.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Möker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiem, J.</span><span> </span><span class="NLM_article-title">Synthesis and hydrolysis studies of novel glyco-functionalized platinum complexes</span> <span class="citation_source-journal">Carbohydr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1016/j.carres.2011.08.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.carres.2011.08.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2012&pages=14-26&author=J.+M%C3%B6kerauthor=J.+Thiem&title=Synthesis+and+hydrolysis+studies+of+novel+glyco-functionalized+platinum+complexes&doi=10.1016%2Fj.carres.2011.08.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1016%2Fj.carres.2011.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.carres.2011.08.024%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ker%26aufirst%3DJ.%26aulast%3DThiem%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520hydrolysis%2520studies%2520of%2520novel%2520glyco-functionalized%2520platinum%2520complexes%26jtitle%3DCarbohydr.%2520Res.%26date%3D2012%26volume%3D348%26spage%3D14%26epage%3D26%26doi%3D10.1016%2Fj.carres.2011.08.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Hartinger, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazarov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashraf, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keppler, B. K.</span><span> </span><span class="NLM_article-title">Carbohydrate-metal complexes and their potential as anticancer agents</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2574</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span><span class="refDoi"> DOI: 10.2174/092986708785908978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.2174%2F092986708785908978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=18855680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SgtbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=2574-2591&author=C.+G.+Hartingerauthor=A.+A.+Nazarovauthor=S.+M.+Ashrafauthor=P.+J.+Dysonauthor=B.+K.+Keppler&title=Carbohydrate-metal+complexes+and+their+potential+as+anticancer+agents&doi=10.2174%2F092986708785908978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8eR"><div class="casContent"><span class="casTitleNuber">8e</span><div class="casTitle"><span class="NLM_cas:atitle">Carbohydrate-metal complexes and their potential as anticancer agents</span></div><div class="casAuthors">Hartinger, Christian G.; Nazarov, Alexey A.; Ashraf, Shaheen M.; Dyson, Paul J.; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2574-2591</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Platinum complex-based chemotherapy is one of the major treatment options of many malignancies.  Although severe side effects occur, and only a limited spectrum of tumors can be cured, Pt compds. are used in every second therapy scheme.  Thus, many different drug design strategies have been employed for improving the properties of anticancer drugs including pH or redox activation in the tumor, variation of the metal center and therefore the redox and ligand exchange properties, the application of multinuclear metal complexes, the development of targeted approaches, etc.  Application of carbohydrate-metal complexes is an example of a targeted approach exploiting the biochem. and metabolic functions of diverse sugars in living organisms for transport and accumulation.  Natural carbohydrates and synthetic derivs. possess a manifold of donors endowing them with the ability to coordinate metal centers and providing some addnl. advantages over other ligands, e.g., biocompatibility, nontoxicity, enantiomeric purity, water soly., and well-explored chem.  In recent years, several examples of carbohydrate compds. have been developed for diverse medicinal applications ranging from compds. with antibiotic, antiviral, or fungicidal activity and anticancer compds.  Herein, metal complexes with carbohydrate ligands are reviewed and the role of the carbohydrate carriers on the antineoplastic activity of these compds., both in vitro and in vivo, is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDKAg8Ljvhn7Vg90H21EOLACvtfcHk0ljj-ym5GWshJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SgtbbE&md5=388b8fe1af336b577f234f79f3b6ba3b</span></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.2174%2F092986708785908978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708785908978%26sid%3Dliteratum%253Aachs%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DNazarov%26aufirst%3DA.%2BA.%26aulast%3DAshraf%26aufirst%3DS.%2BM.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DCarbohydrate-metal%2520complexes%2520and%2520their%2520potential%2520as%2520anticancer%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D2574%26epage%3D2591%26doi%3D10.2174%2F092986708785908978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Patra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suntharalingam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">A potent glucose–platinum conjugate exploits glucose transporters and preferentially accumulates in cancer cells</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2550</span><span class="NLM_x">–</span> <span class="NLM_lpage">2554</span><span class="refDoi"> DOI: 10.1002/anie.201510551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2Fanie.201510551" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=2550-2554&author=M.+Patraauthor=T.+C.+Johnstoneauthor=K.+Suntharalingamauthor=S.+J.+Lippard&title=A+potent+glucose%E2%80%93platinum+conjugate+exploits+glucose+transporters+and+preferentially+accumulates+in+cancer+cells&doi=10.1002%2Fanie.201510551"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=10.1002%2Fanie.201510551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201510551%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DM.%26aulast%3DJohnstone%26aufirst%3DT.%2BC.%26aulast%3DSuntharalingam%26aufirst%3DK.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DA%2520potent%2520glucose%25E2%2580%2593platinum%2520conjugate%2520exploits%2520glucose%2520transporters%2520and%2520preferentially%2520accumulates%2520in%2520cancer%2520cells%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D2550%26epage%3D2554%26doi%3D10.1002%2Fanie.201510551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Patra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awuah, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Chemical approach to positional isomers of glucose platinum conjugates reveals specific cancer targeting through glucose-transporter mediated uptake in vitro and in vivo</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">12541</span><span class="NLM_x">–</span> <span class="NLM_lpage">12551</span><span class="refDoi"> DOI: 10.1021/jacs.6b06937</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b06937" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=12541-12551&author=M.+Patraauthor=S.+G.+Awuahauthor=S.+J.+Lippard&title=Chemical+approach+to+positional+isomers+of+glucose+platinum+conjugates+reveals+specific+cancer+targeting+through+glucose-transporter+mediated+uptake+in+vitro+and+in+vivo&doi=10.1021%2Fjacs.6b06937"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8g&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b06937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b06937%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DM.%26aulast%3DAwuah%26aufirst%3DS.%2BG.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DChemical%2520approach%2520to%2520positional%2520isomers%2520of%2520glucose%2520platinum%2520conjugates%2520reveals%2520specific%2520cancer%2520targeting%2520through%2520glucose-transporter%2520mediated%2520uptake%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26spage%3D12541%26epage%3D12551%26doi%3D10.1021%2Fjacs.6b06937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span> </span><span class="NLM_article-title">Glycosylated platinum(IV) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects</span> <span class="citation_source-journal">Dalton Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">11830</span><span class="NLM_x">–</span> <span class="NLM_lpage">11838</span><span class="refDoi"> DOI: 10.1039/C6DT02207C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1039%2FC6DT02207C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=27373800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGnsLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=11830-11838&author=J.+Maauthor=Q.+Wangauthor=X.+Yangauthor=W.+Haoauthor=Z.+Huangauthor=J.+Zhangauthor=X.+Wangauthor=P.+Wang&title=Glycosylated+platinum%28IV%29+prodrugs+demonstrated+significant+therapeutic+efficacy+in+cancer+cells+and+minimized+side-effects&doi=10.1039%2FC6DT02207C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8hR"><div class="casContent"><span class="casTitleNuber">8h</span><div class="casTitle"><span class="NLM_cas:atitle">Glycosylated platinum(IV) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects</span></div><div class="casAuthors">Ma, Jing; Wang, Qingpeng; Yang, Xiande; Hao, Wenpei; Huang, Zhonglv; Zhang, Jiabao; Wang, Xin; Wang, Peng George</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">11830-11838</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Conjugates (A1-A5) of the Pt(IV) deriv. (A6) with amino groups from peracetyl glucose, rhamnose and mannose with a Pr amino or Et amino linker at the reducing end were synthesized and exhibited significant therapeutic efficacy in tumor cells, esp. for prostate cancer (PCa).  The antitumor activities are greatly affected by glycosyl groups.  Cytotoxic expts. in vitro indicated that the antitumor activities were increased by 5-fold when its Pt(IV) deriv. was conjugated to S18 (IC50 = 4.82 ± 0.45 μM) and by 12-fold when conjugated to S21 (IC50 = 1.9 ± 0.67 μM).  The mannose substituted Pt(IV) complexes A4 and A5 were also over an order of magnitude more potent towards HeLa, A549, MCF-7 and PC3 than cisplatin and oxaliplatin.  Importantly, the glycosylated Pt(IV) derivs. A4 and A5 displayed potential safety for clin. therapeutic exposure with IC50 of 84 μM and 169 μM compared with cisplatin (IC50 = 8 μM) to 3T3.  Cellular uptake and DNA platination are higher than cisplatin and oxaliplatin.  ESI-MS anal. of A5 binding to 5'-dGMP revealed that bifunctional DNA lesions were formed.  The antitumor activities in vivo showed that the MTD and LD50 for A4 and A5 are nearly 4-fold higher than that of oxaliplatin indicating the potential safety for the glycosylated Pt(IV) complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3OOKQeJIPAbVg90H21EOLACvtfcHk0lir94CcaV2R5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGnsLvO&md5=b982d491d8176b4dc24c43cc97621d07</span></div><a href="/servlet/linkout?suffix=cit8h&amp;dbid=16384&amp;doi=10.1039%2FC6DT02207C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6DT02207C%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DHao%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DP.%26atitle%3DGlycosylated%2520platinum%2528IV%2529%2520prodrugs%2520demonstrated%2520significant%2520therapeutic%2520efficacy%2520in%2520cancer%2520cells%2520and%2520minimized%2520side-effects%26jtitle%3DDalton%2520Trans.%26date%3D2016%26volume%3D45%26spage%3D11830%26epage%3D11838%26doi%3D10.1039%2FC6DT02207C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of a novel series of glycosylated Platinum(IV) complexes as antitumor agents</span> <span class="citation_source-journal">Dalton Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">10366</span><span class="NLM_x">–</span> <span class="NLM_lpage">10374</span><span class="refDoi"> DOI: 10.1039/C6DT01562J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1039%2FC6DT01562J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8i&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=27252024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot12jt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=10366-10374&author=Q.+Wangauthor=Z.+Huangauthor=J.+Maauthor=X.+Luauthor=L.+Zhangauthor=X.+Wangauthor=P.+G.+Wang&title=Design%2C+synthesis+and+biological+evaluation+of+a+novel+series+of+glycosylated+Platinum%28IV%29+complexes+as+antitumor+agents&doi=10.1039%2FC6DT01562J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8iR"><div class="casContent"><span class="casTitleNuber">8i</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of a novel series of glycosylated platinum(IV) complexes as antitumor agents</span></div><div class="casAuthors">Wang, Qingpeng; Huang, Zhonglv; Ma, Jing; Lu, Xiaolin; Zhang, Li; Wang, Xin; Peng, George Wang</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">10366-10374</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A new series of glycosylated Pt(IV) complexes were designed, synthesized and evaluated for antitumor activities in vitro and in vivo.  The incorporation of glycosyl groups to the Pt(IV) system has much influence on the antitumor abilities.  Four lead compds. with activities comparable or even superior to cisplatin and oxaliplatin are screened out.  These Pt(IV) complexes could be reduced to release Pt(II) complexes and cause the death of tumor cells.  The apoptosis-inducing properties of these compds. are similar to cisplatin.  The accumulation of the glycosylated Pt(IV) complexes in cells and DNA is higher than cisplatin and oxaliplatin.  The in vivo assay demonstrates that the tested compds. inhibit the growth of HepG2 tumors with low toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgpmOlnnEHmbVg90H21EOLACvtfcHk0lir94CcaV2R5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot12jt78%253D&md5=afb0024161b9623d4dfa664eb41a7366</span></div><a href="/servlet/linkout?suffix=cit8i&amp;dbid=16384&amp;doi=10.1039%2FC6DT01562J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6DT01562J%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DP.%2BG.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520series%2520of%2520glycosylated%2520Platinum%2528IV%2529%2520complexes%2520as%2520antitumor%2520agents%26jtitle%3DDalton%2520Trans.%26date%3D2016%26volume%3D45%26spage%3D10366%26epage%3D10374%26doi%3D10.1039%2FC6DT01562J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Galluzzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senovilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michels, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepp, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castedo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of cisplatin resistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1869</span><span class="NLM_x">–</span> <span class="NLM_lpage">1883</span><span class="refDoi"> DOI: 10.1038/onc.2011.384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1038%2Fonc.2011.384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=21892204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFWrsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=1869-1883&author=L.+Galluzziauthor=L.+Senovillaauthor=I.+Vitaleauthor=J.+Michelsauthor=I.+Martinsauthor=O.+Keppauthor=M.+Castedoauthor=G.+Kroemer&title=Molecular+mechanisms+of+cisplatin+resistance&doi=10.1038%2Fonc.2011.384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of cisplatin resistance</span></div><div class="casAuthors">Galluzzi, L.; Senovilla, L.; Vitale, I.; Michels, J.; Martins, I.; Kepp, O.; Castedo, M.; Kroemer, G.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1869-1883</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Platinum-based drugs, and in particular cis-diamminedichloroplatinum(II) (best known as cisplatin), are employed for the treatment of a wide array of solid malignancies, including testicular, ovarian, head and neck, colorectal, bladder and lung cancers.  Cisplatin exerts anticancer effects via multiple mechanisms, yet its most prominent (and best understood) mode of action involves the generation of DNA lesions followed by the activation of the DNA damage response and the induction of mitochondrial apoptosis.  Despite a consistent rate of initial responses, cisplatin treatment often results in the development of chemoresistance, leading to therapeutic failure.  An intense research has been conducted during the past 30 years and several mechanisms that account for the cisplatin-resistant phenotype of tumor cells have been described.  Here, we provide a systematic discussion of these mechanism by classifying them in alterations (1) that involve steps preceding the binding of cisplatin to DNA (pre-target resistance), (2) that directly relate to DNA-cisplatin adducts (on-target resistance), (3) concerning the lethal signaling pathway(s) elicited by cisplatin-mediated DNA damage (post-target resistance) and (4) affecting mol. circuitries that do not present obvious links with cisplatin-elicited signals (off-target resistance).  As in some clin. settings cisplatin constitutes the major therapeutic option, the development of chemosensitization strategies constitute a goal with important clin. implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxTrgUhh4V17Vg90H21EOLACvtfcHk0lir94CcaV2R5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFWrsr7E&md5=4f947e6d5b834673b819e88b06309a53</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.384%26sid%3Dliteratum%253Aachs%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DSenovilla%26aufirst%3DL.%26aulast%3DVitale%26aufirst%3DI.%26aulast%3DMichels%26aufirst%3DJ.%26aulast%3DMartins%26aufirst%3DI.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DCastedo%26aufirst%3DM.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMolecular%2520mechanisms%2520of%2520cisplatin%2520resistance%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26spage%3D1869%26epage%3D1883%26doi%3D10.1038%2Fonc.2011.384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wexselblatt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yavin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, D.</span><span> </span><span class="NLM_article-title">Review: cellular interactions of platinum drugs</span> <span class="citation_source-journal">Inorg. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span><span class="refDoi"> DOI: 10.1016/j.ica.2012.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.ica.2012.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1emu7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=2012&pages=75-83&author=E.+Wexselblattauthor=E.+Yavinauthor=D.+Gibson&title=Review%3A+cellular+interactions+of+platinum+drugs&doi=10.1016%2Fj.ica.2012.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular interactions of platinum drugs</span></div><div class="casAuthors">Wexselblatt, Ezequiel; Yavin, Eylon; Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Inorganica Chimica Acta</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-83</span>CODEN:
                <span class="NLM_cas:coden">ICHAA3</span>;
        ISSN:<span class="NLM_cas:issn">0020-1693</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  This manuscript represents a crit. review of selected topics relating to the cellular interactions of platinum anticancer drugs.  The intent is not to provide a comprehensive summary of all the work described in the literature but to raise questions and cast doubts about selected topics regarding the approaches taken towards trying to elucidate the event that happens in cancer cells that were exposed to platinum complexes.  The exptl. methods used to study the cellular interactions of platinum complexes are reviewed and the significance of the results obtained from such studies is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4FRKDki-bFLVg90H21EOLACvtfcHk0lja8Suo_Og7yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1emu7fF&md5=54425ed95c14955c9f5f410079606346</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2Fj.ica.2012.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ica.2012.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DWexselblatt%26aufirst%3DE.%26aulast%3DYavin%26aufirst%3DE.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DReview%253A%2520cellular%2520interactions%2520of%2520platinum%2520drugs%26jtitle%3DInorg.%2520Chim.%2520Acta%26date%3D2012%26volume%3D393%26spage%3D75%26epage%3D83%26doi%3D10.1016%2Fj.ica.2012.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W. B.</span><span> </span><span class="NLM_article-title">Application of liposomal technologies for delivery of platinum analogs in oncology</span> <span class="citation_source-journal">Int. J. Nanomed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3309</span><span class="NLM_x">–</span> <span class="NLM_lpage">3319</span><span class="refDoi"> DOI: 10.2147/IJN.S38354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.2147%2FIJN.S38354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=24023517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FosF2jtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=3309-3319&author=D.+M.+Liuauthor=C.+B.+Heauthor=A.+Z.+Wangauthor=W.+B.+Lin&title=Application+of+liposomal+technologies+for+delivery+of+platinum+analogs+in+oncology&doi=10.2147%2FIJN.S38354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Application of liposomal technologies for delivery of platinum analogs in oncology</span></div><div class="casAuthors">Liu Demin; He Chunbai; Wang Andrew Z; Lin Wenbin</div><div class="citationInfo"><span class="NLM_cas:title">International journal of nanomedicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3309-19</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Platinum-based chemotherapy, such as cisplatin, oxaliplatin, and carboplatin, is one of the most widely utilized classes of cancer therapeutics.  While highly effective, the clinical applications of platinum-based drugs are limited by their toxicity profiles as well as suboptimal pharmacokinetic properties.  Therefore, one of the key research areas in oncology has been to develop novel platinum analog drugs and engineer new platinum drug formulations to improve the therapeutic ratio further.  Such efforts have led to the development of platinum analogs including nedaplatin, heptaplatin, and lobaplatin.  Moreover, reformulating platinum drugs using liposomes has resulted in the development of L-NDPP (Aroplatin®), SPI-77, Lipoplatin®, Lipoxal®, and LiPlaCis®.  Liposomes possess several attractive biological activities, including biocompatibility, high drug loading, and improved pharmacokinetics, that are well suited for platinum drug delivery.  In this review, we discuss the various platinum drugs and their delivery using liposome-based drug delivery vehicles.  We compare and contrast the different liposome platforms as well as speculate on the future of platinum drug delivery research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9qo79Plh9RWGmni0r9GoKfW6udTcc2eZ6XATjqxTUU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FosF2jtA%253D%253D&md5=8f8281ea8e2b4bffc63d948c7b960fba</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.2147%2FIJN.S38354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S38354%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%2BM.%26aulast%3DHe%26aufirst%3DC.%2BB.%26aulast%3DWang%26aufirst%3DA.%2BZ.%26aulast%3DLin%26aufirst%3DW.%2BB.%26atitle%3DApplication%2520of%2520liposomal%2520technologies%2520for%2520delivery%2520of%2520platinum%2520analogs%2520in%2520oncology%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2013%26volume%3D8%26spage%3D3309%26epage%3D3319%26doi%3D10.2147%2FIJN.S38354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Haxton, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, H. M.</span><span> </span><span class="NLM_article-title">Polymeric drug delivery of platinum-based anticancer agents</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">2299</span><span class="NLM_x">–</span> <span class="NLM_lpage">2316</span><span class="refDoi"> DOI: 10.1002/jps.21611</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2Fjps.21611" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2009&pages=2299-2316&author=K.+J.+Haxtonauthor=H.+M.+Burt&title=Polymeric+drug+delivery+of+platinum-based+anticancer+agents&doi=10.1002%2Fjps.21611"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1002%2Fjps.21611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21611%26sid%3Dliteratum%253Aachs%26aulast%3DHaxton%26aufirst%3DK.%2BJ.%26aulast%3DBurt%26aufirst%3DH.%2BM.%26atitle%3DPolymeric%2520drug%2520delivery%2520of%2520platinum-based%2520anticancer%2520agents%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D98%26spage%3D2299%26epage%3D2316%26doi%3D10.1002%2Fjps.21611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Min, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. Z.</span><span> </span><span class="NLM_article-title">Gold nanorods for platinum based prodrug delivery</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">8424</span><span class="NLM_x">–</span> <span class="NLM_lpage">8426</span><span class="refDoi"> DOI: 10.1039/c0cc03108a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1039%2Fc0cc03108a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=8424-8426&author=Y.+Z.+Minauthor=C.+Q.+Maoauthor=D.+C.+Xuauthor=J.+Wangauthor=Y.+Z.+Liu&title=Gold+nanorods+for+platinum+based+prodrug+delivery&doi=10.1039%2Fc0cc03108a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1039%2Fc0cc03108a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0cc03108a%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DY.%2BZ.%26aulast%3DMao%26aufirst%3DC.%2BQ.%26aulast%3DXu%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%2BZ.%26atitle%3DGold%2520nanorods%2520for%2520platinum%2520based%2520prodrug%2520delivery%26jtitle%3DChem.%2520Commun.%26date%3D2010%26volume%3D46%26spage%3D8424%26epage%3D8426%26doi%3D10.1039%2Fc0cc03108a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Min, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. Z.</span><span> </span><span class="NLM_article-title">Combating the drug resistance of cisplatin using a platinum prodrug based delivery system</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6742</span><span class="NLM_x">–</span> <span class="NLM_lpage">6747</span><span class="refDoi"> DOI: 10.1002/anie.201201562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2Fanie.201201562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC38Xns1WnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=6742-6747&author=Y.+Z.+Minauthor=C.+Q.+Maoauthor=S.+M.+Chenauthor=G.+L.+Maauthor=J.+Wangauthor=Y.+Z.+Liu&title=Combating+the+drug+resistance+of+cisplatin+using+a+platinum+prodrug+based+delivery+system&doi=10.1002%2Fanie.201201562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10dR"><div class="casContent"><span class="casTitleNuber">10d</span><div class="casTitle"><span class="NLM_cas:atitle">Combating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System</span></div><div class="casAuthors">Min, Yuanzeng; Mao, Cheng-Qiong; Chen, Siming; Ma, Guolin; Wang, Jun; Liu, Yangzhong</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">6742-6747, S6742/1-S6742/10</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors have reported that a platinum(IV) prodrug conjugated with a Pegylated gold nanorods (PEG-GNRs) delivery agent is not affected by the types of cellular resistance that affect other platinum-based drugs.  The authors have shown that cisplatin resistance is assocd. with low expression of Ctr1 and high concns. of GSH and metallothionein in the cisplatin-resistant cells.  The uptake of the Pt-PEG-GNRs conjugate into cells in not affected by low expression levels of Ctr1.  The endocytosis of the Pt-PEG-GNRs conjugate causes it to have a higher cellular uptake into cisplatin-resistant cancer cells than nonconjugated platinum drugs.  The platinum(IV) prodrug that is delivered in the form of the Pt-PEG-GNRs conjugate is more inert than cisplatin in its interaction with the drug deactivation agents glutathione and metallothionein, which are found in high concns. in the cisplatin-resistant cells A549R.  Therefore, this Pt-PEG-GNRs conjugate can overcome cellular resistance assocd. with deactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfHlojtgqiorVg90H21EOLACvtfcHk0lja8Suo_Og7yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xns1WnsLs%253D&md5=b670c3d5584c74127e3afe30ac23ac9a</span></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1002%2Fanie.201201562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201201562%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DY.%2BZ.%26aulast%3DMao%26aufirst%3DC.%2BQ.%26aulast%3DChen%26aufirst%3DS.%2BM.%26aulast%3DMa%26aufirst%3DG.%2BL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%2BZ.%26atitle%3DCombating%2520the%2520drug%2520resistance%2520of%2520cisplatin%2520using%2520a%2520platinum%2520prodrug%2520based%2520delivery%2520system%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D6742%26epage%3D6747%26doi%3D10.1002%2Fanie.201201562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wexselblatt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yavin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, D.</span><span> </span><span class="NLM_article-title">Platinum(IV) prodrugs with haloacetato ligands in the axial positions can undergo hydrolysis under biologically relevant conditions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6059</span><span class="NLM_x">–</span> <span class="NLM_lpage">6062</span><span class="refDoi"> DOI: 10.1002/anie.201300640</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2Fanie.201300640" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6059-6062&author=E.+Wexselblattauthor=E.+Yavinauthor=D.+Gibson&title=Platinum%28IV%29+prodrugs+with+haloacetato+ligands+in+the+axial+positions+can+undergo+hydrolysis+under+biologically+relevant+conditions&doi=10.1002%2Fanie.201300640"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=10.1002%2Fanie.201300640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201300640%26sid%3Dliteratum%253Aachs%26aulast%3DWexselblatt%26aufirst%3DE.%26aulast%3DYavin%26aufirst%3DE.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DPlatinum%2528IV%2529%2520prodrugs%2520with%2520haloacetato%2520ligands%2520in%2520the%2520axial%2520positions%2520can%2520undergo%2520hydrolysis%2520under%2520biologically%2520relevant%2520conditions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D23%26spage%3D6059%26epage%3D6062%26doi%3D10.1002%2Fanie.201300640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Wong, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoong, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagusiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panczyk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ang, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorin, G.</span><span> </span><span class="NLM_article-title">Carbon nanotubes for delivery of small molecule drugs</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1964</span><span class="NLM_x">–</span> <span class="NLM_lpage">2015</span><span class="refDoi"> DOI: 10.1016/j.addr.2013.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.addr.2013.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=23954402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVSgs7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=1964-2015&author=B.+S.+Wongauthor=S.+L.+Yoongauthor=A.+Jagusiakauthor=T.+Panczykauthor=H.+K.+Hoauthor=W.+H.+Angauthor=G.+Pastorin&title=Carbon+nanotubes+for+delivery+of+small+molecule+drugs&doi=10.1016%2Fj.addr.2013.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10fR"><div class="casContent"><span class="casTitleNuber">10f</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon nanotubes for delivery of small molecule drugs</span></div><div class="casAuthors">Wong, Bin Sheng; Yoong, Sia Lee; Jagusiak, Anna; Panczyk, Tomasz; Ho, Han Kiat; Ang, Wee Han; Pastorin, Giorgia</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1964-2015</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the realm of drug delivery, carbon nanotubes (CNTs) have gained tremendous attention as promising nanocarriers, owing to their distinct characteristics, such as high surface area, enhanced cellular uptake and the possibility to be easily conjugated with many therapeutics, including both small mols. and biologics, displaying superior efficacy, enhanced specificity and diminished side effects.  While most CNT-based drug delivery system (DDS) had been engineered to combat cancers, there are also emerging reports that employ CNTs as either the main carrier or adjunct material for the delivery of various non-anticancer drugs.  In this review, the delivery of small mol. drugs is expounded, with special attention paid to the current progress of in vitro and in vivo research involving CNT-based DDSs, before finally concluding with some consideration on inevitable complications that hamper successful disease intervention with CNTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNp6_SqOer3LVg90H21EOLACvtfcHk0ljKv0oL3Grjhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVSgs7nM&md5=daae7a5a9b943877fa2385e87a77166c</span></div><a href="/servlet/linkout?suffix=cit10f&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2013.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2013.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DB.%2BS.%26aulast%3DYoong%26aufirst%3DS.%2BL.%26aulast%3DJagusiak%26aufirst%3DA.%26aulast%3DPanczyk%26aufirst%3DT.%26aulast%3DHo%26aufirst%3DH.%2BK.%26aulast%3DAng%26aufirst%3DW.%2BH.%26aulast%3DPastorin%26aufirst%3DG.%26atitle%3DCarbon%2520nanotubes%2520for%2520delivery%2520of%2520small%2520molecule%2520drugs%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2013%26volume%3D65%26spage%3D1964%26epage%3D2015%26doi%3D10.1016%2Fj.addr.2013.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Oberoi, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nukolova, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabanov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronich, T. K.</span><span> </span><span class="NLM_article-title">Nanocarriers for delivery of platinum anticancer drugs</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1667</span><span class="NLM_x">–</span> <span class="NLM_lpage">1685</span><span class="refDoi"> DOI: 10.1016/j.addr.2013.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.addr.2013.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=24113520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWmurbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=1667-1685&author=H.+S.+Oberoiauthor=N.+V.+Nukolovaauthor=A.+V.+Kabanovauthor=T.+K.+Bronich&title=Nanocarriers+for+delivery+of+platinum+anticancer+drugs&doi=10.1016%2Fj.addr.2013.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10gR"><div class="casContent"><span class="casTitleNuber">10g</span><div class="casTitle"><span class="NLM_cas:atitle">Nanocarriers for delivery of platinum anticancer drugs</span></div><div class="casAuthors">Oberoi, Hardeep S.; Nukolova, Natalia V.; Kabanov, Alexander V.; Bronich, Tatiana K.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">1667-1685</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Platinum based anticancer drugs have revolutionized cancer chemotherapy, and continue to be in widespread clin. use esp. for management of tumors of the ovary, testes, and the head and neck.  However, several dose limiting toxicities assocd. with platinum drug use, partial anti-tumor response in most patients, development of drug resistance, tumor relapse, and many other challenges have severely limited the patient quality of life.  These limitations have motivated an extensive research effort towards development of new strategies for improving platinum therapy.  Nanocarrier-based delivery of platinum compds. is one such area of intense research effort beginning to provide encouraging preclin. and clin. results and may allow the development of the next generation of platinum chemotherapy.  This review highlights current understanding on the pharmacol. and limitations of platinum compds. in clin. use, and provides a comprehensive anal. of various platinum-polymer complexes, micelles, dendrimers, liposomes and other nanoparticles currently under investigation for delivery of platinum drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9t-JIgD2CMrVg90H21EOLACvtfcHk0ljKv0oL3Grjhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWmurbO&md5=25ea0f4f9f5f2712c294c8f37bb541ce</span></div><a href="/servlet/linkout?suffix=cit10g&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2013.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2013.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DOberoi%26aufirst%3DH.%2BS.%26aulast%3DNukolova%26aufirst%3DN.%2BV.%26aulast%3DKabanov%26aufirst%3DA.%2BV.%26aulast%3DBronich%26aufirst%3DT.%2BK.%26atitle%3DNanocarriers%2520for%2520delivery%2520of%2520platinum%2520anticancer%2520drugs%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2013%26volume%3D65%26spage%3D1667%26epage%3D1685%26doi%3D10.1016%2Fj.addr.2013.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span> </span><span class="NLM_article-title">Human serum albumin conjugated nanoparticles for pH and redox-responsive delivery of a prodrug of cisplatin</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">16547</span><span class="NLM_x">–</span> <span class="NLM_lpage">16554</span><span class="refDoi"> DOI: 10.1002/chem.201502756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2Fchem.201502756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=26405808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFGktbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=16547-16554&author=H.+Shiauthor=Q.+Chengauthor=S.+Yuanauthor=X.+Dingauthor=Y.+Liu&title=Human+serum+albumin+conjugated+nanoparticles+for+pH+and+redox-responsive+delivery+of+a+prodrug+of+cisplatin&doi=10.1002%2Fchem.201502756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10hR"><div class="casContent"><span class="casTitleNuber">10h</span><div class="casTitle"><span class="NLM_cas:atitle">Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin</span></div><div class="casAuthors">Shi, Hongdong; Cheng, Qinqin; Yuan, Siming; Ding, Xin; Liu, Yangzhong</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16547-16554</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Platinum anticancer drugs are particularly in need of controlled drug delivery because of their severe side effects.  Platinum(IV) agents are designed as prodrugs to reduce the side effects of platinum(II) drugs; however, premature redn. could limit the effect as a prodrug.  In this work, a highly biocompatible, pH and redox dual-responsive delivery system is prepd. by using hybrid nanoparticles of human serum albumin (HSA) and calcium phosphate (CaP) for the PtIV prodrug of cisplatin.  This conjugate is very stable under extracellular conditions, so that it protects the platinum(IV) prodrug in HSA.  Upon reaching the acidic and hypoxic environment, the platinum drug is released in its active form and is able to bind to the target DNA.  The Pt-HSA/CaP hybrid inhibits the proliferation of various cancer cells more efficiently than cisplatin.  Different cell cycle arrests suggest different cellular responses of the PtIV prodrug in the CaP nanocarrier.  Interestingly, this delivery system demonstrates enhanced cytotoxicity to tumor cells, but not to normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhyedlE3uVpLVg90H21EOLACvtfcHk0lgJnwy5ixF_kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFGktbzK&md5=4f8d82979e4849bd314d625f9afd949f</span></div><a href="/servlet/linkout?suffix=cit10h&amp;dbid=16384&amp;doi=10.1002%2Fchem.201502756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201502756%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DQ.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DHuman%2520serum%2520albumin%2520conjugated%2520nanoparticles%2520for%2520pH%2520and%2520redox-responsive%2520delivery%2520of%2520a%2520prodrug%2520of%2520cisplatin%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2015%26volume%3D21%26spage%3D16547%26epage%3D16554%26doi%3D10.1002%2Fchem.201502756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Zheng, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suntharalingam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">8790</span><span class="NLM_x">–</span> <span class="NLM_lpage">8798</span><span class="refDoi"> DOI: 10.1021/ja5038269</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja5038269" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptl2itrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=8790-8798&author=Y.+R.+Zhengauthor=K.+Suntharalingamauthor=T.+C.+Johnstoneauthor=H.+Yooauthor=W.+Linauthor=J.+G.+Brooksauthor=S.+J.+Lippard&title=Pt%28IV%29+prodrugs+designed+to+bind+non-covalently+to+human+serum+albumin+for+drug+delivery&doi=10.1021%2Fja5038269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery</span></div><div class="casAuthors">Zheng, Yao-Rong; Suntharalingam, Kogularamanan; Johnstone, Timothy C.; Yoo, Hyunsuk; Lin, Wei; Brooks, Jamar G.; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8790-8798</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Albumin is the most abundant protein in human serum and drugs that are administered i.v. inevitably interact with it.  We present here a series of platinum(IV) prodrugs designed specifically to enhance interaction with human serum albumin (HSA) for drug delivery.  This goal is achieved by asym. functionalizing the axial ligands of the prodrug so as to mimic the overall features of a fatty acid.  Systematic variation of the length of the aliph. tail tunes the cellular uptake and, consequently, the cytotoxicity of cis,cis,trans-[Pt(NH3)2Cl2(O2CCH2CH2COOH)(OCONHR)], 4, where R is a linear alkyl group.  Investigation of an analog bearing a fluorophore conjugated to the succinate ligand confirmed that these compds. are reduced by biol. reductants with loss of the axial ligands.  Intracellular release of cisplatin from 4 was further confirmed by observing the characteristic effects of cisplatin on the cell cycle and morphol. following treatment with the prodrug.  The most potent member of series 4, for which R is a hexadecyl chain, interacts with HSA in a 1:1 stoichiometry to form the platinum-protein complex 7.  The interaction is non-covalent and extn. with octanol completely removes the prodrug from an aq. soln. of HSA.  Construct 7 is robust and can be isolated following fast protein liq. chromatog.  The nature of the tight interaction was investigated computationally, and these studies suggest that the prodrug is buried below the surface of the protein.  Consequently, complexation to HSA is able to reduce the rate of redn. of the prodrug by ascorbate.  The lead compd. from series 4 also exhibited significant stability in whole human blood, attributed to its interaction with HSA.  This favorable redox profile, in conjunction with the established nonimmunogenicity, biocompatibility, and enhanced tumor accumulation of HSA, produces a system that holds significant therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOojHJiVKj17Vg90H21EOLACvtfcHk0lgJnwy5ixF_kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptl2itrs%253D&md5=541fe9e155e3f4e2f8d6f61f3d81ee5a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fja5038269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja5038269%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BR.%26aulast%3DSuntharalingam%26aufirst%3DK.%26aulast%3DJohnstone%26aufirst%3DT.%2BC.%26aulast%3DYoo%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DW.%26aulast%3DBrooks%26aufirst%3DJ.%2BG.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DPt%2528IV%2529%2520prodrugs%2520designed%2520to%2520bind%2520non-covalently%2520to%2520human%2520serum%2520albumin%2520for%2520drug%2520delivery%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D8790%26epage%3D8798%26doi%3D10.1021%2Fja5038269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Leu, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chern, J. W.</span><span> </span><span class="NLM_article-title">Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1740</span><span class="NLM_x">–</span> <span class="NLM_lpage">1746</span><span class="refDoi"> DOI: 10.1021/jm701151c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701151c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislKqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1740-1746&author=Y.+L.+Leuauthor=C.+S.+Chenauthor=Y.+J.+Wuauthor=J.+W.+Chern&title=Benzyl+ether-linked+glucuronide+derivative+of+10-hydroxycamptothecin+designed+for+selective+camptothecin-based+anticancer+therapy&doi=10.1021%2Fjm701151c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Benzyl Ether-Linked Glucuronide Derivative of 10-Hydroxycamptothecin Designed for Selective Camptothecin-Based Anticancer Therapy</span></div><div class="casAuthors">Leu, Yu-Ling; Chen, Chien-Shu; Wu, Yih-Jang; Chern, Ji-Wang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1740-1746</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A β-glucuronidase-activated prodrug approach was applied to 10-hydroxycamptothecin, a Camptotheca alkaloid with promising antitumor activity but poor water soly.  A glucuronide prodrug of 10-hydroxycamptothecin I in which glucuronic acid is connected via a self-immolative 3-nitrobenzyl ether linker to the 10-OH group of 10-hydroxycamptothecin was synthesized.  I was 80 times more sol. than 10-hydroxycamptothecin in aq. soln. at pH 4.0 and was stable in human plasma.  I was 10- to 15-fold less toxic than the parent drug to four human tumor cell lines.  In the presence of β-glucuronidase, I could be activated to elicit similar cytotoxicity to the parent drug in tumor cells.  Enzyme kinetic studies showed that Escherichia coli β-glucuronidase had a quite low Km of 0.18 μM for I and exhibited 520 times higher catalytic efficiency for I than for a glucuronide prodrug of 9-aminocamptothecin.  Mol. modeling studies predicted that I would have a higher binding affinity to human β-glucuronidase than that glucuronide prodrug of 9-aminocamptothecin.  Prodrug I may be useful for selective cancer chemotherapy by a prodrug monotherapy (PMT) or antibody-directed enzyme prodrug therapy (ADEPT) strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcP5rY2HD4i7Vg90H21EOLACvtfcHk0lgJnwy5ixF_kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislKqt7k%253D&md5=93a025144bca4b097d7f5e9a8b2f0cea</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjm701151c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701151c%26sid%3Dliteratum%253Aachs%26aulast%3DLeu%26aufirst%3DY.%2BL.%26aulast%3DChen%26aufirst%3DC.%2BS.%26aulast%3DWu%26aufirst%3DY.%2BJ.%26aulast%3DChern%26aufirst%3DJ.%2BW.%26atitle%3DBenzyl%2520ether-linked%2520glucuronide%2520derivative%2520of%252010-hydroxycamptothecin%2520designed%2520for%2520selective%2520camptothecin-based%2520anticancer%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1740%26epage%3D1746%26doi%3D10.1021%2Fjm701151c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sudlow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birkett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, D. N.</span><span> </span><span class="NLM_article-title">Further characterization of specific drug binding sites on human serum albumin</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1052</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1004490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADyaE2sXjslCqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1976&pages=1052-1061&author=G.+Sudlowauthor=D.+J.+Birkettauthor=D.+N.+Wade&title=Further+characterization+of+specific+drug+binding+sites+on+human+serum+albumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Further characterization of specific drug binding sites on human serum albumin</span></div><div class="casAuthors">Sudlow, G.; Birkett, D. J.; Wade, D. N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1052-61</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The fluorescent probes, 5-dimethylaminonaphthalene-1-sulfonamide (I) [1431-39-6] and dansylsarcosine [1093-96-5] function as specific markers for 2 distinct binding sites for anionic drugs on human serum albumin (HSA).  The binding of drugs to site I or II was detected by measuring the displacement of these probes.  The results give an indication of some of the structural features required for binding at these sites.  Stearic acid [57-11-4] binding to HSA induced different conformational changes in the albumin at sites I and II, which were detected by changes in the fluorescence and/or strength of binding of probes specific for the 2 sites.  This provides further evidence for qual. differences between the 2 sites.  The specificity of the sites for particular drugs, even at high drug to albumin ratios, was established, and the specificity and characteristics of the 2 sites on human adult and neonatal sera were shown to be similar to those on cryst. HSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZMQN1NBrHM7Vg90H21EOLACvtfcHk0limBHgA600uTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXjslCqsA%253D%253D&md5=5286ae0da826f2764eb595b22361fe80</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSudlow%26aufirst%3DG.%26aulast%3DBirkett%26aufirst%3DD.%2BJ.%26aulast%3DWade%26aufirst%3DD.%2BN.%26atitle%3DFurther%2520characterization%2520of%2520specific%2520drug%2520binding%2520sites%2520on%2520human%2520serum%2520albumin%26jtitle%3DMol.%2520Pharmacol.%26date%3D1976%26volume%3D12%26spage%3D1052%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Deng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, N.</span><span> </span><span class="NLM_article-title">Crystal structure of the human glucose transporter GLUT1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">510</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span><span class="refDoi"> DOI: 10.1038/nature13306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1038%2Fnature13306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=24847886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFGitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=2014&pages=121-125&author=D.+Dengauthor=C.+Xuauthor=P.+Sunauthor=J.+Wuauthor=C.+Yanauthor=M.+Huauthor=N.+Yan&title=Crystal+structure+of+the+human+glucose+transporter+GLUT1&doi=10.1038%2Fnature13306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human glucose transporter GLUT1</span></div><div class="casAuthors">Deng, Dong; Xu, Chao; Sun, Pengcheng; Wu, Jianping; Yan, Chuangye; Hu, Mingxu; Yan, Nieng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">7503</span>),
    <span class="NLM_cas:pages">121-125</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The glucose transporter GLUT1 catalyzes facilitative diffusion of glucose into erythrocytes and is responsible for glucose supply to the brain and other organs.  Dysfunctional mutations may lead to GLUT1 deficiency syndrome, whereas overexpression of GLUT1 is a prognostic indicator for cancer.  Despite decades of investigation, the structure of GLUT1 remains unknown.  Here we report the crystal structure of human GLUT1 at 3.2 Å resoln.  The full-length protein, which has a canonical major facilitator superfamily fold, is captured in an inward-open conformation.  This structure allows accurate mapping and potential mechanistic interpretation of disease-assocd. mutations in GLUT1.  Structure-based anal. of these mutations provides an insight into the alternating access mechanism of GLUT1 and other members of the sugar porter subfamily.  Structural comparison of the uniporter GLUT1 with its bacterial homolog XylE, a proton-coupled xylose symporter, allows examn. of the transport mechanisms of both passive facilitators and active transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSeBmEBIMIurVg90H21EOLACvtfcHk0limBHgA600uTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFGitL8%253D&md5=b9426a934cddf7347fdc6c9073aa8636</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1038%2Fnature13306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13306%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DN.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520glucose%2520transporter%2520GLUT1%26jtitle%3DNature%26date%3D2014%26volume%3D510%26spage%3D121%26epage%3D125%26doi%3D10.1038%2Fnature13306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovejoy, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shima, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagpacan, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapuk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomini, K. M.</span><span> </span><span class="NLM_article-title">Organic cation transporters are determinants of oxaliplatin cytotoxicity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8847</span><span class="NLM_x">–</span> <span class="NLM_lpage">8857</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-0769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1158%2F0008-5472.CAN-06-0769" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8847-8857&author=S.+Zhangauthor=K.+S.+Lovejoyauthor=J.+E.+Shimaauthor=L.+L.+Lagpacanauthor=Y.+Shuauthor=A.+Lapukauthor=Y.+Chenauthor=T.+Komoriauthor=J.+W.+Grayauthor=X.+Chenauthor=S.+J.+Lippardauthor=K.+M.+Giacomini&title=Organic+cation+transporters+are+determinants+of+oxaliplatin+cytotoxicity&doi=10.1158%2F0008-5472.CAN-06-0769"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-0769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-0769%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DLovejoy%26aufirst%3DK.%2BS.%26aulast%3DShima%26aufirst%3DJ.%2BE.%26aulast%3DLagpacan%26aufirst%3DL.%2BL.%26aulast%3DShu%26aufirst%3DY.%26aulast%3DLapuk%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKomori%26aufirst%3DT.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26aulast%3DGiacomini%26aufirst%3DK.%2BM.%26atitle%3DOrganic%2520cation%2520transporters%2520are%2520determinants%2520of%2520oxaliplatin%2520cytotoxicity%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8847%26epage%3D8857%26doi%3D10.1158%2F0008-5472.CAN-06-0769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Burger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoumaro-Djayoon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boersma, A. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berns, E. M. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathijssen, R. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loos, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiemer, E. A. C.</span><span> </span><span class="NLM_article-title">Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">898</span><span class="NLM_x">–</span> <span class="NLM_lpage">908</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2009.00569.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1111%2Fj.1476-5381.2009.00569.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=20067471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtF2hsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2010&pages=898-908&author=H.+Burgerauthor=A.+Zoumaro-Djayoonauthor=A.+W.+M.+Boersmaauthor=J.+Hellemanauthor=E.+M.+J.+J.+Bernsauthor=R.+H.+J.+Mathijssenauthor=W.+J.+Loosauthor=E.+A.+C.+Wiemer&title=Differential+transport+of+platinum+compounds+by+the+human+organic+cation+transporter+hOCT2+%28hSLC22A2%29&doi=10.1111%2Fj.1476-5381.2009.00569.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)</span></div><div class="casAuthors">Burger, H.; Zoumaro-Djayoon, A.; Boersma, A. W. M.; Helleman, J.; Berns, E. M. J. J.; Mathijssen, R. H. J.; Loos, W. J.; Wiemer, E. A. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">898-908</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background: Solute carriers (SLCs), in particular org. cation transporters (OCTs), have been implicated in the cellular uptake of platinum-contg. anticancer compds.  The activity of these carriers may det. the pharmacokinetics and the severity of side effects, including neuro- and nephrotoxicity of platinum-based chemotherapy.  As decreased drug accumulation is a key mechanism of platinum resistance, SLCs may also contribute to the development of resistance.  Here, we define the role of hSLC22A2 (OCT2) in the cellular uptake of platinum compds.  Exptl. approach: Human embryonic kidney (HEK) 293 cells stably expressing the hSLC22A2 gene (HEK293/hSLC22A2) were used in platinum accumulation studies.  Following a 2 h exposure to various platinum compds. (100 μM), intracellular platinum levels were detd. by flameless at. absorption spectrometry.  Key results: HEK293/hSLC22A2 cells, compared with HEK293/Neo control cells, displayed significant increases in oxaliplatin (28.6-fold), Pt[DACH]Cl2 (20.6-fold), ormaplatin (8.1-fold), tetraplatin (4.5-fold), transplatin (3.7-fold) and cisplatin (1.3-fold), but not carboplatin.  SLC22A2-mediated transport could be inhibited by 1-methyl-4-phenylpyridinium.  Furthermore, hSLC22A2-mediated oxaliplatin and cisplatin accumulation was time- and concn.-dependent, but non-saturable.  Expression of hSLC22A2 in HEK293 cells resulted in enhanced sensitivity to oxaliplatin (12-fold) and cisplatin (1.8-fold).  Although, hSLC22A2 mRNA expression was frequently found in ovarian cancer cell lines, its expression in clin. ovarian cancer specimens (n = 80) was low and did not correlate with the treatment outcome of platinum-based regimens.  Conclusions and implications: The hSLC22A2 drug transporter is a crit. determinant in the uptake and cytotoxicity of various platinum compds., particularly oxaliplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Co2EGGOHCrVg90H21EOLACvtfcHk0limBHgA600uTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtF2hsL0%253D&md5=bde8b1e962d95d69d67b2f194c2ee266</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00569.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00569.x%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DH.%26aulast%3DZoumaro-Djayoon%26aufirst%3DA.%26aulast%3DBoersma%26aufirst%3DA.%2BW.%2BM.%26aulast%3DHelleman%26aufirst%3DJ.%26aulast%3DBerns%26aufirst%3DE.%2BM.%2BJ.%2BJ.%26aulast%3DMathijssen%26aufirst%3DR.%2BH.%2BJ.%26aulast%3DLoos%26aufirst%3DW.%2BJ.%26aulast%3DWiemer%26aufirst%3DE.%2BA.%2BC.%26atitle%3DDifferential%2520transport%2520of%2520platinum%2520compounds%2520by%2520the%2520human%2520organic%2520cation%2520transporter%2520hOCT2%2520%2528hSLC22A2%2529%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D159%26spage%3D898%26epage%3D908%26doi%3D10.1111%2Fj.1476-5381.2009.00569.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jamieson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Structure, recognition, and processing of cisplatin-DNA adducts</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2467</span><span class="NLM_x">–</span> <span class="NLM_lpage">2498</span><span class="refDoi"> DOI: 10.1021/cr980421n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr980421n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADyaK1MXltV2lsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2467-2498&author=E.+R.+Jamiesonauthor=S.+J.+Lippard&title=Structure%2C+recognition%2C+and+processing+of+cisplatin-DNA+adducts&doi=10.1021%2Fcr980421n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, recognition, and processing of cisplatin-DNA adducts</span></div><div class="casAuthors">Jamieson, Elizabeth R.; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2467-2498</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 330 refs. on DNA, the biol. target of the anticancer drugs, and the effects of cisplatin adduct formation on DNA-dependent cellular functions and identification of the proteins that mediate the biol. response of cells to cisplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra6eC00RXB-bVg90H21EOLACvtfcHk0lgFkNhG1pB4yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltV2lsrg%253D&md5=ca3c75db0ad1446f3b28940ce36ac435</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fcr980421n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr980421n%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DE.%2BR.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DStructure%252C%2520recognition%252C%2520and%2520processing%2520of%2520cisplatin-DNA%2520adducts%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26spage%3D2467%26epage%3D2498%26doi%3D10.1021%2Fcr980421n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Warnke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kloft, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galanski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartinger, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keppler, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaehde, U.</span><span> </span><span class="NLM_article-title">Analysis of platinum adducts with DNA nucleotides and nucleosides by capillary electrophoresis coupled to ESI-MS: indications of guanosine 5′-monophosphate O6-N7 chelation</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1543</span><span class="NLM_x">–</span> <span class="NLM_lpage">1549</span><span class="refDoi"> DOI: 10.1002/cbic.200400015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2Fcbic.200400015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1543-1549&author=U.+Warnkeauthor=C.+Rappelauthor=H.+Meierauthor=C.+Kloftauthor=M.+Galanskiauthor=C.+G.+Hartingerauthor=B.+K.+Kepplerauthor=U.+Jaehde&title=Analysis+of+platinum+adducts+with+DNA+nucleotides+and+nucleosides+by+capillary+electrophoresis+coupled+to+ESI-MS%3A+indications+of+guanosine+5%E2%80%B2-monophosphate+O6-N7+chelation&doi=10.1002%2Fcbic.200400015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200400015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200400015%26sid%3Dliteratum%253Aachs%26aulast%3DWarnke%26aufirst%3DU.%26aulast%3DRappel%26aufirst%3DC.%26aulast%3DMeier%26aufirst%3DH.%26aulast%3DKloft%26aufirst%3DC.%26aulast%3DGalanski%26aufirst%3DM.%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26aulast%3DJaehde%26aufirst%3DU.%26atitle%3DAnalysis%2520of%2520platinum%2520adducts%2520with%2520DNA%2520nucleotides%2520and%2520nucleosides%2520by%2520capillary%2520electrophoresis%2520coupled%2520to%2520ESI-MS%253A%2520indications%2520of%2520guanosine%25205%25E2%2580%25B2-monophosphate%2520O6-N7%2520chelation%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D1543%26epage%3D1549%26doi%3D10.1002%2Fcbic.200400015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">van der Veer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reedijk, J.</span><span> </span><span class="NLM_article-title">Reaction products from platinum(IV) amine compounds and 5′-GMP are mainly bis(5′-GMP)platinum(II) amine adducts</span> <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span><span class="refDoi"> DOI: 10.1016/0162-0134(86)80006-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2F0162-0134%2886%2980006-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1986&pages=137-142&author=J.+L.+van+der+Veerauthor=A.+R.+Petersauthor=J.+Reedijk&title=Reaction+products+from+platinum%28IV%29+amine+compounds+and+5%E2%80%B2-GMP+are+mainly+bis%285%E2%80%B2-GMP%29platinum%28II%29+amine+adducts&doi=10.1016%2F0162-0134%2886%2980006-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1016%2F0162-0134%2886%2980006-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0162-0134%252886%252980006-X%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BVeer%26aufirst%3DJ.%2BL.%26aulast%3DPeters%26aufirst%3DA.%2BR.%26aulast%3DReedijk%26aufirst%3DJ.%26atitle%3DReaction%2520products%2520from%2520platinum%2528IV%2529%2520amine%2520compounds%2520and%25205%25E2%2580%25B2-GMP%2520are%2520mainly%2520bis%25285%25E2%2580%25B2-GMP%2529platinum%2528II%2529%2520amine%2520adducts%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D1986%26volume%3D26%26spage%3D137%26epage%3D142%26doi%3D10.1016%2F0162-0134%2886%2980006-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c','cit5d','cit5e','cit5f','cit5g','cit5h','cit5i'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7a','cit7b','cit7c'],'ref8':['cit8a','cit8b','cit8c','cit8d','cit8e','cit8f','cit8g','cit8h','cit8i'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b','cit10c','cit10d','cit10e','cit10f','cit10g','cit10h'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c'],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b','cit14c']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 53 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Cheng-Ru Wu, Yi-Da Huang, Yong-Huei Hong, Ya-Hsin Liu, Manmath Narwane, Yu-Hsiang Chang, Trinh Kieu Dinh, Hsin-Tzu Hsieh, Yi-Jen Hseuh, Ping-Ching Wu, Chih-Wen Pao, Ting-Shan Chan, I-Jui Hsu, Yunching Chen, Hung-Chi Chen, Ting-Yu Chin, <span class="NLM_string-name hlFld-ContribAuthor">Tsai-Te Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Endogenous Conjugation of Biomimetic Dinitrosyl Iron Complex with Protein Vehicles for Oral Delivery of Nitric Oxide to Brain and Activation of Hippocampal Neurogenesis. </span><span class="cited-content_cbyCitation_journal-name">JACS Au</span><span> <strong>2021,</strong> <em>1 </em>
                                    (7)
                                     , 998-1013. <a href="https://doi.org/10.1021/jacsau.1c00160" title="DOI URL">https://doi.org/10.1021/jacsau.1c00160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacsau.1c00160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacsau.1c00160%26sid%3Dliteratum%253Aachs%26jtitle%3DJACS%2520Au%26atitle%3DEndogenous%252BConjugation%252Bof%252BBiomimetic%252BDinitrosyl%252BIron%252BComplex%252Bwith%252BProtein%252BVehicles%252Bfor%252BOral%252BDelivery%252Bof%252BNitric%252BOxide%252Bto%252BBrain%252Band%252BActivation%252Bof%252BHippocampal%252BNeurogenesis%26aulast%3DWu%26aufirst%3DCheng-Ru%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D09042021%26date%3D07062021%26volume%3D1%26issue%3D7%26spage%3D998%26epage%3D1013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vanitha Ramu, Paramita Kundu, Paturu Kondaiah, <span class="NLM_string-name hlFld-ContribAuthor">Akhil R. Chakravarty</span>. </span><span class="cited-content_cbyCitation_article-title">Maloplatin-B, a Cisplatin-Based BODIPY-Tagged Mito-Specific “Chemo-PDT” Agent Active in Red Light. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2021,</strong> <em>60 </em>
                                    (9)
                                     , 6410-6420. <a href="https://doi.org/10.1021/acs.inorgchem.1c00124" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.1c00124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.1c00124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.1c00124%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DMaloplatin-B%25252C%252Ba%252BCisplatin-Based%252BBODIPY-Tagged%252BMito-Specific%252B%2525E2%252580%25259CChemo-PDT%2525E2%252580%25259D%252BAgent%252BActive%252Bin%252BRed%252BLight%26aulast%3DRamu%26aufirst%3DVanitha%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15012021%26date%3D12042021%26volume%3D60%26issue%3D9%26spage%3D6410%26epage%3D6420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alexander Seitz, Raffael C. Wende, Emily Roesner, Dominik Niedek, Christopher Topp, Avene C. Colgan, Eoghan M. McGarrigle, <span class="NLM_string-name hlFld-ContribAuthor">Peter R. Schreiner</span>. </span><span class="cited-content_cbyCitation_article-title">Site-Selective Acylation of Pyranosides with Oligopeptide Catalysts. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (5)
                                     , 3907-3922. <a href="https://doi.org/10.1021/acs.joc.0c02772" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02772%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSite-Selective%252BAcylation%252Bof%252BPyranosides%252Bwith%252BOligopeptide%252BCatalysts%26aulast%3DSeitz%26aufirst%3DAlexander%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D19112020%26date%3D22022021%26volume%3D86%26issue%3D5%26spage%3D3907%26epage%3D3922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nafees Muhammad, Cai-Ping Tan, Uroosa Nawaz, Jie Wang, Fang-Xin Wang, Sadia Nasreen, Liang-Nian Ji, <span class="NLM_string-name hlFld-ContribAuthor">Zong-Wan Mao</span>. </span><span class="cited-content_cbyCitation_article-title">Multiaction Platinum(IV) Prodrug Containing Thymidylate Synthase Inhibitor and Metabolic Modifier against Triple-Negative Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2020,</strong> <em>59 </em>
                                    (17)
                                     , 12632-12642. <a href="https://doi.org/10.1021/acs.inorgchem.0c01736" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.0c01736</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.0c01736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.0c01736%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DMultiaction%252BPlatinum%252528IV%252529%252BProdrug%252BContaining%252BThymidylate%252BSynthase%252BInhibitor%252Band%252BMetabolic%252BModifier%252Bagainst%252BTriple-Negative%252BBreast%252BCancer%26aulast%3DMuhammad%26aufirst%3DNafees%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12062020%26date%3D24082020%26volume%3D59%26issue%3D17%26spage%3D12632%26epage%3D12642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Houzong Yao, Shu Chen, Zhiqin Deng, Man-Kit Tse, Yudai Matsuda, <span class="NLM_string-name hlFld-ContribAuthor">Guangyu Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2020,</strong> <em>59 </em>
                                    (16)
                                     , 11823-11833. <a href="https://doi.org/10.1021/acs.inorgchem.0c01880" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.0c01880</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.0c01880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.0c01880%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DBODI-Pt%25252C%252Ba%252BGreen-Light-Activatable%252Band%252BCarboplatin-Based%252BPlatinum%252528IV%252529%252BAnticancer%252BProdrug%252Bwith%252BEnhanced%252BActivation%252Band%252BCytotoxicity%26aulast%3DYao%26aufirst%3DHouzong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D25062020%26date%3D06082020%26volume%3D59%26issue%3D16%26spage%3D11823%26epage%3D11833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jie Cheng, Wei Zhao, Hui Yao, Yuemao Shen, Youming Zhang, Yue-zhong Li, Qingsheng QI, Kanokpan Wongprasert, <span class="NLM_string-name hlFld-ContribAuthor">Ya-Jie Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4,6-O-Thenylidene-β-d-glucopyranoside-(2″-acetamido, 3″-acetyl-di-S-5-fluorobenzothizole/5-fluorobenzoxazole)-4′-demethylepipodophyllotoxin as Potential Less Toxic Antitumor Candidate Drugs by Reducing DNA Damage and Less Inhibition of PI3K. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 2877-2893. <a href="https://doi.org/10.1021/acs.jmedchem.9b01354" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01354%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4%25252C6-O-Thenylidene-%2525CE%2525B2-d-glucopyranoside-%2525282%2525E2%252580%2525B3-acetamido%25252C%252B3%2525E2%252580%2525B3-acetyl-di-S-5-fluorobenzothizole%25252F5-fluorobenzoxazole%252529-4%2525E2%252580%2525B2-demethylepipodophyllotoxin%252Bas%252BPotential%252BLess%252BToxic%252BAntitumor%252BCandidate%252BDrugs%252Bby%252BReducing%252BDNA%252BDamage%252Band%252BLess%252BInhibition%252Bof%252BPI3K%26aulast%3DCheng%26aufirst%3DJie%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D16082019%26date%3D10032020%26date%3D21022020%26volume%3D63%26issue%3D6%26spage%3D2877%26epage%3D2893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hanfang Liu, Jing Ma, Yingguang Li, Kexin Yue, Linrong Li, Zhuoqing Xi, Xiao Zhang, Jianing Liu, Kai Feng, Qi Ma, Sitong Liu, Shudi Guo, Peng George Wang, Chaojie Wang, <span class="NLM_string-name hlFld-ContribAuthor">Songqiang Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Polyamine-Based Pt(IV) Prodrugs as Substrates for Polyamine Transporters Preferentially Accumulate in Cancer Metastases as DNA and Polyamine Metabolism Dual-Targeted Antimetastatic Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 11324-11334. <a href="https://doi.org/10.1021/acs.jmedchem.9b01641" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01641%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPolyamine-Based%252BPt%252528IV%252529%252BProdrugs%252Bas%252BSubstrates%252Bfor%252BPolyamine%252BTransporters%252BPreferentially%252BAccumulate%252Bin%252BCancer%252BMetastases%252Bas%252BDNA%252Band%252BPolyamine%252BMetabolism%252BDual-Targeted%252BAntimetastatic%252BAgents%26aulast%3DLiu%26aufirst%3DHanfang%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04102019%26date%3D12122019%26date%3D25112019%26volume%3D62%26issue%3D24%26spage%3D11324%26epage%3D11334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Houzong Yao, Zoufeng Xu, Cai Li, Man-Kit Tse, Zixuan Tong, <span class="NLM_string-name hlFld-ContribAuthor">Guangyu Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Cytotoxic Study of a Platinum(IV) Anticancer Prodrug with Selectivity toward Luteinizing Hormone-Releasing Hormone (LHRH) Receptor-Positive Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (16)
                                     , 11076-11084. <a href="https://doi.org/10.1021/acs.inorgchem.9b01583" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.9b01583</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.9b01583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.9b01583%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252BCytotoxic%252BStudy%252Bof%252Ba%252BPlatinum%252528IV%252529%252BAnticancer%252BProdrug%252Bwith%252BSelectivity%252Btoward%252BLuteinizing%252BHormone-Releasing%252BHormone%252B%252528LHRH%252529%252BReceptor-Positive%252BCancer%252BCells%26aulast%3DYao%26aufirst%3DHouzong%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D28052019%26date%3D08082019%26volume%3D58%26issue%3D16%26spage%3D11076%26epage%3D11084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ran Zhang, Xue-Qing Song, Rui-Ping Liu, Zhong-Ying Ma, <span class="NLM_string-name hlFld-ContribAuthor">Jing-Yuan Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Fuplatin: An Efficient and Low-Toxic Dual-Prodrug. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4543-4554. <a href="https://doi.org/10.1021/acs.jmedchem.9b00128" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00128</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00128%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFuplatin%25253A%252BAn%252BEfficient%252Band%252BLow-Toxic%252BDual-Prodrug%26aulast%3DZhang%26aufirst%3DRan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D22012019%26date%3D30042019%26date%3D19042019%26volume%3D62%26issue%3D9%26spage%3D4543%26epage%3D4554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Reece
G. Kenny, <span class="NLM_string-name hlFld-ContribAuthor">Celine J. Marmion</span>. </span><span class="cited-content_cbyCitation_article-title">Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (2)
                                     , 1058-1137. <a href="https://doi.org/10.1021/acs.chemrev.8b00271" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00271%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DToward%252BMulti-Targeted%252BPlatinum%252Band%252BRuthenium%252BDrugs%2525E2%252580%252594A%252BNew%252BParadigm%252Bin%252BCancer%252BDrug%252BTreatment%252BRegimens%25253F%26aulast%3DKenny%26aufirst%3DReece%2BG.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D27042018%26date%3D14012019%26volume%3D119%26issue%3D2%26spage%3D1058%26epage%3D1137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaimaa A.  Khalid</span>, <span class="hlFld-ContribAuthor ">Ahmed S.  Abo Dena</span>, <span class="hlFld-ContribAuthor ">Ibrahim M.  El-Sherbiny</span>. </span><span class="cited-content_cbyCitation_article-title">Biopolymeric-Inorganic Composites for Drug Delivery Applications. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2022,</strong>,, 271-298. <a href="https://doi.org/10.1007/978-3-030-70266-3_9" title="DOI URL">https://doi.org/10.1007/978-3-030-70266-3_9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-70266-3_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-70266-3_9%26sid%3Dliteratum%253Aachs%26atitle%3DBiopolymeric-Inorganic%252BComposites%252Bfor%252BDrug%252BDelivery%252BApplications%26aulast%3DKhalid%26aufirst%3DShaimaa%2BA.%26date%3D2022%26date%3D2021%26spage%3D271%26epage%3D298%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPolymeric%252Band%252BNatural%252BComposites%26aulast%3DHasnain%26aufirst%3DMd%2BSaquib%26date%3D2022%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Ma</span>, <span class="hlFld-ContribAuthor ">Linrong  Li</span>, <span class="hlFld-ContribAuthor ">Kexin  Yue</span>, <span class="hlFld-ContribAuthor ">Zhansheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Shihao  Su</span>, <span class="hlFld-ContribAuthor ">Yutong  Chen</span>, <span class="hlFld-ContribAuthor ">Lu  Yu</span>, <span class="hlFld-ContribAuthor ">Pengfei  Zhang</span>, <span class="hlFld-ContribAuthor ">Ruijuan  Ma</span>, <span class="hlFld-ContribAuthor ">Yingguang  Li</span>, <span class="hlFld-ContribAuthor ">Yinxia  Ma</span>, <span class="hlFld-ContribAuthor ">Huinan  Jia</span>, <span class="hlFld-ContribAuthor ">Chaojie  Wang</span>, <span class="hlFld-ContribAuthor ">Jiajia  Wang</span>, <span class="hlFld-ContribAuthor ">Songqiang  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">A naphthalimide-polyamine conjugate preferentially accumulates in hepatic carcinoma metastases as a lysosome-targeted antimetastatic agent. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113469. <a href="https://doi.org/10.1016/j.ejmech.2021.113469" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113469</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113469%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bnaphthalimide-polyamine%252Bconjugate%252Bpreferentially%252Baccumulates%252Bin%252Bhepatic%252Bcarcinoma%252Bmetastases%252Bas%252Ba%252Blysosome-targeted%252Bantimetastatic%252Bagent%26aulast%3DMa%26aufirst%3DJing%26date%3D2021%26volume%3D221%26spage%3D113469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zoufeng  Xu</span>, <span class="hlFld-ContribAuthor ">Zhigang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhiqin  Deng</span>, <span class="hlFld-ContribAuthor ">Guangyu  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2021,</strong> <em>442 </em>, 213991. <a href="https://doi.org/10.1016/j.ccr.2021.213991" title="DOI URL">https://doi.org/10.1016/j.ccr.2021.213991</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2021.213991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2021.213991%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bsynthesis%25252C%252Bstability%25252C%252Band%252Bactivation%252Bof%252Bplatinum%252528IV%252529%252Banticancer%252Bprodrugs%26aulast%3DXu%26aufirst%3DZoufeng%26date%3D2021%26volume%3D442%26spage%3D213991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan  Gibson</span>. </span><span class="cited-content_cbyCitation_article-title">Pt(IV) Anticancer Prodrugs – A Tale of Mice and Men. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em> </em><a href="https://doi.org/10.1002/cmdc.202100115" title="DOI URL">https://doi.org/10.1002/cmdc.202100115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100115%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DPt%252528IV%252529%252BAnticancer%252BProdrugs%252B%2525E2%252580%252593%252BA%252BTale%252Bof%252BMice%252Band%252BMen%26aulast%3DGibson%26aufirst%3DDan%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan  Gibson</span>. </span><span class="cited-content_cbyCitation_article-title">Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2021,</strong> <em>217 </em>, 111353. <a href="https://doi.org/10.1016/j.jinorgbio.2020.111353" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2020.111353</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2020.111353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2020.111353%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DPlatinum%252528IV%252529%252Banticancer%252Bagents%25253B%252Bare%252Bwe%252Ben%252Broute%252Bto%252Bthe%252Bholy%252Bgrail%252Bor%252Bto%252Ba%252Bdead%252Bend%25253F%26aulast%3DGibson%26aufirst%3DDan%26date%3D2021%26volume%3D217%26spage%3D111353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vanitha  Ramu</span>, <span class="hlFld-ContribAuthor ">Paramita  Kundu</span>, <span class="hlFld-ContribAuthor ">Aarti  Upadhyay</span>, <span class="hlFld-ContribAuthor ">Paturu  Kondaiah</span>, <span class="hlFld-ContribAuthor ">Akhil R.  Chakravarty</span>. </span><span class="cited-content_cbyCitation_article-title">Lysosome Specific Platinum(II) Catecholates with Photoactive BODIPY for Imaging and Photodynamic Therapy in Near‐IR Light. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Inorganic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (9)
                                     , 831-839. <a href="https://doi.org/10.1002/ejic.202001146" title="DOI URL">https://doi.org/10.1002/ejic.202001146</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejic.202001146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejic.202001146%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Inorganic%2520Chemistry%26atitle%3DLysosome%252BSpecific%252BPlatinum%252528II%252529%252BCatecholates%252Bwith%252BPhotoactive%252BBODIPY%252Bfor%252BImaging%252Band%252BPhotodynamic%252BTherapy%252Bin%252BNear%2525E2%252580%252590IR%252BLight%26aulast%3DRamu%26aufirst%3DVanitha%26date%3D2021%26date%3D2021%26volume%3D2021%26issue%3D9%26spage%3D831%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rudra  Pangeni</span>, <span class="hlFld-ContribAuthor ">Soim  Kang</span>, <span class="hlFld-ContribAuthor ">Saurav Kumar  Jha</span>, <span class="hlFld-ContribAuthor ">Laxman  Subedi</span>, <span class="hlFld-ContribAuthor ">Jin Woo  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Intestinal membrane transporter-mediated approaches to improve oral drug delivery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical Investigation</span><span> <strong>2021,</strong> <em>51 </em>
                                    (2)
                                     , 137-158. <a href="https://doi.org/10.1007/s40005-021-00515-1" title="DOI URL">https://doi.org/10.1007/s40005-021-00515-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40005-021-00515-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40005-021-00515-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520Investigation%26atitle%3DIntestinal%252Bmembrane%252Btransporter-mediated%252Bapproaches%252Bto%252Bimprove%252Boral%252Bdrug%252Bdelivery%26aulast%3DPangeni%26aufirst%3DRudra%26date%3D2021%26date%3D2021%26volume%3D51%26issue%3D2%26spage%3D137%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheng  Zeng</span>, <span class="hlFld-ContribAuthor ">Hanlin  Ou</span>, <span class="hlFld-ContribAuthor ">Zhiyuan  Gao</span>, <span class="hlFld-ContribAuthor ">Jingtian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chuang  Li</span>, <span class="hlFld-ContribAuthor ">Qian  Liu</span>, <span class="hlFld-ContribAuthor ">Dan  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">HCPT-peptide prodrug with tumor microenvironment -responsive morphology transformable characteristic for boosted bladder tumor chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Controlled Release</span><span> <strong>2021,</strong> <em>330 </em>, 715-725. <a href="https://doi.org/10.1016/j.jconrel.2020.12.042" title="DOI URL">https://doi.org/10.1016/j.jconrel.2020.12.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jconrel.2020.12.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jconrel.2020.12.042%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Controlled%2520Release%26atitle%3DHCPT-peptide%252Bprodrug%252Bwith%252Btumor%252Bmicroenvironment%252B-responsive%252Bmorphology%252Btransformable%252Bcharacteristic%252Bfor%252Bboosted%252Bbladder%252Btumor%252Bchemotherapy%26aulast%3DZeng%26aufirst%3DSheng%26date%3D2021%26volume%3D330%26spage%3D715%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Bononi</span>, <span class="hlFld-ContribAuthor ">Dalila  Iacopini</span>, <span class="hlFld-ContribAuthor ">Gaspare  Cicio</span>, <span class="hlFld-ContribAuthor ">Sebastiano  Di Pietro</span>, <span class="hlFld-ContribAuthor ">Carlotta  Granchi</span>, <span class="hlFld-ContribAuthor ">Valeria  Di Bussolo</span>, <span class="hlFld-ContribAuthor ">Filippo  Minutolo</span>. </span><span class="cited-content_cbyCitation_article-title">Glycoconjugated Metal Complexes as Cancer Diagnostic and Therapeutic Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (1)
                                     , 30-64. <a href="https://doi.org/10.1002/cmdc.202000456" title="DOI URL">https://doi.org/10.1002/cmdc.202000456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000456%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DGlycoconjugated%252BMetal%252BComplexes%252Bas%252BCancer%252BDiagnostic%252Band%252BTherapeutic%252BAgents%26aulast%3DBononi%26aufirst%3DGiulia%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D1%26spage%3D30%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhifang  Liu</span>, <span class="hlFld-ContribAuthor ">Zuojie  Li</span>, <span class="hlFld-ContribAuthor ">Tao  Du</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Qingpeng  Wang</span>, <span class="hlFld-ContribAuthor ">Guoshuai  Li</span>, <span class="hlFld-ContribAuthor ">Min  Liu</span>, <span class="hlFld-ContribAuthor ">Ning  Zhang</span>, <span class="hlFld-ContribAuthor ">Dacheng  Li</span>, <span class="hlFld-ContribAuthor ">Jun  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of dihydro-2-quinolone platinum(
              iv
              ) hybrids as antitumor agents displaying mitochondria injury and DNA damage mechanism. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2021,</strong> <em>50 </em>
                                    (1)
                                     , 362-375. <a href="https://doi.org/10.1039/D0DT03194A" title="DOI URL">https://doi.org/10.1039/D0DT03194A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT03194A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT03194A%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bdihydro-2-quinolone%252Bplatinum%252528%252Biv%252B%252529%252Bhybrids%252Bas%252Bantitumor%252Bagents%252Bdisplaying%252Bmitochondria%252Binjury%252Band%252BDNA%252Bdamage%252Bmechanism%26aulast%3DLiu%26aufirst%3DZhifang%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D1%26spage%3D362%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shubham  Khot</span>, <span class="hlFld-ContribAuthor ">Shruti U.  Rawal</span>, <span class="hlFld-ContribAuthor ">Mayur M.  Patel</span>. </span><span class="cited-content_cbyCitation_article-title">Dissolvable-soluble or biodegradable polymers. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 367-394. <a href="https://doi.org/10.1016/B978-0-12-819838-4.00024-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-819838-4.00024-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-819838-4.00024-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-819838-4.00024-9%26sid%3Dliteratum%253Aachs%26atitle%3DDissolvable-soluble%252Bor%252Bbiodegradable%252Bpolymers%26aulast%3DKhot%26aufirst%3DShubham%26date%3D2021%26spage%3D367%26epage%3D394%26pub%3DElsevier%26atitle%3DDrug%252BDelivery%252BDevices%252Band%252BTherapeutic%252BSystems%26date%3D2021%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrycja  Golińska</span>. </span><span class="cited-content_cbyCitation_article-title">Biopolymer-based nanofilms: Utility and toxicity. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 353-385. <a href="https://doi.org/10.1016/B978-0-12-823381-8.00014-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-823381-8.00014-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-823381-8.00014-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-823381-8.00014-4%26sid%3Dliteratum%253Aachs%26atitle%3DBiopolymer-based%252Bnanofilms%25253A%252BUtility%252Band%252Btoxicity%26aulast%3DGoli%25C5%2584ska%26aufirst%3DPatrycja%26date%3D2021%26spage%3D353%26epage%3D385%26pub%3DElsevier%26atitle%3DBiopolymer-Based%252BNano%252BFilms%26date%3D2021%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junjie  Fu</span>, <span class="hlFld-ContribAuthor ">Jiaxin  Yang</span>, <span class="hlFld-ContribAuthor ">Peter H.  Seeberger</span>, <span class="hlFld-ContribAuthor ">Jian  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Glycoconjugates for glucose transporter-mediated cancer-specific targeting and treatment. </span><span class="cited-content_cbyCitation_journal-name">Carbohydrate Research</span><span> <strong>2020,</strong> <em>498 </em>, 108195. <a href="https://doi.org/10.1016/j.carres.2020.108195" title="DOI URL">https://doi.org/10.1016/j.carres.2020.108195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.carres.2020.108195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.carres.2020.108195%26sid%3Dliteratum%253Aachs%26jtitle%3DCarbohydrate%2520Research%26atitle%3DGlycoconjugates%252Bfor%252Bglucose%252Btransporter-mediated%252Bcancer-specific%252Btargeting%252Band%252Btreatment%26aulast%3DFu%26aufirst%3DJunjie%26date%3D2020%26volume%3D498%26spage%3D108195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingguang  Li</span>, <span class="hlFld-ContribAuthor ">Kexin  Yue</span>, <span class="hlFld-ContribAuthor ">Linrong  Li</span>, <span class="hlFld-ContribAuthor ">Jie  Niu</span>, <span class="hlFld-ContribAuthor ">Hanfang  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Ma</span>, <span class="hlFld-ContribAuthor ">Songqiang  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">A Pt(IV)-based mononitro-naphthalimide conjugate with minimized side-effects targeting DNA damage response via a dual-DNA-damage approach to overcome cisplatin resistance. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>101 </em>, 104011. <a href="https://doi.org/10.1016/j.bioorg.2020.104011" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DA%252BPt%252528IV%252529-based%252Bmononitro-naphthalimide%252Bconjugate%252Bwith%252Bminimized%252Bside-effects%252Btargeting%252BDNA%252Bdamage%252Bresponse%252Bvia%252Ba%252Bdual-DNA-damage%252Bapproach%252Bto%252Bovercome%252Bcisplatin%252Bresistance%26aulast%3DLi%26aufirst%3DYingguang%26date%3D2020%26volume%3D101%26spage%3D104011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Ma</span>, <span class="hlFld-ContribAuthor ">Linrong  Li</span>, <span class="hlFld-ContribAuthor ">Kexin  Yue</span>, <span class="hlFld-ContribAuthor ">Yingguang  Li</span>, <span class="hlFld-ContribAuthor ">Hanfang  Liu</span>, <span class="hlFld-ContribAuthor ">Peng George  Wang</span>, <span class="hlFld-ContribAuthor ">Chaojie  Wang</span>, <span class="hlFld-ContribAuthor ">Jiajia  Wang</span>, <span class="hlFld-ContribAuthor ">Wen  Luo</span>, <span class="hlFld-ContribAuthor ">Songqiang  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Bromocoumarinplatin, targeting simultaneously mitochondria and nuclei with p53 apoptosis pathway to overcome cisplatin resistance. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103768. <a href="https://doi.org/10.1016/j.bioorg.2020.103768" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103768</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103768%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DBromocoumarinplatin%25252C%252Btargeting%252Bsimultaneously%252Bmitochondria%252Band%252Bnuclei%252Bwith%252Bp53%252Bapoptosis%252Bpathway%252Bto%252Bovercome%252Bcisplatin%252Bresistance%26aulast%3DMa%26aufirst%3DJing%26date%3D2020%26volume%3D99%26spage%3D103768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleen  Khoury</span>, <span class="hlFld-ContribAuthor ">Krishant M.  Deo</span>, <span class="hlFld-ContribAuthor ">Janice R.  Aldrich-Wright</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2020,</strong> <em>207 </em>, 111070. <a href="https://doi.org/10.1016/j.jinorgbio.2020.111070" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2020.111070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2020.111070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2020.111070%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DRecent%252Badvances%252Bin%252Bplatinum-based%252Bchemotherapeutics%252Bthat%252Bexhibit%252Binhibitory%252Band%252Btargeted%252Bmechanisms%252Bof%252Baction%26aulast%3DKhoury%26aufirst%3DAleen%26date%3D2020%26volume%3D207%26spage%3D111070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiajia  Wang</span>, <span class="hlFld-ContribAuthor ">Yinhang  Wen</span>, <span class="hlFld-ContribAuthor ">Lu  Zheng</span>, <span class="hlFld-ContribAuthor ">Biao  Dou</span>, <span class="hlFld-ContribAuthor ">Linrong  Li</span>, <span class="hlFld-ContribAuthor ">Kangkang  Zhao</span>, <span class="hlFld-ContribAuthor ">Na  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of chemical profiles of pH-sensitive cleavable D-gluconhydroximo-1, 5-lactam hydrolysates by LC–MS: A potential agent for promoting tumor-targeted drug delivery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2020,</strong> <em>185 </em>, 113244. <a href="https://doi.org/10.1016/j.jpba.2020.113244" title="DOI URL">https://doi.org/10.1016/j.jpba.2020.113244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2020.113244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2020.113244%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DCharacterization%252Bof%252Bchemical%252Bprofiles%252Bof%252BpH-sensitive%252Bcleavable%252BD-gluconhydroximo-1%25252C%252B5-lactam%252Bhydrolysates%252Bby%252BLC%2525E2%252580%252593MS%25253A%252BA%252Bpotential%252Bagent%252Bfor%252Bpromoting%252Btumor-targeted%252Bdrug%252Bdelivery%26aulast%3DWang%26aufirst%3DJiajia%26date%3D2020%26volume%3D185%26spage%3D113244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Qingpeng  Wang</span>, <span class="hlFld-ContribAuthor ">Zuojie  Li</span>, <span class="hlFld-ContribAuthor ">Zhifang  Liu</span>, <span class="hlFld-ContribAuthor ">Yanna  Zhao</span>, <span class="hlFld-ContribAuthor ">Junfeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Min  Liu</span>, <span class="hlFld-ContribAuthor ">Zhengping  Wang</span>, <span class="hlFld-ContribAuthor ">Dacheng  Li</span>, <span class="hlFld-ContribAuthor ">Jun  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Naproxen platinum(
              iv
              ) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents
              in vitro
              and
              in vivo. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2020,</strong> <em>49 </em>
                                    (16)
                                     , 5192-5204. <a href="https://doi.org/10.1039/D0DT00424C" title="DOI URL">https://doi.org/10.1039/D0DT00424C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT00424C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT00424C%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DNaproxen%252Bplatinum%252528%252Biv%252B%252529%252Bhybrids%252Binhibiting%252Bcycloxygenases%252Band%252Bmatrix%252Bmetalloproteinases%252Band%252Bcausing%252BDNA%252Bdamage%25253A%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bas%252Bantitumor%252Bagents%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DChen%26aufirst%3DYan%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D16%26spage%3D5192%26epage%3D5204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Ma</span>, <span class="hlFld-ContribAuthor ">Yingguang  Li</span>, <span class="hlFld-ContribAuthor ">Linrong  Li</span>, <span class="hlFld-ContribAuthor ">Kexin  Yue</span>, <span class="hlFld-ContribAuthor ">Hanfang  Liu</span>, <span class="hlFld-ContribAuthor ">Jiajia  Wang</span>, <span class="hlFld-ContribAuthor ">Zhuoqing  Xi</span>, <span class="hlFld-ContribAuthor ">Man  Shi</span>, <span class="hlFld-ContribAuthor ">Sihan  Zhao</span>, <span class="hlFld-ContribAuthor ">Qi  Ma</span>, <span class="hlFld-ContribAuthor ">Sitong  Liu</span>, <span class="hlFld-ContribAuthor ">Shudi  Guo</span>, <span class="hlFld-ContribAuthor ">Jianing  Liu</span>, <span class="hlFld-ContribAuthor ">Lili  Hou</span>, <span class="hlFld-ContribAuthor ">Chaojie  Wang</span>, <span class="hlFld-ContribAuthor ">Peng George  Wang</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Tian</span>, <span class="hlFld-ContribAuthor ">Songqiang  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">A Polyamine-Based Dinitro-Naphthalimide Conjugate as Substrates for Polyamine Transporters Preferentially Accumulates in Cancer Cells and Minimizes Side Effects in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fchem.2020.00166" title="DOI URL">https://doi.org/10.3389/fchem.2020.00166</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2020.00166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2020.00166%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DA%252BPolyamine-Based%252BDinitro-Naphthalimide%252BConjugate%252Bas%252BSubstrates%252Bfor%252BPolyamine%252BTransporters%252BPreferentially%252BAccumulates%252Bin%252BCancer%252BCells%252Band%252BMinimizes%252BSide%252BEffects%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DMa%26aufirst%3DJing%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio  Franconetti</span>, <span class="hlFld-ContribAuthor ">Óscar  López</span>, <span class="hlFld-ContribAuthor ">José G.  Fernandez-Bolanos</span>. </span><span class="cited-content_cbyCitation_article-title">Carbohydrates: Potential Sweet Tools Against Cancer. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (8)
                                     , 1206-1242. <a href="https://doi.org/10.2174/0929867325666180719114150" title="DOI URL">https://doi.org/10.2174/0929867325666180719114150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180719114150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180719114150%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DCarbohydrates%25253A%252BPotential%252BSweet%252BTools%252BAgainst%252BCancer%26aulast%3DFranconetti%26aufirst%3DAntonio%26date%3D2020%26volume%3D27%26issue%3D8%26spage%3D1206%26epage%3D1242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Jing  Ding</span>, <span class="hlFld-ContribAuthor ">Ran  Zhang</span>, <span class="hlFld-ContribAuthor ">Rui-Ping  Liu</span>, <span class="hlFld-ContribAuthor ">Xue-Qing  Song</span>, <span class="hlFld-ContribAuthor ">Xin  Qiao</span>, <span class="hlFld-ContribAuthor ">Cheng-Zhi  Xie</span>, <span class="hlFld-ContribAuthor ">Xiu-He  Zhao</span>, <span class="hlFld-ContribAuthor ">Jing-Yuan  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">A class of Pt(
              iv
              ) triple-prodrugs targeting nucleic acids, thymidylate synthases and histone deacetylases. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (5)
                                     , 1220-1228. <a href="https://doi.org/10.1039/C9QI01453E" title="DOI URL">https://doi.org/10.1039/C9QI01453E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9QI01453E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9QI01453E%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%2520Frontiers%26atitle%3DA%252Bclass%252Bof%252BPt%252528%252Biv%252B%252529%252Btriple-prodrugs%252Btargeting%252Bnucleic%252Bacids%25252C%252Bthymidylate%252Bsynthases%252Band%252Bhistone%252Bdeacetylases%26aulast%3DDing%26aufirst%3DXiao-Jing%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D5%26spage%3D1220%26epage%3D1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zuojie  Li</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Zhifang  Liu</span>, <span class="hlFld-ContribAuthor ">Qingpeng  Wang</span>, <span class="hlFld-ContribAuthor ">Yanna  Zhao</span>, <span class="hlFld-ContribAuthor ">Jinjian  Wei</span>, <span class="hlFld-ContribAuthor ">Min  Liu</span>, <span class="hlFld-ContribAuthor ">Zhengping  Wang</span>, <span class="hlFld-ContribAuthor ">Dacheng  Li</span>, <span class="hlFld-ContribAuthor ">Jun  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of new mono naphthalimide platinum(IV) derivatives as antitumor agents with dual DNA damage mechanism. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2020,</strong> <em>151 </em>
                                    (3)
                                     , 353-367. <a href="https://doi.org/10.1007/s00706-020-02561-1" title="DOI URL">https://doi.org/10.1007/s00706-020-02561-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-020-02561-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-020-02561-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252Bmono%252Bnaphthalimide%252Bplatinum%252528IV%252529%252Bderivatives%252Bas%252Bantitumor%252Bagents%252Bwith%252Bdual%252BDNA%252Bdamage%252Bmechanism%26aulast%3DLi%26aufirst%3DZuojie%26date%3D2020%26date%3D2020%26volume%3D151%26issue%3D3%26spage%3D353%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aarti  Upadhyay</span>, <span class="hlFld-ContribAuthor ">Srishti  Gautam</span>, <span class="hlFld-ContribAuthor ">Vanitha  Ramu</span>, <span class="hlFld-ContribAuthor ">Paturu  Kondaiah</span>, <span class="hlFld-ContribAuthor ">Akhil R.  Chakravarty</span>. </span><span class="cited-content_cbyCitation_article-title">Photocytotoxic cancer cell-targeting platinum(
              ii
              ) complexes of glucose-appended curcumin and biotinylated 1,10-phenanthroline. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2019,</strong> <em>48 </em>
                                    (47)
                                     , 17556-17565. <a href="https://doi.org/10.1039/C9DT03490K" title="DOI URL">https://doi.org/10.1039/C9DT03490K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9DT03490K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9DT03490K%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DPhotocytotoxic%252Bcancer%252Bcell-targeting%252Bplatinum%252528%252Bii%252B%252529%252Bcomplexes%252Bof%252Bglucose-appended%252Bcurcumin%252Band%252Bbiotinylated%252B1%25252C10-phenanthroline%26aulast%3DUpadhyay%26aufirst%3DAarti%26date%3D2019%26date%3D2019%26volume%3D48%26issue%3D47%26spage%3D17556%26epage%3D17565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaochao  Huang</span>, <span class="hlFld-ContribAuthor ">Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Chungu  Wang</span>, <span class="hlFld-ContribAuthor ">Weiwei  Hu</span>, <span class="hlFld-ContribAuthor ">Qinghong  You</span>, <span class="hlFld-ContribAuthor ">Yong  Yang</span>, <span class="hlFld-ContribAuthor ">Chunhao  Yu</span>, <span class="hlFld-ContribAuthor ">Zhixin  Liao</span>, <span class="hlFld-ContribAuthor ">Shaohua  Gou</span>, <span class="hlFld-ContribAuthor ">Hengshan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-targeting antitumor conjugates derived from platinum(IV) prodrugs and microtubule inhibitor CA-4 significantly exhibited potent ability to overcome cisplatin resistance. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>92 </em>, 103236. <a href="https://doi.org/10.1016/j.bioorg.2019.103236" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103236%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDual-targeting%252Bantitumor%252Bconjugates%252Bderived%252Bfrom%252Bplatinum%252528IV%252529%252Bprodrugs%252Band%252Bmicrotubule%252Binhibitor%252BCA-4%252Bsignificantly%252Bexhibited%252Bpotent%252Bability%252Bto%252Bovercome%252Bcisplatin%252Bresistance%26aulast%3DHuang%26aufirst%3DXiaochao%26date%3D2019%26volume%3D92%26spage%3D103236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Hongwu  Tian</span>, <span class="hlFld-ContribAuthor ">Liyao  Xu</span>, <span class="hlFld-ContribAuthor ">Li  Zhou</span>, <span class="hlFld-ContribAuthor ">Jinhu  Wang</span>, <span class="hlFld-ContribAuthor ">Benyan  Xu</span>, <span class="hlFld-ContribAuthor ">Chunli  Liu</span>, <span class="hlFld-ContribAuthor ">Lars I.  Elding</span>, <span class="hlFld-ContribAuthor ">Tiesheng  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Investigations of the Kinetics and Mechanism of Reduction of a Carboplatin Pt(IV) Prodrug by the Major Small-Molecule Reductants in Human Plasma. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (22)
                                     , 5660. <a href="https://doi.org/10.3390/ijms20225660" title="DOI URL">https://doi.org/10.3390/ijms20225660</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20225660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20225660%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DInvestigations%252Bof%252Bthe%252BKinetics%252Band%252BMechanism%252Bof%252BReduction%252Bof%252Ba%252BCarboplatin%252BPt%252528IV%252529%252BProdrug%252Bby%252Bthe%252BMajor%252BSmall-Molecule%252BReductants%252Bin%252BHuman%252BPlasma%26aulast%3DLiu%26aufirst%3DYang%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D22%26spage%3D5660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingpeng  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Guoshuai  Li</span>, <span class="hlFld-ContribAuthor ">Yanna  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhifang  Liu</span>, <span class="hlFld-ContribAuthor ">Ruiyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Min  Liu</span>, <span class="hlFld-ContribAuthor ">Dacheng  Li</span>, <span class="hlFld-ContribAuthor ">Jun  Han</span>. </span><span class="cited-content_cbyCitation_article-title">A potent aminonaphthalimide platinum(IV) complex with effective antitumor activities in vitro and in vivo displaying dual DNA damage effects on tumor cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (20)
                                     , 126670. <a href="https://doi.org/10.1016/j.bmcl.2019.126670" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126670</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126670%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bpotent%252Baminonaphthalimide%252Bplatinum%252528IV%252529%252Bcomplex%252Bwith%252Beffective%252Bantitumor%252Bactivities%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bdisplaying%252Bdual%252BDNA%252Bdamage%252Beffects%252Bon%252Btumor%252Bcells%26aulast%3DWang%26aufirst%3DQingpeng%26date%3D2019%26volume%3D29%26issue%3D20%26spage%3D126670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandra  Glenister</span>, <span class="hlFld-ContribAuthor ">Michela I.  Simone</span>, <span class="hlFld-ContribAuthor ">Trevor W.  Hambley</span>, . </span><span class="cited-content_cbyCitation_article-title">A Warburg effect targeting vector designed to increase the uptake of compounds by cancer cells demonstrates glucose and hypoxia dependent uptake. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2019,</strong> <em>14 </em>
                                    (7)
                                     , e0217712. <a href="https://doi.org/10.1371/journal.pone.0217712" title="DOI URL">https://doi.org/10.1371/journal.pone.0217712</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0217712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0217712%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DA%252BWarburg%252Beffect%252Btargeting%252Bvector%252Bdesigned%252Bto%252Bincrease%252Bthe%252Buptake%252Bof%252Bcompounds%252Bby%252Bcancer%252Bcells%252Bdemonstrates%252Bglucose%252Band%252Bhypoxia%252Bdependent%252Buptake%26aulast%3DGlenister%26aufirst%3DAlexandra%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D7%26spage%3De0217712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiu-Zhen  Su</span>, <span class="hlFld-ContribAuthor ">Ran  Chen</span>, <span class="hlFld-ContribAuthor ">Cai-Bing  Wang</span>, <span class="hlFld-ContribAuthor ">Xi-Lin  Ouyang</span>, <span class="hlFld-ContribAuthor ">Yan  Jiang</span>, <span class="hlFld-ContribAuthor ">Ming-Yi  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Astaxanthin Combine with Human Serum Albumin to Abrogate Cell Proliferation, Migration, and Drug-resistant in Human Ovarian Carcinoma SKOV3 Cells. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Agents in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (6)
                                     , 792-801. <a href="https://doi.org/10.2174/1871520619666190225123003" title="DOI URL">https://doi.org/10.2174/1871520619666190225123003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871520619666190225123003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871520619666190225123003%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Agents%2520in%2520Medicinal%2520Chemistry%26atitle%3DAstaxanthin%252BCombine%252Bwith%252BHuman%252BSerum%252BAlbumin%252Bto%252BAbrogate%252BCell%252BProliferation%25252C%252BMigration%25252C%252Band%252BDrug-resistant%252Bin%252BHuman%252BOvarian%252BCarcinoma%252BSKOV3%252BCells%26aulast%3DSu%26aufirst%3DXiu-Zhen%26date%3D2019%26volume%3D19%26issue%3D6%26spage%3D792%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng-Yang  Wang</span>, <span class="hlFld-ContribAuthor ">Romg  Liu</span>, <span class="hlFld-ContribAuthor ">Ke-Bin  Huang</span>, <span class="hlFld-ContribAuthor ">Hai-Wen  Feng</span>, <span class="hlFld-ContribAuthor ">You-Nian  Liu</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">New platinum(II)-based DNA intercalator: Synthesis, characterization and anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry Communications</span><span> <strong>2019,</strong> <em>105 </em>, 182-187. <a href="https://doi.org/10.1016/j.inoche.2019.04.039" title="DOI URL">https://doi.org/10.1016/j.inoche.2019.04.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.inoche.2019.04.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.inoche.2019.04.039%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%2520Communications%26atitle%3DNew%252Bplatinum%252528II%252529-based%252BDNA%252Bintercalator%25253A%252BSynthesis%25252C%252Bcharacterization%252Band%252Banticancer%252Bactivity%26aulast%3DWang%26aufirst%3DFeng-Yang%26date%3D2019%26volume%3D105%26spage%3D182%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Trevor W.  Hambley</span>. </span><span class="cited-content_cbyCitation_article-title">Transporter and protease mediated delivery of platinum complexes for precision oncology. </span><span class="cited-content_cbyCitation_journal-name">JBIC Journal of Biological Inorganic Chemistry</span><span> <strong>2019,</strong> <em>24 </em>
                                    (4)
                                     , 457-466. <a href="https://doi.org/10.1007/s00775-019-01660-7" title="DOI URL">https://doi.org/10.1007/s00775-019-01660-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00775-019-01660-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00775-019-01660-7%26sid%3Dliteratum%253Aachs%26jtitle%3DJBIC%2520Journal%2520of%2520Biological%2520Inorganic%2520Chemistry%26atitle%3DTransporter%252Band%252Bprotease%252Bmediated%252Bdelivery%252Bof%252Bplatinum%252Bcomplexes%252Bfor%252Bprecision%252Boncology%26aulast%3DHambley%26aufirst%3DTrevor%2BW.%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D4%26spage%3D457%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shen-Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Mo-Yu  Ding</span>, <span class="hlFld-ContribAuthor ">Shuangcheng  Ma</span>, <span class="hlFld-ContribAuthor ">Jing  Zhao</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Shaoping  Li</span>. </span><span class="cited-content_cbyCitation_article-title">2-O-β-d-glucopyranosyl- -ascorbic acid, a novel vitamin C derivative from Lycium barbarum, prevents oxidative stress. </span><span class="cited-content_cbyCitation_journal-name">Redox Biology</span><span> <strong>2019,</strong> <em>24 </em>, 101173. <a href="https://doi.org/10.1016/j.redox.2019.101173" title="DOI URL">https://doi.org/10.1016/j.redox.2019.101173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.redox.2019.101173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.redox.2019.101173%26sid%3Dliteratum%253Aachs%26jtitle%3DRedox%2520Biology%26atitle%3D2-O-%2525CE%2525B2-d-glucopyranosyl-%252B-ascorbic%252Bacid%25252C%252Ba%252Bnovel%252Bvitamin%252BC%252Bderivative%252Bfrom%252BLycium%252Bbarbarum%25252C%252Bprevents%252Boxidative%252Bstress%26aulast%3DWang%26aufirst%3DShen-Fei%26date%3D2019%26volume%3D24%26spage%3D101173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingpeng  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Guoshuai  Li</span>, <span class="hlFld-ContribAuthor ">Zhifang  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Ma</span>, <span class="hlFld-ContribAuthor ">Min  Liu</span>, <span class="hlFld-ContribAuthor ">Dacheng  Li</span>, <span class="hlFld-ContribAuthor ">Jun  Han</span>, <span class="hlFld-ContribAuthor ">Bingquan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of bi-functional 7-hydroxycoumarin platinum(IV) complexes as antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (10)
                                     , 2112-2121. <a href="https://doi.org/10.1016/j.bmc.2019.04.009" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.04.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.04.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bbi-functional%252B7-hydroxycoumarin%252Bplatinum%252528IV%252529%252Bcomplexes%252Bas%252Bantitumor%252Bagents%26aulast%3DWang%26aufirst%3DQingpeng%26date%3D2019%26volume%3D27%26issue%3D10%26spage%3D2112%26epage%3D2121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoshuai  Li</span>, <span class="hlFld-ContribAuthor ">Junfeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhifang  Liu</span>, <span class="hlFld-ContribAuthor ">Qingpeng  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Min  Liu</span>, <span class="hlFld-ContribAuthor ">Dacheng  Li</span>, <span class="hlFld-ContribAuthor ">Jun  Han</span>, <span class="hlFld-ContribAuthor ">Bingquan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a series of 4-hydroxycoumarin platinum(IV) hybrids as antitumor agents: Synthesis, biological evaluation and action mechanism investigation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2019,</strong> <em>194 </em>, 34-43. <a href="https://doi.org/10.1016/j.jinorgbio.2019.02.011" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2019.02.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2019.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2019.02.011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DDevelopment%252Bof%252Ba%252Bseries%252Bof%252B4-hydroxycoumarin%252Bplatinum%252528IV%252529%252Bhybrids%252Bas%252Bantitumor%252Bagents%25253A%252BSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Baction%252Bmechanism%252Binvestigation%26aulast%3DLi%26aufirst%3DGuoshuai%26date%3D2019%26volume%3D194%26spage%3D34%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haifeng  Wang</span>, <span class="hlFld-ContribAuthor ">Xiande  Yang</span>, <span class="hlFld-ContribAuthor ">Caili  Zhao</span>, <span class="hlFld-ContribAuthor ">Peng George  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (8)
                                     , 1639-1645. <a href="https://doi.org/10.1016/j.bmc.2019.03.006" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DGlucose-conjugated%252Bplatinum%252528IV%252529%252Bcomplexes%252Bas%252Btumor-targeting%252Bagents%25253A%252Bdesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DWang%26aufirst%3DHaifeng%26date%3D2019%26volume%3D27%26issue%3D8%26spage%3D1639%26epage%3D1645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue-Qing  Song</span>, <span class="hlFld-ContribAuthor ">Zhong-Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Yi-Gang  Wu</span>, <span class="hlFld-ContribAuthor ">Miao-Liang  Dai</span>, <span class="hlFld-ContribAuthor ">Dong-Bo  Wang</span>, <span class="hlFld-ContribAuthor ">Jing-Yuan  Xu</span>, <span class="hlFld-ContribAuthor ">Yangzhong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">New NSAID-Pt(IV) prodrugs to suppress metastasis and invasion of tumor cells and enhance anti-tumor effect in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>167 </em>, 377-387. <a href="https://doi.org/10.1016/j.ejmech.2019.02.041" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.041%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252BNSAID-Pt%252528IV%252529%252Bprodrugs%252Bto%252Bsuppress%252Bmetastasis%252Band%252Binvasion%252Bof%252Btumor%252Bcells%252Band%252Benhance%252Banti-tumor%252Beffect%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%26aulast%3DSong%26aufirst%3DXue-Qing%26date%3D2019%26volume%3D167%26spage%3D377%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng-Yang  Wang</span>, <span class="hlFld-ContribAuthor ">Ke-Bin  Huang</span>, <span class="hlFld-ContribAuthor ">Hai-Wen  Feng</span>, <span class="hlFld-ContribAuthor ">Zhen-Feng  Chen</span>, <span class="hlFld-ContribAuthor ">You-Nian  Liu</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">New Platinum(II) agent induces bimodal death of apoptosis and autophagy against A549 cancer cell. </span><span class="cited-content_cbyCitation_journal-name">Free Radical Biology and Medicine</span><span> <strong>2018,</strong> <em>129 </em>, 418-429. <a href="https://doi.org/10.1016/j.freeradbiomed.2018.09.040" title="DOI URL">https://doi.org/10.1016/j.freeradbiomed.2018.09.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.freeradbiomed.2018.09.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.freeradbiomed.2018.09.040%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Biology%2520and%2520Medicine%26atitle%3DNew%252BPlatinum%252528II%252529%252Bagent%252Binduces%252Bbimodal%252Bdeath%252Bof%252Bapoptosis%252Band%252Bautophagy%252Bagainst%252BA549%252Bcancer%252Bcell%26aulast%3DWang%26aufirst%3DFeng-Yang%26date%3D2018%26volume%3D129%26spage%3D418%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingpeng  Wang</span>, <span class="hlFld-ContribAuthor ">Guoshuai  Li</span>, <span class="hlFld-ContribAuthor ">Zhifang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaoxiao  Tan</span>, <span class="hlFld-ContribAuthor ">Zhuang  Ding</span>, <span class="hlFld-ContribAuthor ">Jing  Ma</span>, <span class="hlFld-ContribAuthor ">Lanjie  Li</span>, <span class="hlFld-ContribAuthor ">Dacheng  Li</span>, <span class="hlFld-ContribAuthor ">Jun  Han</span>, <span class="hlFld-ContribAuthor ">Bingquan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Naphthalimide Platinum(IV) Compounds as Antitumor Agents with Dual DNA Damage Mechanism to Overcome Cisplatin Resistance. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Inorganic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (40)
                                     , 4442-4451. <a href="https://doi.org/10.1002/ejic.201800799" title="DOI URL">https://doi.org/10.1002/ejic.201800799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejic.201800799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejic.201800799%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Inorganic%2520Chemistry%26atitle%3DNaphthalimide%252BPlatinum%252528IV%252529%252BCompounds%252Bas%252BAntitumor%252BAgents%252Bwith%252BDual%252BDNA%252BDamage%252BMechanism%252Bto%252BOvercome%252BCisplatin%252BResistance%26aulast%3DWang%26aufirst%3DQingpeng%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D40%26spage%3D4442%26epage%3D4451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingpeng  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoxiao  Tan</span>, <span class="hlFld-ContribAuthor ">Zhifang  Liu</span>, <span class="hlFld-ContribAuthor ">Guoshuai  Li</span>, <span class="hlFld-ContribAuthor ">Ruiyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinjian  Wei</span>, <span class="hlFld-ContribAuthor ">Shiben  Wang</span>, <span class="hlFld-ContribAuthor ">Dacheng  Li</span>, <span class="hlFld-ContribAuthor ">Bingquan  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of a new series of low toxic naphthalimide platinum(IV) antitumor complexes with dual DNA damage mechanism. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2018,</strong> <em>124 </em>, 127-136. <a href="https://doi.org/10.1016/j.ejps.2018.08.032" title="DOI URL">https://doi.org/10.1016/j.ejps.2018.08.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2018.08.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2018.08.032%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Ba%252Bnew%252Bseries%252Bof%252Blow%252Btoxic%252Bnaphthalimide%252Bplatinum%252528IV%252529%252Bantitumor%252Bcomplexes%252Bwith%252Bdual%252BDNA%252Bdamage%252Bmechanism%26aulast%3DWang%26aufirst%3DQingpeng%26date%3D2018%26volume%3D124%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuejiao  Li</span>, <span class="hlFld-ContribAuthor ">Yahong  Liu</span>, <span class="hlFld-ContribAuthor ">Hongqi  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioinorganic Chemistry and Applications</span><span> <strong>2018,</strong> <em>2018 </em>, 1-18. <a href="https://doi.org/10.1155/2018/8276139" title="DOI URL">https://doi.org/10.1155/2018/8276139</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2018/8276139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2018%2F8276139%26sid%3Dliteratum%253Aachs%26jtitle%3DBioinorganic%2520Chemistry%2520and%2520Applications%26atitle%3DCurrent%252BDevelopments%252Bin%252BPt%252528IV%252529%252BProdrugs%252BConjugated%252Bwith%252BBioactive%252BLigands%26aulast%3DLi%26aufirst%3DXuejiao%26date%3D2018%26volume%3D2018%26spage%3D1%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Ma</span>, <span class="hlFld-ContribAuthor ">Hanfang  Liu</span>, <span class="hlFld-ContribAuthor ">Zhuoqing  Xi</span>, <span class="hlFld-ContribAuthor ">Jiuzhou  Hou</span>, <span class="hlFld-ContribAuthor ">Yingguang  Li</span>, <span class="hlFld-ContribAuthor ">Jie  Niu</span>, <span class="hlFld-ContribAuthor ">Tong  Liu</span>, <span class="hlFld-ContribAuthor ">Shuning  Bi</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Chaojie  Wang</span>, <span class="hlFld-ContribAuthor ">Jiajia  Wang</span>, <span class="hlFld-ContribAuthor ">Songqiang  Xie</span>, <span class="hlFld-ContribAuthor ">Peng G.  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Protected and De-protected Platinum(IV) Glycoconjugates With GLUT1 and OCT2-Mediated Selective Cancer Targeting: Demonstrated Enhanced Transporter-Mediated Cytotoxic Properties in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2018,</strong> <em>6 </em><a href="https://doi.org/10.3389/fchem.2018.00386" title="DOI URL">https://doi.org/10.3389/fchem.2018.00386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2018.00386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2018.00386%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DProtected%252Band%252BDe-protected%252BPlatinum%252528IV%252529%252BGlycoconjugates%252BWith%252BGLUT1%252Band%252BOCT2-Mediated%252BSelective%252BCancer%252BTargeting%25253A%252BDemonstrated%252BEnhanced%252BTransporter-Mediated%252BCytotoxic%252BProperties%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DMa%26aufirst%3DJing%26date%3D2018%26date%3D2018%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joby  Jacob</span>, <span class="hlFld-ContribAuthor ">Józef T.  Haponiuk</span>, <span class="hlFld-ContribAuthor ">Sabu  Thomas</span>, <span class="hlFld-ContribAuthor ">Sreeraj  Gopi</span>. </span><span class="cited-content_cbyCitation_article-title">Biopolymer based nanomaterials in drug delivery systems: A review. </span><span class="cited-content_cbyCitation_journal-name">Materials Today Chemistry</span><span> <strong>2018,</strong> <em>9 </em>, 43-55. <a href="https://doi.org/10.1016/j.mtchem.2018.05.002" title="DOI URL">https://doi.org/10.1016/j.mtchem.2018.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mtchem.2018.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mtchem.2018.05.002%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Today%2520Chemistry%26atitle%3DBiopolymer%252Bbased%252Bnanomaterials%252Bin%252Bdrug%252Bdelivery%252Bsystems%25253A%252BA%252Breview%26aulast%3DJacob%26aufirst%3DJoby%26date%3D2018%26volume%3D9%26spage%3D43%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingxue  Li</span>, <span class="hlFld-ContribAuthor ">Xiaochao  Huang</span>, <span class="hlFld-ContribAuthor ">Rizhen  Huang</span>, <span class="hlFld-ContribAuthor ">Shaohua  Gou</span>, <span class="hlFld-ContribAuthor ">Zhimei  Wang</span>, <span class="hlFld-ContribAuthor ">Hengshan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Pt(IV) prodrugs containing microtubule inhibitors displayed potent antitumor activity and ability to overcome cisplatin resistance. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>156 </em>, 666-679. <a href="https://doi.org/10.1016/j.ejmech.2018.07.016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.07.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.07.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPt%252528IV%252529%252Bprodrugs%252Bcontaining%252Bmicrotubule%252Binhibitors%252Bdisplayed%252Bpotent%252Bantitumor%252Bactivity%252Band%252Bability%252Bto%252Bovercome%252Bcisplatin%252Bresistance%26aulast%3DLi%26aufirst%3DLingxue%26date%3D2018%26volume%3D156%26spage%3D666%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng-Yang  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Ming  Tang</span>, <span class="hlFld-ContribAuthor ">Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Ke-Bin  Huang</span>, <span class="hlFld-ContribAuthor ">Hai-Wen  Feng</span>, <span class="hlFld-ContribAuthor ">Zhen-Feng  Chen</span>, <span class="hlFld-ContribAuthor ">You-Nian  Liu</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Mitochondria-targeted platinum(II) complexes induce apoptosis-dependent autophagic cell death mediated by ER-stress in A549 cancer cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>155 </em>, 639-650. <a href="https://doi.org/10.1016/j.ejmech.2018.06.018" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.06.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.06.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMitochondria-targeted%252Bplatinum%252528II%252529%252Bcomplexes%252Binduce%252Bapoptosis-dependent%252Bautophagic%252Bcell%252Bdeath%252Bmediated%252Bby%252BER-stress%252Bin%252BA549%252Bcancer%252Bcells%26aulast%3DWang%26aufirst%3DFeng-Yang%26date%3D2018%26volume%3D155%26spage%3D639%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Structures of <b>1</b>–<b>8</b> and <b>1a</b>–<b>5a</b> as positive control. Docking studies of <b>6</b> with HSA and GLUT1. (b) <b>6</b> interacting with a variety of amino acid residues of GLUT1 (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PYP">4PYP</a>). (c) The lowest energy structure and <b>6</b> buried beneath the protein surface (HSA pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E7H">1E7H</a>). (d) <b>6</b> interacting with a variety of amino acid residues of HSA (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E7H">1E7H</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route of Target Compounds <b>1</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions and reagents: (a) BnOH, CH<sub>3</sub>COCl 50 °C, 2 h; (b) TrtCl, DMAP Py, 50 °C; (c) BnBr, NaH, DMF, rt, overnight; (d) HBr/AcOH 10 °C; (e) K<sub>2</sub>Cr<sub>2</sub>O<sub>7</sub>, H<sub>2</sub>SO<sub>4</sub>, acetone, 55 °C, 2 h; (f) C<sub>2</sub>O<sub>2</sub>Cl<sub>2</sub> DMF(cat.); (g) Dry acetone rt, 2 d; (h) BCl<sub>3</sub>, DCM −78 °C, 2 h; (i) Ac<sub>2</sub>O, AcONa 80 °C, 6 h; (j) <i>p</i>-toluenethiol BF<sub>3</sub> Et<sub>2</sub>O, DCM; (k) MeONa, MeOH rt, overnight; (l) BnBr, NaH, DMF, overnight; (m) TMSOTf, NIS, CH<sub>3</sub>CN, 2 h; (n) NaOH (1 M), 24 h.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Effects of EDG (1), phloretin (2), Ctd (3), and a mixture of EDG and Ctd (4) on the IC<sub>50</sub> values of compounds <b>1</b>, <b>6</b>, and <b>1a</b> in MCF-7 cells. (b) Effects of Ctd (3) on the IC<sub>50</sub> values of on the compounds <b>5</b>, <b>7</b>, <b>8</b>, and <b>3a</b> in MCF-7 cells. (c) Effects of EDG on the cellular uptake of compounds <b>1</b>, <b>6</b>, and <b>3a</b> in MCF-7 cells. (d) Effect of Ctd on the cellular uptake of compounds <b>1</b>, <b>6</b>, and <b>3a</b> in MCF-7 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Viability of MCF-7 cells, HeLa cells, 293T cells, and 3T3 cells in a 48 h incubation assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Stability of <b>6</b> in whole human blood (a) and RPMI 1640 (b).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Binding studies of <b>6</b> with HSA after 0, 24, 48, and 196 h. (b) Reduction of <b>6</b> by ascorbate with and without HSA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A–D) Biodistribution of <b>5</b>, <b>6</b>, <b>8</b>, and <b>5a</b>, as the positive control in MCF-7 bearing animals was assessed by ICP-MS at 9 and 24 h post administration (iv). (E,F) Biodistribution of <b>5</b>, <b>6</b>, <b>8</b>, and <b>5a</b> at 9 and 24 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of EDG (1), phloretin (2), Ctd (3), and the mixture of EDG and Ctd (4) on the IC<sub>50</sub> values of compounds <b>6</b> and <b>5a</b> in MDCK cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/medium/jm-2017-00433s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. In vivo antitumor activities of compounds Glc-Pt(IV) <b>6</b> and oxaliplatin in MCF-7. (A) Tumor growth as a function of time. (B) The bodyweight of mice during the treatments. (C) Images of tumors at the end of the experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00433/20170707/images/large/jm-2017-00433s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00433&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32282" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32282" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 14 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Cellular processing of platinum anticancer drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span><span class="refDoi"> DOI: 10.1038/nrd1691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1038%2Fnrd1691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=15789122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVart7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=307-320&author=D.+Wangauthor=S.+J.+Lippard&title=Cellular+processing+of+platinum+anticancer+drugs&doi=10.1038%2Fnrd1691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular processing of platinum anticancer drugs</span></div><div class="casAuthors">Wang, Dong; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-320</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cisplatin, carboplatin and oxaliplatin are platinum-based drugs that are widely used in cancer chemotherapy.  Platinum-DNA adducts, which are formed following uptake of the drug into the nucleus of cells, activate several cellular processes that mediate the cytotoxicity of these platinum drugs.  This review focuses on recently discovered cellular pathways that are activated in response to cisplatin, including those involved in regulating drug uptake, the signaling of DNA damage, cell-cycle checkpoints and arrest, DNA repair and cell death.  Such knowledge of the cellular processing of cisplatin adducts with DNA provides valuable clues for the rational design of more efficient platinum-based drugs as well as the development of new therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHJfZNaqwy67Vg90H21EOLACvtfcHk0liHrXJETMemvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVart7c%253D&md5=e44a8e87683ba5cfe3e165f9f4229fee</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1691%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DCellular%2520processing%2520of%2520platinum%2520anticancer%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D307%26epage%3D320%26doi%3D10.1038%2Fnrd1691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wheate, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oun, R.</span><span> </span><span class="NLM_article-title">The status of platinum anticancer drugs in the clinic and in clinical trials</span> <span class="citation_source-journal">Dalton Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">8113</span><span class="NLM_x">–</span> <span class="NLM_lpage">8127</span><span class="refDoi"> DOI: 10.1039/c0dt00292e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1039%2Fc0dt00292e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=20593091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVOhsrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=8113-8127&author=N.+J.+Wheateauthor=S.+Walkerauthor=G.+E.+Craigauthor=R.+Oun&title=The+status+of+platinum+anticancer+drugs+in+the+clinic+and+in+clinical+trials&doi=10.1039%2Fc0dt00292e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The status of platinum anticancer drugs in the clinic and in clinical trials</span></div><div class="casAuthors">Wheate, Nial J.; Walker, Shonagh; Craig, Gemma E.; Oun, Rabbab</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">8113-8127</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Since its approval in 1979 cisplatin has become an important component in chemotherapy regimes for the treatment of ovarian, testicular, lung and bladder cancers, as well as lymphomas, myelomas and melanoma.  Unfortunately its continued use is greatly limited by severe dose limiting side effects and intrinsic or acquired drug resistance.  Over the last 30 years, 23 other platinum-based drugs have entered clin. trials with only two (carboplatin and oxaliplatin) of these gaining international marketing approval, and another three (nedaplatin, lobaplatin and heptaplatin) gaining approval in individual nations.  During this time there have been more failures than successes with the development of 14 drugs being halted during clin. trials.  Currently there are four drugs in the various phases of clin. trial (satraplatin, picoplatin, Lipoplatin and ProLindac).  No new small mol. platinum drug has entered clin. trials since 1999 which is representative of a shift in focus away from drug design and towards drug delivery in the last decade.  In this perspective article we update the status of platinum anticancer drugs currently approved for use, those undergoing clin. trials and those discontinued during clin. trials, and discuss the results in the context of where we believe the field will develop over the next decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqSuqxBzUTjbVg90H21EOLACvtfcHk0liHrXJETMemvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVOhsrnO&md5=bfa2fef3a7c3c4a3122a0fa60e45f804</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1039%2Fc0dt00292e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0dt00292e%26sid%3Dliteratum%253Aachs%26aulast%3DWheate%26aufirst%3DN.%2BJ.%26aulast%3DWalker%26aufirst%3DS.%26aulast%3DCraig%26aufirst%3DG.%2BE.%26aulast%3DOun%26aufirst%3DR.%26atitle%3DThe%2520status%2520of%2520platinum%2520anticancer%2520drugs%2520in%2520the%2520clinic%2520and%2520in%2520clinical%2520trials%26jtitle%3DDalton%2520Trans.%26date%3D2010%26volume%3D39%26spage%3D8113%26epage%3D8127%26doi%3D10.1039%2Fc0dt00292e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Siddik, Z. H.</span><span> </span><span class="NLM_article-title">Cisplatin: mode of cytotoxic action and molecular basis of resistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7265</span><span class="NLM_x">–</span> <span class="NLM_lpage">7279</span><span class="refDoi"> DOI: 10.1038/sj.onc.1206933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1038%2Fsj.onc.1206933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=14576837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotlajtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7265-7279&author=Z.+H.+Siddik&title=Cisplatin%3A+mode+of+cytotoxic+action+and+molecular+basis+of+resistance&doi=10.1038%2Fsj.onc.1206933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cisplatin: mode of cytotoxic action and molecular basis of resistance</span></div><div class="casAuthors">Siddik, Zahid H.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">7265-7279</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cisplatin is one of the most potent antitumor agents known, displaying clin. activity against a wide variety of solid tumors.  Its cytotoxic mode of action is mediated by its interaction with DNA to form DNA adducts, primarily intrastrand crosslink adducts, which activate several signal transduction pathways, including those involving ATR, p53, p73, and MAPK, and culminate in the activation of apoptosis.  DNA damage-mediated apoptotic signals, however, can be attenuated, and the resistance that ensues is a major limitation of cisplatin-based chemotherapy.  The mechanisms responsible for cisplatin resistance are several, and contribute to the multifactorial nature of the problem.  Resistance mechanisms that limit the extent of DNA damage include reduced drug uptake, increased drug inactivation, and increased DNA adduct repair.  Origins of these pharmacol.-based mechanisms, however, are at the mol. level.  Mechanisms that inhibit propagation of the DNA damage signal to the apoptotic machinery include loss of damage recognition, overexpression of HER-2/neu, activation of the PI3-K/Akt (also known as PI3-K/PKB) pathway, loss of p53 function, overexpression of antiapoptotic bcl-2, and interference in caspase activation.  The mol. signature defining the resistant phenotype varies between tumors, and the no. of resistance mechanisms activated in response to selection pressures dictates the overall extent of cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3k2Fki_ax2rVg90H21EOLACvtfcHk0liHrXJETMemvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotlajtbY%253D&md5=8520a82f029717c4352d23e4bd7166fe</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206933%26sid%3Dliteratum%253Aachs%26aulast%3DSiddik%26aufirst%3DZ.%2BH.%26atitle%3DCisplatin%253A%2520mode%2520of%2520cytotoxic%2520action%2520and%2520molecular%2520basis%2520of%2520resistance%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D7265%26epage%3D7279%26doi%3D10.1038%2Fsj.onc.1206933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kelland, L.</span><span> </span><span class="NLM_article-title">The resurgence of platinum-based cancer chemotherapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">584</span><span class="refDoi"> DOI: 10.1038/nrc2167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1038%2Fnrc2167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=17625587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVKru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=573-584&author=L.+Kelland&title=The+resurgence+of+platinum-based+cancer+chemotherapy&doi=10.1038%2Fnrc2167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of platinum-based cancer chemotherapy</span></div><div class="casAuthors">Kelland, Lloyd</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">573-584</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The accidental discovery of the anticancer properties of cisplatin and its clin. introduction in the 1970s represent a major landmark in the history of successful anticancer drugs.  Although carboplatin - a second-generation analog that is safer but shows a similar spectrum of activity to cisplatin - was introduced in the 1980s, the pace of further improvements slowed for many years.  However, in the past several years interest in platinum drugs has increased.  Key developments include the elucidation of mechanisms of tumor resistance to these drugs, the introduction of new platinum-based agents (oxaliplatin, satraplatin and picoplatin), and clin. combination studies using platinum drugs with resistance modulators or new molecularly targeted drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTEI4HRCjxQrVg90H21EOLACvtfcHk0lgcWZYCwdEwUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVKru7c%253D&md5=9d55f600a83a19d7836a2524de20efbf</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2167%26sid%3Dliteratum%253Aachs%26aulast%3DKelland%26aufirst%3DL.%26atitle%3DThe%2520resurgence%2520of%2520platinum-based%2520cancer%2520chemotherapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D573%26epage%3D584%26doi%3D10.1038%2Fnrc2167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Miller, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadagavadi, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, W. B.</span><span> </span><span class="NLM_article-title">Mechanisms of cisplatin nephrotoxicity</span> <span class="citation_source-journal">Toxins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2518</span><span class="refDoi"> DOI: 10.3390/toxins2112490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.3390%2Ftoxins2112490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=22069563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSht7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=2490-2518&author=R.+P.+Millerauthor=R.+K.+Tadagavadiauthor=G.+Rameshauthor=W.+B.+Reeves&title=Mechanisms+of+cisplatin+nephrotoxicity&doi=10.3390%2Ftoxins2112490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of cisplatin nephrotoxicity</span></div><div class="casAuthors">Miller, Ronald P.; Tadagavadi, Raghu K.; Ramesh, Ganesan; Reeves, William Brian</div><div class="citationInfo"><span class="NLM_cas:title">Toxins</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2490-2518</span>CODEN:
                <span class="NLM_cas:coden">TOXIB7</span>;
        ISSN:<span class="NLM_cas:issn">2072-6651</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Cisplatin is a widely used and highly effective cancer chemotherapeutic agent.  One of the limiting side effects of cisplatin use is nephrotoxicity.  Research over the past 10 years has uncovered many of the cellular mechanisms which underlie cisplatin-induced renal cell death.  It has also become apparent that inflammation provoked by injury to renal epithelial cells serves to amplify kidney injury and dysfunction in vivo.  This review summarizes recent advances in our understanding of cisplatin nephrotoxicity and discusses how these advances might lead to more effective prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquPxscC-wQ87Vg90H21EOLACvtfcHk0lgcWZYCwdEwUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSht7vJ&md5=7fd6f1103c5e8185eeae1b2d9e9f3969</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.3390%2Ftoxins2112490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Ftoxins2112490%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DR.%2BP.%26aulast%3DTadagavadi%26aufirst%3DR.%2BK.%26aulast%3DRamesh%26aufirst%3DG.%26aulast%3DReeves%26aufirst%3DW.%2BB.%26atitle%3DMechanisms%2520of%2520cisplatin%2520nephrotoxicity%26jtitle%3DToxins%26date%3D2010%26volume%3D2%26spage%3D2490%26epage%3D2518%26doi%3D10.3390%2Ftoxins2112490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Graf, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Adxcv. Redox activation of metal-based prodrugs as a strategy for drug delivery</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span><span class="refDoi"> DOI: 10.1016/j.addr.2012.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.addr.2012.01.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=993-1004&author=N.+Grafauthor=S.+J.+Lippard&title=Adxcv.+Redox+activation+of+metal-based+prodrugs+as+a+strategy+for+drug+delivery&doi=10.1016%2Fj.addr.2012.01.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2012.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2012.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DGraf%26aufirst%3DN.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DAdxcv.%2520Redox%2520activation%2520of%2520metal-based%2520prodrugs%2520as%2520a%2520strategy%2520for%2520drug%2520delivery%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2012%26volume%3D64%26spage%3D993%26epage%3D1004%26doi%3D10.1016%2Fj.addr.2012.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shamsuddin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santillan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitmire, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddik, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khokhar, A. R.</span><span> </span><span class="NLM_article-title">Synthesis, characterization, and antitumor activity of new platinum(IV) trans-carboxylate complexes: crystal structure of [Pt(cis-1,4-DACH)trans-(acetate)<sub>2</sub>Cl<sub>2</sub>]</span> <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1016/S0162-0134(98)10029-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2FS0162-0134%2898%2910029-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=9755489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVKhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1998&pages=29-35&author=S.+Shamsuddinauthor=C.+C.+Santillanauthor=J.+L.+Starkauthor=K.+H.+Whitmireauthor=Z.+H.+Siddikauthor=A.+R.+Khokhar&title=Synthesis%2C+characterization%2C+and+antitumor+activity+of+new+platinum%28IV%29+trans-carboxylate+complexes%3A+crystal+structure+of+%5BPt%28cis-1%2C4-DACH%29trans-%28acetate%292Cl2%5D&doi=10.1016%2FS0162-0134%2898%2910029-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization, and antitumor activity of new platinum(IV) trans-carboxylate complexes: crystal structure of [Pt(cis-1,4-DACH)trans-(acetate)2Cl2]</span></div><div class="casAuthors">Shamsuddin, Shaikh; Santillan, Claudia C.; Stark, Joseph L.; Whitmire, Kenton H.; Siddik, Zahid H.; Khokhar, Abdul R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">29-35</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Novel platinum(IV) cisplatin analogs [Pt(cis-1,4-DACH)trans-(L)2Cl2] (cis-1,4-DACH = cis-1,4-diaminocyclohexane and L = acetate, propionate, butyrate, valerate, hexanoate, heptanoate, octanoate, nonanoate, or decanoate) was synthesized and characterized by elemental anal., IR, 13C-NMR, and 195Pt-NMR spectroscopy.  The structure of [Pt(cis-1,4-DACH)trans-(acetate)2Cl2] (1) was detd. by x-ray crystallog.  The crystals were monoclinic, space group P21/n with a 10.193(2), b 10.687(2), c 14.265(3) Å, β 99.67(3)°, Z = 4.  The total reflections collected were 2556.  The structure refinement converged to R1 = 0.0539 and wR2 = 0.1531.  In this complex, platinum has a distorted octahedral geometry, and cis-1,4-DACH is in a unique twist-boat configuration.  Cis-1,4-DACH forms a seven-member chelating ring with platinum, leading to considerable strain in bidentate DACH binding.  The strain is evidenced by a large 126.5(9)° C-N-Pt angle.  The N-Pt-N angle is expanded to 97.4(5)° owing to geometric constraints of the cis-1,4-DACH geometry.  Three lower homologs of the cis-1,4-DACH-Pt(IV) series were tested in the murine L1210/0 leukemia model for antitumor activity.  Activity decreases in ascending the homologous series, and the activity of two of the complexes is substantially better than that of cisplatin with respect to increase in life span and cures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOWfrPyFBr97Vg90H21EOLACvtfcHk0lgcWZYCwdEwUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVKhtLs%253D&md5=8da564a8e2aa07d8c64012c0652fceaa</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2FS0162-0134%2898%2910029-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0162-0134%252898%252910029-6%26sid%3Dliteratum%253Aachs%26aulast%3DShamsuddin%26aufirst%3DS.%26aulast%3DSantillan%26aufirst%3DC.%2BC.%26aulast%3DStark%26aufirst%3DJ.%2BL.%26aulast%3DWhitmire%26aufirst%3DK.%2BH.%26aulast%3DSiddik%26aufirst%3DZ.%2BH.%26aulast%3DKhokhar%26aufirst%3DA.%2BR.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520antitumor%2520activity%2520of%2520new%2520platinum%2528IV%2529%2520trans-carboxylate%2520complexes%253A%2520crystal%2520structure%2520of%2520%255BPt%2528cis-1%252C4-DACH%2529trans-%2528acetate%25292Cl2%255D%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D1998%26volume%3D71%26spage%3D29%26epage%3D35%26doi%3D10.1016%2FS0162-0134%2898%2910029-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hambley, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battle, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrenz, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fallon, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatehouse, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainone, S.</span><span> </span><span class="NLM_article-title">Modifying the properties of platinum (IV) complexes in order to increase biological effectiveness</span> <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/S0162-0134(99)00133-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2FS0162-0134%2899%2900133-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1999&pages=3-12&author=T.+W.+Hambleyauthor=A.+R.+Battleauthor=G.+B.+Deaconauthor=E.+T.+Lawrenzauthor=G.+D.+Fallonauthor=B.+M.+Gatehouseauthor=L.+K.+Websterauthor=S.+Rainone&title=Modifying+the+properties+of+platinum+%28IV%29+complexes+in+order+to+increase+biological+effectiveness&doi=10.1016%2FS0162-0134%2899%2900133-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2FS0162-0134%2899%2900133-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0162-0134%252899%252900133-6%26sid%3Dliteratum%253Aachs%26aulast%3DHambley%26aufirst%3DT.%2BW.%26aulast%3DBattle%26aufirst%3DA.%2BR.%26aulast%3DDeacon%26aufirst%3DG.%2BB.%26aulast%3DLawrenz%26aufirst%3DE.%2BT.%26aulast%3DFallon%26aufirst%3DG.%2BD.%26aulast%3DGatehouse%26aufirst%3DB.%2BM.%26aulast%3DWebster%26aufirst%3DL.%2BK.%26aulast%3DRainone%26aufirst%3DS.%26atitle%3DModifying%2520the%2520properties%2520of%2520platinum%2520%2528IV%2529%2520complexes%2520in%2520order%2520to%2520increase%2520biological%2520effectiveness%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D1999%26volume%3D77%26spage%3D3%26epage%3D12%26doi%3D10.1016%2FS0162-0134%2899%2900133-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mukho-padhyay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haskel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Short, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span><span class="refDoi"> DOI: 10.1021/bc070031k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc070031k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=39-49&author=S.+Mukho-padhyayauthor=C.+M.+Barnesauthor=A.+Haskelauthor=S.+M.+Shortauthor=K.+R.+Barnesauthor=S.+J.+Lippard&title=Conjugated+platinum%28IV%29-peptide+complexes+for+targeting+angiogenic+tumor+vasculature&doi=10.1021%2Fbc070031k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1021%2Fbc070031k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc070031k%26sid%3Dliteratum%253Aachs%26aulast%3DMukho-padhyay%26aufirst%3DS.%26aulast%3DBarnes%26aufirst%3DC.%2BM.%26aulast%3DHaskel%26aufirst%3DA.%26aulast%3DShort%26aufirst%3DS.%2BM.%26aulast%3DBarnes%26aufirst%3DK.%2BR.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DConjugated%2520platinum%2528IV%2529-peptide%2520complexes%2520for%2520targeting%2520angiogenic%2520tumor%2520vasculature%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D39%26epage%3D49%26doi%3D10.1021%2Fbc070031k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Graf, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokhtari, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papayannopoulos, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells</span> <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1016/j.jinorgbio.2012.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.jinorgbio.2012.02.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2012&pages=58-63&author=N.+Grafauthor=T.+E.+Mokhtariauthor=I.+A.+Papayannopoulosauthor=S.+J.+Lippard&title=Platinum%28IV%29-chlorotoxin+%28CTX%29+conjugates+for+targeting+cancer+cells&doi=10.1016%2Fj.jinorgbio.2012.02.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2012.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2012.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DGraf%26aufirst%3DN.%26aulast%3DMokhtari%26aufirst%3DT.%2BE.%26aulast%3DPapayannopoulos%26aufirst%3DI.%2BA.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DPlatinum%2528IV%2529-chlorotoxin%2520%2528CTX%2529%2520conjugates%2520for%2520targeting%2520cancer%2520cells%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2012%26volume%3D110%26spage%3D58%26epage%3D63%26doi%3D10.1016%2Fj.jinorgbio.2012.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Barnes, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2004.03.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.chembiol.2004.03.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=15123250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1Cms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=557-564&author=K.+R.+Barnesauthor=A.+Kutikovauthor=S.+J.+Lippard&title=Synthesis%2C+characterization%2C+and+cytotoxicity+of+a+series+of+estrogen-tethered+platinum%28IV%29+complexes&doi=10.1016%2Fj.chembiol.2004.03.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Characterization, and Cytotoxicity of a Series of Estrogen-Tethered Platinum(IV) Complexes</span></div><div class="casAuthors">Barnes, Katie R.; Kutikov, Alexander; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">557-564</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Several estrogen-tethered platinum(IV) complexes were prepd. and characterized by ESI-MS and 1H NMR spectroscopy.  Their design was inspired by the observation that estrogen receptor-pos. cells exposed to the hormone are sensitized to cisplatin.  Intracellular redn. of bis-estrogen-cis-diamminedichloroplatinum(IV), BEPn (where n = 1-5 methylene groups between Pt and estrogen), occurs to afford cisplatin and two equiv. of the linker-modified estrogen.  The ability of BEPn to induce overexpression of HMGB1 was established by immunofluorescence microscopy.  The cytotoxicity of the compds. was evaluated in ER(+) MCF-7 and ER(-) HCC-1937 human breast cancer cell lines.  BEP3 selectively induces overexpression of HMGB1 in MCF-7 cells, compared to HCC-1937 cells, and enhances their sensitivity (IC50 = 2.1±0.4 μM vs. 3.7±0.9 μM, resp.) to the compd.  The difference in compd. activities and the potential of compds. of this class for treating breast and ovarian cancer are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3dZz7v_qRUbVg90H21EOLACvtfcHk0lhK6qL3yLjaXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1Cms70%253D&md5=871e7ef7a62018dc13df36b0be3a9a0a</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.03.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.03.024%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DK.%2BR.%26aulast%3DKutikov%26aufirst%3DA.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520cytotoxicity%2520of%2520a%2520series%2520of%2520estrogen-tethered%2520platinum%2528IV%2529%2520complexes%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D557%26epage%3D564%26doi%3D10.1016%2Fj.chembiol.2004.03.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Ang, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khalaila, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allardyce, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyson, P. J.</span><span> </span><span class="NLM_article-title">Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">1382</span><span class="NLM_x">–</span> <span class="NLM_lpage">1383</span><span class="refDoi"> DOI: 10.1021/ja0432618</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0432618" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=1382-1383&author=W.+H.+Angauthor=I.+Khalailaauthor=C.+S.+Allardyceauthor=L.+Juillerat-Jeanneretauthor=P.+J.+Dyson&title=Rational+design+of+platinum%28IV%29+compounds+to+overcome+glutathione-S-transferase+mediated+drug+resistance&doi=10.1021%2Fja0432618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5fR"><div class="casContent"><span class="casTitleNuber">5f</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Platinum(IV) Compounds to Overcome Glutathione-S-Transferase Mediated Drug Resistance</span></div><div class="casAuthors">Ang, Wee Han; Khalaila, Isam; Allardyce, Claire S.; Juillerat-Jeanneret, Lucienne; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1382-1383</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A rationally designed Pt(IV) anticancer compd. is described, employing the novel concept of tethering an inhibitor of glutathione-S-transferase, an enzyme assocd. with Pt-based drug-resistance, to cisplatin.  Its enzyme inhibition activity, investigated using spectrophotometric and mass spectrometry-based techniques, and cytotoxic profile in resistant cancer cells are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7VgXIgOAQKLVg90H21EOLACvtfcHk0lgRVHnt5w46gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFGmsA%253D%253D&md5=814c125e4c704b8b1a3811f1e01eedfd</span></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=10.1021%2Fja0432618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0432618%26sid%3Dliteratum%253Aachs%26aulast%3DAng%26aufirst%3DW.%2BH.%26aulast%3DKhalaila%26aufirst%3DI.%26aulast%3DAllardyce%26aufirst%3DC.%2BS.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DRational%2520design%2520of%2520platinum%2528IV%2529%2520compounds%2520to%2520overcome%2520glutathione-S-transferase%2520mediated%2520drug%2520resistance%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D1382%26epage%3D1383%26doi%3D10.1021%2Fja0432618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Dhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">22199</span><span class="NLM_x">–</span> <span class="NLM_lpage">22204</span><span class="refDoi"> DOI: 10.1073/pnas.0912276106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1073%2Fpnas.0912276106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=20007777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=22199-22204&author=S.+Dharauthor=S.+J.+Lippard&title=Mitaplatin%2C+a+potent+fusion+of+cisplatin+and+the+orphan+drug+dichloroacetate&doi=10.1073%2Fpnas.0912276106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5gR"><div class="casContent"><span class="casTitleNuber">5g</span><div class="casTitle"><span class="NLM_cas:atitle">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span></div><div class="casAuthors">Dhar, Shanta; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">22199-22204, S22199/1-S22199/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The unique glycolytic metab. of most solid tumors, known as the Warburg effect, is assocd. with resistance to apoptosis that enables cancer cells to survive.  Dichloroacetate (DCA) is an anticancer agent that can reverse the Warburg effect by inhibiting a key enzyme in cancer cells, pyruvate dehydrogenase kinase (PDK), that is required for the process.  DCA is currently not approved for cancer treatment in the USA.  Here, we present the synthesis, characterization, and anticancer properties of c,t,c-[Pt(NH3)2(02CHCl2)2Cl2], mitaplatin, in which two DCA units are appended to the axial positions of a six-coordinate Pt(IV) center.  The neg. intracellular redox potential reduces the platinum to release cisplatin, a Pt(II) compd., and two equiv. of DCA.  By a unique mechanism, mitaplatin thereby attacks both nuclear DNA with cisplatin and mitochondria with DCA selectively in cancer cells.  The cytotoxicity of mitaplatin in a variety of cancer cell lines equals or exceeds that of all known Pt(IV) compds. and is comparable to that of cisplatin.  Mitaplatin alters the mitochondrial membrane potential gradient (Δψm) of cancer cells, promoting apoptosis by releasing cytochrome c and translocating apoptosis inducing factor from mitochondria to the nucleus.  Cisplatin formed upon cellular redn. of mitaplatin enters the nucleus and targets DNA to form 1,2-intrastrand d(GpG) cross-links characteristic of its own potency as an anticancer drug.  These properties of mitaplatin are manifest in its ability to selectively kill cancer cells cocultured with normal fibroblasts and to partially overcome cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Dar40eUqpLVg90H21EOLACvtfcHk0lgRVHnt5w46gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D&md5=7d8f3946238537b33ff15a49a4b13d3d</span></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0912276106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0912276106%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DS.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DMitaplatin%252C%2520a%2520potent%2520fusion%2520of%2520cisplatin%2520and%2520the%2520orphan%2520drug%2520dichloroacetate%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D22199%26epage%3D22204%26doi%3D10.1073%2Fpnas.0912276106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span> </span><span class="NLM_article-title">Conjugate of Pt(IV)-histone deacetylase inhibitor as a prodrug for cancer chemotherapy</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2793</span><span class="NLM_x">–</span> <span class="NLM_lpage">2800</span><span class="refDoi"> DOI: 10.1021/mp200597r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp200597r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=2793-2800&author=J.+Yangauthor=X.+Sunauthor=W.+Maoauthor=M.+Suiauthor=J.+Tangauthor=Y.+Shen&title=Conjugate+of+Pt%28IV%29-histone+deacetylase+inhibitor+as+a+prodrug+for+cancer+chemotherapy&doi=10.1021%2Fmp200597r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5hR"><div class="casContent"><span class="casTitleNuber">5h</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugate of Pt(IV)-Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy</span></div><div class="casAuthors">Yang, Jun; Sun, Xuanrong; Mao, Weiwei; Sui, Meihua; Tang, Jianbin; Shen, Youqing</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2793-2800</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Platinum(IV) prodrug diaminedichlorodihydroxyplatinum (ACHP) conjugated with a histone deacetylase (HDAC) inhibitor valproic acid (VA), VAAP, exhibited strong synergistic cytotoxicity, about 50-100 times more cytotoxic than ACHP or its simple mixt. with VA, against various human carcinoma cell lines.  VAAP could be quickly absorbed in the cell membrane and diffused into the cytosol.  VAAP loaded in polyethylene glycol-polycaprolactone micelles (PEG-PCL) was taken up via endocytosis.  The cytosolic VAAP was intracellular reduced to Pt(II) and released VA eliciting a HDAC inhibitory effect and subsequently induced cell cycle arrest at the S phase in 24 h and cell apoptosis in a time-dependent manner.  The in vivo antitumor expt. on A549-xenograft tumor model showed that VAAP dispersed in Tween 80 or loaded in PEG-PCL nanoparticles had long blood circulation times and thereby high accumulation in tumors and exerted a significant in vivo inhibitory effect on tumor growth with low systemic toxicity.  Therefore, this novel conjugate is very promising for cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeW1MFD6bedbVg90H21EOLACvtfcHk0lgRVHnt5w46gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrrK&md5=838e90dcb852b4dddeb424832f46ab15</span></div><a href="/servlet/linkout?suffix=cit5h&amp;dbid=16384&amp;doi=10.1021%2Fmp200597r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp200597r%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DSui%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DConjugate%2520of%2520Pt%2528IV%2529-histone%2520deacetylase%2520inhibitor%2520as%2520a%2520prodrug%2520for%2520cancer%2520chemotherapy%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D2793%26epage%3D2800%26doi%3D10.1021%2Fmp200597r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Suntharalingam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Conjugation of vitamin E analog a-TOS to Pt(IV) complexes for dual-targeting anticancer therapy</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2465</span><span class="NLM_x">–</span> <span class="NLM_lpage">2468</span><span class="refDoi"> DOI: 10.1039/c3cc48740g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1039%2Fc3cc48740g" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=2465-2468&author=K.+Suntharalingamauthor=Y.+Songauthor=S.+J.+Lippard&title=Conjugation+of+vitamin+E+analog+a-TOS+to+Pt%28IV%29+complexes+for+dual-targeting+anticancer+therapy&doi=10.1039%2Fc3cc48740g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5i&amp;dbid=16384&amp;doi=10.1039%2Fc3cc48740g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cc48740g%26sid%3Dliteratum%253Aachs%26aulast%3DSuntharalingam%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DConjugation%2520of%2520vitamin%2520E%2520analog%2520a-TOS%2520to%2520Pt%2528IV%2529%2520complexes%2520for%2520dual-targeting%2520anticancer%2520therapy%26jtitle%3DChem.%2520Commun.%26date%3D2014%26volume%3D50%26spage%3D2465%26epage%3D2468%26doi%3D10.1039%2Fc3cc48740g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Calvaresi, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hergenrother, P. J.</span><span> </span><span class="NLM_article-title">Glucose conjugation for the specific targeting and treatment of cancer</span> <span class="citation_source-journal">Chem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2319</span><span class="NLM_x">–</span> <span class="NLM_lpage">2333</span><span class="refDoi"> DOI: 10.1039/c3sc22205e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1039%2Fc3sc22205e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=24077675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntV2jsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2319-2333&author=E.+C.+Calvaresiauthor=P.+J.+Hergenrother&title=Glucose+conjugation+for+the+specific+targeting+and+treatment+of+cancer&doi=10.1039%2Fc3sc22205e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose conjugation for the specific targeting and treatment of cancer</span></div><div class="casAuthors">Calvaresi, Emilia C.; Hergenrother, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2319-2333</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Cancers of diverse origins exhibit marked glucose avidity and high rates of aerobic glycolysis.  Increased understanding of this dysfunctional metab. known as the Warburg effect has led to an interest in targeting it for cancer therapy.  One promising strategy for such targeting is glycoconjugation, the linking of a drug to glucose or another sugar.  This review summarizes the most salient examples of glycoconjugates, in which known cytotoxins or anticancer therapeutics were linked to glucose (or another glucose transporter substrate sugar) for improved cancer targeting and selectivity.  Building on these examples, this review also provides a series of guidelines for the design and mechanistic evaluation of future glycoconjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRBb0dfq_1NrVg90H21EOLACvtfcHk0lhL8Bis20Whxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntV2jsrY%253D&md5=3ede88f390b141479c271a220fae56d2</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1039%2Fc3sc22205e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3sc22205e%26sid%3Dliteratum%253Aachs%26aulast%3DCalvaresi%26aufirst%3DE.%2BC.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DGlucose%2520conjugation%2520for%2520the%2520specific%2520targeting%2520and%2520treatment%2520of%2520cancer%26jtitle%3DChem.%2520Sci.%26date%3D2013%26volume%3D4%26spage%3D2319%26epage%3D2333%26doi%3D10.1039%2Fc3sc22205e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ben-Haim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ell, P.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-FDG PET and PET/CT in the evaluation of cancer treatment response</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.2967/jnumed.108.054205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.2967%2Fjnumed.108.054205" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=88-99&author=S.+Ben-Haimauthor=P.+Ell&title=18F-FDG+PET+and+PET%2FCT+in+the+evaluation+of+cancer+treatment+response&doi=10.2967%2Fjnumed.108.054205"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.108.054205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.108.054205%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Haim%26aufirst%3DS.%26aulast%3DEll%26aufirst%3DP.%26atitle%3D18F-FDG%2520PET%2520and%2520PET%252FCT%2520in%2520the%2520evaluation%2520of%2520cancer%2520treatment%2520response%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2009%26volume%3D50%26spage%3D88%26epage%3D99%26doi%3D10.2967%2Fjnumed.108.054205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">He, Q.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. O.</span><span> </span><span class="NLM_article-title">Targeted delivery and sustained antitumor activity of triptolide through glucose conjugation</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">12035</span><span class="NLM_x">–</span> <span class="NLM_lpage">12039</span><span class="refDoi"> DOI: 10.1002/anie.201606121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2Fanie.201606121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=12035-12039&author=Q.-L.+Heauthor=I.+Minnauthor=Q.+Wangauthor=P.+Xuauthor=S.+A.+Headauthor=E.+Datanauthor=B.+Yuauthor=M.+G.+Pomperauthor=J.+O.+Liu&title=Targeted+delivery+and+sustained+antitumor+activity+of+triptolide+through+glucose+conjugation&doi=10.1002%2Fanie.201606121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1002%2Fanie.201606121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201606121%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DQ.-L.%26aulast%3DMinn%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DHead%26aufirst%3DS.%2BA.%26aulast%3DDatan%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26atitle%3DTargeted%2520delivery%2520and%2520sustained%2520antitumor%2520activity%2520of%2520triptolide%2520through%2520glucose%2520conjugation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D12035%26epage%3D12039%26doi%3D10.1002%2Fanie.201606121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vander Heiden, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">Understanding the warburg effect: the metabolic requirements of cell proliferation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1033</span><span class="refDoi"> DOI: 10.1126/science.1160809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1126%2Fscience.1160809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=19460998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=1029-1033&author=M.+G.+Vander+Heidenauthor=L.+C.+Cantleyauthor=C.+B.+Thompson&title=Understanding+the+warburg+effect%3A+the+metabolic+requirements+of+cell+proliferation&doi=10.1126%2Fscience.1160809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation</span></div><div class="casAuthors">Vander Heiden, Matthew G.; Cantley, Lewis C.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5930</span>),
    <span class="NLM_cas:pages">1029-1033</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes, most cancer cells instead rely on aerobic glycolysis, a phenomenon termed "the Warburg effect".  Aerobic glycolysis is an inefficient way to generate ATP, however, and the advantage it confers to cancer cells has been unclear.  Here we propose that the metab. of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass (e.g., nucleotides, amino acids, and lipids) needed to produce a new cell.  Supporting this idea are recent studies showing that (i) several signaling pathways implicated in cell proliferation also regulate metabolic pathways that incorporate nutrients into biomass; and that (ii) certain cancer-assocd. mutations enable cancer cells to acquire and metabolize nutrients in a manner conducive to proliferation rather than efficient ATP prodn.  A better understanding of the mechanistic links between cellular metab. and growth control may ultimately lead to better treatments for human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGvLHGQ9TX77Vg90H21EOLACvtfcHk0lhL8Bis20Whxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D&md5=f927402a43cdca471c3f4874dcbeb943</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1160809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1160809%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DUnderstanding%2520the%2520warburg%2520effect%253A%2520the%2520metabolic%2520requirements%2520of%2520cell%2520proliferation%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D1029%26epage%3D1033%26doi%3D10.1126%2Fscience.1160809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Warburg, O.</span><span> </span><span class="NLM_article-title">On the origin of cancer cells</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1956</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span><span class="refDoi"> DOI: 10.1126/science.123.3191.309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1126%2Fscience.123.3191.309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=13298683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1956&pages=309-314&author=O.+Warburg&title=On+the+origin+of+cancer+cells&doi=10.1126%2Fscience.123.3191.309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">On the origin of cancer cells</span></div><div class="casAuthors">WARBURG O</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">3191</span>),
    <span class="NLM_cas:pages">309-14</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDsp1coYpQW669lAbTj9rGfW6udTcc2eYX0jVIkLXcHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D&md5=860d5ce9456831968fcc897b37d6d9c2</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1126%2Fscience.123.3191.309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.123.3191.309%26sid%3Dliteratum%253Aachs%26aulast%3DWarburg%26aufirst%3DO.%26atitle%3DOn%2520the%2520origin%2520of%2520cancer%2520cells%26jtitle%3DScience%26date%3D1956%26volume%3D123%26spage%3D309%26epage%3D314%26doi%3D10.1126%2Fscience.123.3191.309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Szablewski, L.</span><span> </span><span class="NLM_article-title">Biochim. Biophys. Expression of glucose transporters in cancers</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1835</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span><span class="refDoi"> DOI: 10.1016/j.bbcan.2012.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.bbcan.2012.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=23266512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVeksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1835&publication_year=2013&pages=164-169&author=L.+Szablewski&title=Biochim.+Biophys.+Expression+of+glucose+transporters+in+cancers&doi=10.1016%2Fj.bbcan.2012.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of glucose transporters in cancers</span></div><div class="casAuthors">Szablewski, Leszek</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1835</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-169</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  It has been known for 80 years that cancer cell growth in an energy-related process supported by an increased glucose metab.  This phenomenon suggests a need for a corresponding increased uptake of glucose across the plasma membrane through an enhancement in the glucose transporter proteins, SGLT proteins as well as GLUT proteins.  The results of many studies have demonstrated that the expression of glucose transporters, esp. GLUT1, is increased in a variety of malignancies.  GLUT1 overexpression has been found to be assocd. with tumor progression.  It was found that GLUT1 overexpression is assocd. with poor overall survival in various malignant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg5-w4WRFRJLVg90H21EOLACvtfcHk0lids-4fO839dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVeksLo%253D&md5=10875eb2ffba33f6890befed65fa21d3</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2012.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2012.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DSzablewski%26aufirst%3DL.%26atitle%3DBiochim.%2520Biophys.%2520Expression%2520of%2520glucose%2520transporters%2520in%2520cancers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2013%26volume%3D1835%26spage%3D164%26epage%3D169%26doi%3D10.1016%2Fj.bbcan.2012.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braunschweiger, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span> </span><span class="NLM_article-title">A carbohydrate-linked cisplatin analogue having antitumor activity</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1768</span><span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19990614)38:12<1768::AID-ANIE1768>3.0.CO;2-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1768%3A%3AAID-ANIE1768%3E3.0.CO%3B2-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADyaK1MXktVCntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1768&author=Y.+Chenauthor=M.+J.+Heegauthor=P.+G.+Braunschweigerauthor=W.+Xieauthor=P.+G.+Wang&title=A+carbohydrate-linked+cisplatin+analogue+having+antitumor+activity&doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1768%3A%3AAID-ANIE1768%3E3.0.CO%3B2-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">A carbohydrate-linked cisplatin analogue having antitumor activity</span></div><div class="casAuthors">Chen, Yongsheng; Heeg, Mary J.; Braunschweiger, Paul G.; Xie, Wenhua; Wang, Peng G.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1768-1769</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The authors report on the synthesis, characterization, and cytotoxicity of a novel carbohydrate-linked cisplatin analog, cis-dichloro[(2-3-D-glucopyranosidyl)propane-l,3-diamine]platinum (I).  I was characterized by 1H and 13C NMR spectroscopy which confirms complex formation in water.  The x-ray crystal structure anal. of I reveals that there are two independent mols. in the crystal.  In both mols., the intact and unprotected β-D-glucopyranose moiety is connected to platinum through the 2-propane-1,3-diamine linker group, which acts as a neutral bidendate ligand and coordinates through the two amino groups.  The coordination about platinum is roughly square planar as expected, and the six-membered chelate ring is in a chair conformation as is the glucopyranose ring.  The in vitro antitumor activity of I shows that it is as active as cisplatin against human ovarian cancer cell A278OS and human melanoma cancer cell MeWo, but less active against human ovarian cancer cell A2780cP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo54HRm2aRFI7Vg90H21EOLACvtfcHk0lids-4fO839dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVCntLg%253D&md5=c480614723cccb5078b2a6a808a6c1a6</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1768%3A%3AAID-ANIE1768%3E3.0.CO%3B2-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819990614%252938%253A12%253C1768%253A%253AAID-ANIE1768%253E3.0.CO%253B2-6%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHeeg%26aufirst%3DM.%2BJ.%26aulast%3DBraunschweiger%26aufirst%3DP.%2BG.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DP.%2BG.%26atitle%3DA%2520carbohydrate-linked%2520cisplatin%2520analogue%2520having%2520antitumor%2520activity%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D1768%26doi%3D10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1768%3A%3AAID-ANIE1768%3E3.0.CO%3B2-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang-Negrerie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span> </span><span class="NLM_article-title">Highly water-soluble platinum(II) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2421</span><span class="NLM_x">–</span> <span class="NLM_lpage">2423</span><span class="refDoi"> DOI: 10.1039/c3cc38589b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1039%2Fc3cc38589b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=23420130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVClt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=2421-2423&author=P.+Liuauthor=Y.+Luauthor=X.+Gaoauthor=R.+Liuauthor=D.+Zhang-Negrerieauthor=Y.+Shiauthor=Y.+Wangauthor=S.+Wangauthor=Q.+Gao&title=Highly+water-soluble+platinum%28II%29+complexes+as+GLUT+substrates+for+targeted+therapy%3A+improved+anticancer+efficacy+and+transporter-mediated+cytotoxic+properties&doi=10.1039%2Fc3cc38589b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Highly water-soluble platinum(II) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties</span></div><div class="casAuthors">Liu, Pengxing; Lu, Yanhui; Gao, Xiangqian; Liu, Ran; Zhang-Negrerie, Daisy; Shi, Ying; Wang, Yiqiang; Wang, Songqing; Gao, Qingzhi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2421-2423</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Glucose-conjugated malonato Pt(II) R,R-cyclohexanediamine complexes are designed and synthesized to target tumor-specific active transporters, namely, glucose transporters (GLUTs).  The complexes exhibit much higher aq. soly. by 150 times, improved potency in cytotoxicities by 10 times, and increased therapeutic index by over 30 fold compared to the newest generation of clin. drugs oxaliplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGbUs-f_ZR-LVg90H21EOLACvtfcHk0lids-4fO839dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVClt7w%253D&md5=dc9b30b67047b8b9797965e40eff516f</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1039%2Fc3cc38589b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cc38589b%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DZhang-Negrerie%26aufirst%3DD.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DQ.%26atitle%3DHighly%2520water-soluble%2520platinum%2528II%2529%2520complexes%2520as%2520GLUT%2520substrates%2520for%2520targeted%2520therapy%253A%2520improved%2520anticancer%2520efficacy%2520and%2520transporter-mediated%2520cytotoxic%2520properties%26jtitle%3DChem.%2520Commun.%26date%3D2013%26volume%3D49%26spage%3D2421%26epage%3D2423%26doi%3D10.1039%2Fc3cc38589b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span> </span><span class="NLM_article-title">Glucose conjugated platinum(II) complex: antitumor superiority to oxaliplatin, combination effect and mechanism of action</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.ejmech.2015.07.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2015&pages=400-408&author=H.+Liauthor=X.+Gaoauthor=R.+Liuauthor=Y.+Wangauthor=M.+Zhangauthor=Z.+Fuauthor=Y.+Miauthor=Y.+Wangauthor=Z.+Yaoauthor=Q.+Gao&title=Glucose+conjugated+platinum%28II%29+complex%3A+antitumor+superiority+to+oxaliplatin%2C+combination+effect+and+mechanism+of+action&doi=10.1016%2Fj.ejmech.2015.07.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DZ.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DQ.%26atitle%3DGlucose%2520conjugated%2520platinum%2528II%2529%2520complex%253A%2520antitumor%2520superiority%2520to%2520oxaliplatin%252C%2520combination%2520effect%2520and%2520mechanism%2520of%2520action%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D101%26spage%3D400%26epage%3D408%26doi%3D10.1016%2Fj.ejmech.2015.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Möker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiem, J.</span><span> </span><span class="NLM_article-title">Synthesis and hydrolysis studies of novel glyco-functionalized platinum complexes</span> <span class="citation_source-journal">Carbohydr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1016/j.carres.2011.08.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.carres.2011.08.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2012&pages=14-26&author=J.+M%C3%B6kerauthor=J.+Thiem&title=Synthesis+and+hydrolysis+studies+of+novel+glyco-functionalized+platinum+complexes&doi=10.1016%2Fj.carres.2011.08.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1016%2Fj.carres.2011.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.carres.2011.08.024%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ker%26aufirst%3DJ.%26aulast%3DThiem%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520hydrolysis%2520studies%2520of%2520novel%2520glyco-functionalized%2520platinum%2520complexes%26jtitle%3DCarbohydr.%2520Res.%26date%3D2012%26volume%3D348%26spage%3D14%26epage%3D26%26doi%3D10.1016%2Fj.carres.2011.08.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Hartinger, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazarov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashraf, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keppler, B. K.</span><span> </span><span class="NLM_article-title">Carbohydrate-metal complexes and their potential as anticancer agents</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2574</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span><span class="refDoi"> DOI: 10.2174/092986708785908978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.2174%2F092986708785908978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=18855680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SgtbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=2574-2591&author=C.+G.+Hartingerauthor=A.+A.+Nazarovauthor=S.+M.+Ashrafauthor=P.+J.+Dysonauthor=B.+K.+Keppler&title=Carbohydrate-metal+complexes+and+their+potential+as+anticancer+agents&doi=10.2174%2F092986708785908978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8eR"><div class="casContent"><span class="casTitleNuber">8e</span><div class="casTitle"><span class="NLM_cas:atitle">Carbohydrate-metal complexes and their potential as anticancer agents</span></div><div class="casAuthors">Hartinger, Christian G.; Nazarov, Alexey A.; Ashraf, Shaheen M.; Dyson, Paul J.; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2574-2591</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Platinum complex-based chemotherapy is one of the major treatment options of many malignancies.  Although severe side effects occur, and only a limited spectrum of tumors can be cured, Pt compds. are used in every second therapy scheme.  Thus, many different drug design strategies have been employed for improving the properties of anticancer drugs including pH or redox activation in the tumor, variation of the metal center and therefore the redox and ligand exchange properties, the application of multinuclear metal complexes, the development of targeted approaches, etc.  Application of carbohydrate-metal complexes is an example of a targeted approach exploiting the biochem. and metabolic functions of diverse sugars in living organisms for transport and accumulation.  Natural carbohydrates and synthetic derivs. possess a manifold of donors endowing them with the ability to coordinate metal centers and providing some addnl. advantages over other ligands, e.g., biocompatibility, nontoxicity, enantiomeric purity, water soly., and well-explored chem.  In recent years, several examples of carbohydrate compds. have been developed for diverse medicinal applications ranging from compds. with antibiotic, antiviral, or fungicidal activity and anticancer compds.  Herein, metal complexes with carbohydrate ligands are reviewed and the role of the carbohydrate carriers on the antineoplastic activity of these compds., both in vitro and in vivo, is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDKAg8Ljvhn7Vg90H21EOLACvtfcHk0lgH3EwPZZrrGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SgtbbE&md5=388b8fe1af336b577f234f79f3b6ba3b</span></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.2174%2F092986708785908978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708785908978%26sid%3Dliteratum%253Aachs%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DNazarov%26aufirst%3DA.%2BA.%26aulast%3DAshraf%26aufirst%3DS.%2BM.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DCarbohydrate-metal%2520complexes%2520and%2520their%2520potential%2520as%2520anticancer%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D2574%26epage%3D2591%26doi%3D10.2174%2F092986708785908978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Patra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suntharalingam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">A potent glucose–platinum conjugate exploits glucose transporters and preferentially accumulates in cancer cells</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2550</span><span class="NLM_x">–</span> <span class="NLM_lpage">2554</span><span class="refDoi"> DOI: 10.1002/anie.201510551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2Fanie.201510551" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=2550-2554&author=M.+Patraauthor=T.+C.+Johnstoneauthor=K.+Suntharalingamauthor=S.+J.+Lippard&title=A+potent+glucose%E2%80%93platinum+conjugate+exploits+glucose+transporters+and+preferentially+accumulates+in+cancer+cells&doi=10.1002%2Fanie.201510551"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=10.1002%2Fanie.201510551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201510551%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DM.%26aulast%3DJohnstone%26aufirst%3DT.%2BC.%26aulast%3DSuntharalingam%26aufirst%3DK.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DA%2520potent%2520glucose%25E2%2580%2593platinum%2520conjugate%2520exploits%2520glucose%2520transporters%2520and%2520preferentially%2520accumulates%2520in%2520cancer%2520cells%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D2550%26epage%3D2554%26doi%3D10.1002%2Fanie.201510551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Patra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awuah, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Chemical approach to positional isomers of glucose platinum conjugates reveals specific cancer targeting through glucose-transporter mediated uptake in vitro and in vivo</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">12541</span><span class="NLM_x">–</span> <span class="NLM_lpage">12551</span><span class="refDoi"> DOI: 10.1021/jacs.6b06937</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b06937" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=12541-12551&author=M.+Patraauthor=S.+G.+Awuahauthor=S.+J.+Lippard&title=Chemical+approach+to+positional+isomers+of+glucose+platinum+conjugates+reveals+specific+cancer+targeting+through+glucose-transporter+mediated+uptake+in+vitro+and+in+vivo&doi=10.1021%2Fjacs.6b06937"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8g&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b06937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b06937%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DM.%26aulast%3DAwuah%26aufirst%3DS.%2BG.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DChemical%2520approach%2520to%2520positional%2520isomers%2520of%2520glucose%2520platinum%2520conjugates%2520reveals%2520specific%2520cancer%2520targeting%2520through%2520glucose-transporter%2520mediated%2520uptake%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26spage%3D12541%26epage%3D12551%26doi%3D10.1021%2Fjacs.6b06937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span> </span><span class="NLM_article-title">Glycosylated platinum(IV) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects</span> <span class="citation_source-journal">Dalton Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">11830</span><span class="NLM_x">–</span> <span class="NLM_lpage">11838</span><span class="refDoi"> DOI: 10.1039/C6DT02207C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1039%2FC6DT02207C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=27373800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGnsLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=11830-11838&author=J.+Maauthor=Q.+Wangauthor=X.+Yangauthor=W.+Haoauthor=Z.+Huangauthor=J.+Zhangauthor=X.+Wangauthor=P.+Wang&title=Glycosylated+platinum%28IV%29+prodrugs+demonstrated+significant+therapeutic+efficacy+in+cancer+cells+and+minimized+side-effects&doi=10.1039%2FC6DT02207C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8hR"><div class="casContent"><span class="casTitleNuber">8h</span><div class="casTitle"><span class="NLM_cas:atitle">Glycosylated platinum(IV) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects</span></div><div class="casAuthors">Ma, Jing; Wang, Qingpeng; Yang, Xiande; Hao, Wenpei; Huang, Zhonglv; Zhang, Jiabao; Wang, Xin; Wang, Peng George</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">11830-11838</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Conjugates (A1-A5) of the Pt(IV) deriv. (A6) with amino groups from peracetyl glucose, rhamnose and mannose with a Pr amino or Et amino linker at the reducing end were synthesized and exhibited significant therapeutic efficacy in tumor cells, esp. for prostate cancer (PCa).  The antitumor activities are greatly affected by glycosyl groups.  Cytotoxic expts. in vitro indicated that the antitumor activities were increased by 5-fold when its Pt(IV) deriv. was conjugated to S18 (IC50 = 4.82 ± 0.45 μM) and by 12-fold when conjugated to S21 (IC50 = 1.9 ± 0.67 μM).  The mannose substituted Pt(IV) complexes A4 and A5 were also over an order of magnitude more potent towards HeLa, A549, MCF-7 and PC3 than cisplatin and oxaliplatin.  Importantly, the glycosylated Pt(IV) derivs. A4 and A5 displayed potential safety for clin. therapeutic exposure with IC50 of 84 μM and 169 μM compared with cisplatin (IC50 = 8 μM) to 3T3.  Cellular uptake and DNA platination are higher than cisplatin and oxaliplatin.  ESI-MS anal. of A5 binding to 5'-dGMP revealed that bifunctional DNA lesions were formed.  The antitumor activities in vivo showed that the MTD and LD50 for A4 and A5 are nearly 4-fold higher than that of oxaliplatin indicating the potential safety for the glycosylated Pt(IV) complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3OOKQeJIPAbVg90H21EOLACvtfcHk0lhqEylJW94uVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGnsLvO&md5=b982d491d8176b4dc24c43cc97621d07</span></div><a href="/servlet/linkout?suffix=cit8h&amp;dbid=16384&amp;doi=10.1039%2FC6DT02207C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6DT02207C%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DHao%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DP.%26atitle%3DGlycosylated%2520platinum%2528IV%2529%2520prodrugs%2520demonstrated%2520significant%2520therapeutic%2520efficacy%2520in%2520cancer%2520cells%2520and%2520minimized%2520side-effects%26jtitle%3DDalton%2520Trans.%26date%3D2016%26volume%3D45%26spage%3D11830%26epage%3D11838%26doi%3D10.1039%2FC6DT02207C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of a novel series of glycosylated Platinum(IV) complexes as antitumor agents</span> <span class="citation_source-journal">Dalton Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">10366</span><span class="NLM_x">–</span> <span class="NLM_lpage">10374</span><span class="refDoi"> DOI: 10.1039/C6DT01562J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1039%2FC6DT01562J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8i&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=27252024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot12jt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=10366-10374&author=Q.+Wangauthor=Z.+Huangauthor=J.+Maauthor=X.+Luauthor=L.+Zhangauthor=X.+Wangauthor=P.+G.+Wang&title=Design%2C+synthesis+and+biological+evaluation+of+a+novel+series+of+glycosylated+Platinum%28IV%29+complexes+as+antitumor+agents&doi=10.1039%2FC6DT01562J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8iR"><div class="casContent"><span class="casTitleNuber">8i</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of a novel series of glycosylated platinum(IV) complexes as antitumor agents</span></div><div class="casAuthors">Wang, Qingpeng; Huang, Zhonglv; Ma, Jing; Lu, Xiaolin; Zhang, Li; Wang, Xin; Peng, George Wang</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">10366-10374</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A new series of glycosylated Pt(IV) complexes were designed, synthesized and evaluated for antitumor activities in vitro and in vivo.  The incorporation of glycosyl groups to the Pt(IV) system has much influence on the antitumor abilities.  Four lead compds. with activities comparable or even superior to cisplatin and oxaliplatin are screened out.  These Pt(IV) complexes could be reduced to release Pt(II) complexes and cause the death of tumor cells.  The apoptosis-inducing properties of these compds. are similar to cisplatin.  The accumulation of the glycosylated Pt(IV) complexes in cells and DNA is higher than cisplatin and oxaliplatin.  The in vivo assay demonstrates that the tested compds. inhibit the growth of HepG2 tumors with low toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgpmOlnnEHmbVg90H21EOLACvtfcHk0lht1RkTHvpBvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot12jt78%253D&md5=afb0024161b9623d4dfa664eb41a7366</span></div><a href="/servlet/linkout?suffix=cit8i&amp;dbid=16384&amp;doi=10.1039%2FC6DT01562J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6DT01562J%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DP.%2BG.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520series%2520of%2520glycosylated%2520Platinum%2528IV%2529%2520complexes%2520as%2520antitumor%2520agents%26jtitle%3DDalton%2520Trans.%26date%3D2016%26volume%3D45%26spage%3D10366%26epage%3D10374%26doi%3D10.1039%2FC6DT01562J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Galluzzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senovilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michels, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepp, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castedo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of cisplatin resistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1869</span><span class="NLM_x">–</span> <span class="NLM_lpage">1883</span><span class="refDoi"> DOI: 10.1038/onc.2011.384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1038%2Fonc.2011.384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=21892204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFWrsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=1869-1883&author=L.+Galluzziauthor=L.+Senovillaauthor=I.+Vitaleauthor=J.+Michelsauthor=I.+Martinsauthor=O.+Keppauthor=M.+Castedoauthor=G.+Kroemer&title=Molecular+mechanisms+of+cisplatin+resistance&doi=10.1038%2Fonc.2011.384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of cisplatin resistance</span></div><div class="casAuthors">Galluzzi, L.; Senovilla, L.; Vitale, I.; Michels, J.; Martins, I.; Kepp, O.; Castedo, M.; Kroemer, G.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1869-1883</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Platinum-based drugs, and in particular cis-diamminedichloroplatinum(II) (best known as cisplatin), are employed for the treatment of a wide array of solid malignancies, including testicular, ovarian, head and neck, colorectal, bladder and lung cancers.  Cisplatin exerts anticancer effects via multiple mechanisms, yet its most prominent (and best understood) mode of action involves the generation of DNA lesions followed by the activation of the DNA damage response and the induction of mitochondrial apoptosis.  Despite a consistent rate of initial responses, cisplatin treatment often results in the development of chemoresistance, leading to therapeutic failure.  An intense research has been conducted during the past 30 years and several mechanisms that account for the cisplatin-resistant phenotype of tumor cells have been described.  Here, we provide a systematic discussion of these mechanism by classifying them in alterations (1) that involve steps preceding the binding of cisplatin to DNA (pre-target resistance), (2) that directly relate to DNA-cisplatin adducts (on-target resistance), (3) concerning the lethal signaling pathway(s) elicited by cisplatin-mediated DNA damage (post-target resistance) and (4) affecting mol. circuitries that do not present obvious links with cisplatin-elicited signals (off-target resistance).  As in some clin. settings cisplatin constitutes the major therapeutic option, the development of chemosensitization strategies constitute a goal with important clin. implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxTrgUhh4V17Vg90H21EOLACvtfcHk0lht1RkTHvpBvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFWrsr7E&md5=4f947e6d5b834673b819e88b06309a53</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.384%26sid%3Dliteratum%253Aachs%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DSenovilla%26aufirst%3DL.%26aulast%3DVitale%26aufirst%3DI.%26aulast%3DMichels%26aufirst%3DJ.%26aulast%3DMartins%26aufirst%3DI.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DCastedo%26aufirst%3DM.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMolecular%2520mechanisms%2520of%2520cisplatin%2520resistance%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26spage%3D1869%26epage%3D1883%26doi%3D10.1038%2Fonc.2011.384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wexselblatt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yavin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, D.</span><span> </span><span class="NLM_article-title">Review: cellular interactions of platinum drugs</span> <span class="citation_source-journal">Inorg. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span><span class="refDoi"> DOI: 10.1016/j.ica.2012.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.ica.2012.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1emu7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=2012&pages=75-83&author=E.+Wexselblattauthor=E.+Yavinauthor=D.+Gibson&title=Review%3A+cellular+interactions+of+platinum+drugs&doi=10.1016%2Fj.ica.2012.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular interactions of platinum drugs</span></div><div class="casAuthors">Wexselblatt, Ezequiel; Yavin, Eylon; Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Inorganica Chimica Acta</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-83</span>CODEN:
                <span class="NLM_cas:coden">ICHAA3</span>;
        ISSN:<span class="NLM_cas:issn">0020-1693</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  This manuscript represents a crit. review of selected topics relating to the cellular interactions of platinum anticancer drugs.  The intent is not to provide a comprehensive summary of all the work described in the literature but to raise questions and cast doubts about selected topics regarding the approaches taken towards trying to elucidate the event that happens in cancer cells that were exposed to platinum complexes.  The exptl. methods used to study the cellular interactions of platinum complexes are reviewed and the significance of the results obtained from such studies is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4FRKDki-bFLVg90H21EOLACvtfcHk0lht1RkTHvpBvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1emu7fF&md5=54425ed95c14955c9f5f410079606346</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2Fj.ica.2012.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ica.2012.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DWexselblatt%26aufirst%3DE.%26aulast%3DYavin%26aufirst%3DE.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DReview%253A%2520cellular%2520interactions%2520of%2520platinum%2520drugs%26jtitle%3DInorg.%2520Chim.%2520Acta%26date%3D2012%26volume%3D393%26spage%3D75%26epage%3D83%26doi%3D10.1016%2Fj.ica.2012.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W. B.</span><span> </span><span class="NLM_article-title">Application of liposomal technologies for delivery of platinum analogs in oncology</span> <span class="citation_source-journal">Int. J. Nanomed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3309</span><span class="NLM_x">–</span> <span class="NLM_lpage">3319</span><span class="refDoi"> DOI: 10.2147/IJN.S38354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.2147%2FIJN.S38354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=24023517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FosF2jtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=3309-3319&author=D.+M.+Liuauthor=C.+B.+Heauthor=A.+Z.+Wangauthor=W.+B.+Lin&title=Application+of+liposomal+technologies+for+delivery+of+platinum+analogs+in+oncology&doi=10.2147%2FIJN.S38354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Application of liposomal technologies for delivery of platinum analogs in oncology</span></div><div class="casAuthors">Liu Demin; He Chunbai; Wang Andrew Z; Lin Wenbin</div><div class="citationInfo"><span class="NLM_cas:title">International journal of nanomedicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3309-19</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Platinum-based chemotherapy, such as cisplatin, oxaliplatin, and carboplatin, is one of the most widely utilized classes of cancer therapeutics.  While highly effective, the clinical applications of platinum-based drugs are limited by their toxicity profiles as well as suboptimal pharmacokinetic properties.  Therefore, one of the key research areas in oncology has been to develop novel platinum analog drugs and engineer new platinum drug formulations to improve the therapeutic ratio further.  Such efforts have led to the development of platinum analogs including nedaplatin, heptaplatin, and lobaplatin.  Moreover, reformulating platinum drugs using liposomes has resulted in the development of L-NDPP (Aroplatin®), SPI-77, Lipoplatin®, Lipoxal®, and LiPlaCis®.  Liposomes possess several attractive biological activities, including biocompatibility, high drug loading, and improved pharmacokinetics, that are well suited for platinum drug delivery.  In this review, we discuss the various platinum drugs and their delivery using liposome-based drug delivery vehicles.  We compare and contrast the different liposome platforms as well as speculate on the future of platinum drug delivery research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9qo79Plh9RWGmni0r9GoKfW6udTcc2eYy_4NV8U8HjLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FosF2jtA%253D%253D&md5=8f8281ea8e2b4bffc63d948c7b960fba</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.2147%2FIJN.S38354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S38354%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%2BM.%26aulast%3DHe%26aufirst%3DC.%2BB.%26aulast%3DWang%26aufirst%3DA.%2BZ.%26aulast%3DLin%26aufirst%3DW.%2BB.%26atitle%3DApplication%2520of%2520liposomal%2520technologies%2520for%2520delivery%2520of%2520platinum%2520analogs%2520in%2520oncology%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2013%26volume%3D8%26spage%3D3309%26epage%3D3319%26doi%3D10.2147%2FIJN.S38354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Haxton, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, H. M.</span><span> </span><span class="NLM_article-title">Polymeric drug delivery of platinum-based anticancer agents</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">2299</span><span class="NLM_x">–</span> <span class="NLM_lpage">2316</span><span class="refDoi"> DOI: 10.1002/jps.21611</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2Fjps.21611" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2009&pages=2299-2316&author=K.+J.+Haxtonauthor=H.+M.+Burt&title=Polymeric+drug+delivery+of+platinum-based+anticancer+agents&doi=10.1002%2Fjps.21611"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1002%2Fjps.21611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21611%26sid%3Dliteratum%253Aachs%26aulast%3DHaxton%26aufirst%3DK.%2BJ.%26aulast%3DBurt%26aufirst%3DH.%2BM.%26atitle%3DPolymeric%2520drug%2520delivery%2520of%2520platinum-based%2520anticancer%2520agents%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D98%26spage%3D2299%26epage%3D2316%26doi%3D10.1002%2Fjps.21611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Min, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. Z.</span><span> </span><span class="NLM_article-title">Gold nanorods for platinum based prodrug delivery</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">8424</span><span class="NLM_x">–</span> <span class="NLM_lpage">8426</span><span class="refDoi"> DOI: 10.1039/c0cc03108a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1039%2Fc0cc03108a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=8424-8426&author=Y.+Z.+Minauthor=C.+Q.+Maoauthor=D.+C.+Xuauthor=J.+Wangauthor=Y.+Z.+Liu&title=Gold+nanorods+for+platinum+based+prodrug+delivery&doi=10.1039%2Fc0cc03108a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1039%2Fc0cc03108a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0cc03108a%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DY.%2BZ.%26aulast%3DMao%26aufirst%3DC.%2BQ.%26aulast%3DXu%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%2BZ.%26atitle%3DGold%2520nanorods%2520for%2520platinum%2520based%2520prodrug%2520delivery%26jtitle%3DChem.%2520Commun.%26date%3D2010%26volume%3D46%26spage%3D8424%26epage%3D8426%26doi%3D10.1039%2Fc0cc03108a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Min, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. Z.</span><span> </span><span class="NLM_article-title">Combating the drug resistance of cisplatin using a platinum prodrug based delivery system</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6742</span><span class="NLM_x">–</span> <span class="NLM_lpage">6747</span><span class="refDoi"> DOI: 10.1002/anie.201201562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2Fanie.201201562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC38Xns1WnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=6742-6747&author=Y.+Z.+Minauthor=C.+Q.+Maoauthor=S.+M.+Chenauthor=G.+L.+Maauthor=J.+Wangauthor=Y.+Z.+Liu&title=Combating+the+drug+resistance+of+cisplatin+using+a+platinum+prodrug+based+delivery+system&doi=10.1002%2Fanie.201201562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10dR"><div class="casContent"><span class="casTitleNuber">10d</span><div class="casTitle"><span class="NLM_cas:atitle">Combating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System</span></div><div class="casAuthors">Min, Yuanzeng; Mao, Cheng-Qiong; Chen, Siming; Ma, Guolin; Wang, Jun; Liu, Yangzhong</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">6742-6747, S6742/1-S6742/10</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors have reported that a platinum(IV) prodrug conjugated with a Pegylated gold nanorods (PEG-GNRs) delivery agent is not affected by the types of cellular resistance that affect other platinum-based drugs.  The authors have shown that cisplatin resistance is assocd. with low expression of Ctr1 and high concns. of GSH and metallothionein in the cisplatin-resistant cells.  The uptake of the Pt-PEG-GNRs conjugate into cells in not affected by low expression levels of Ctr1.  The endocytosis of the Pt-PEG-GNRs conjugate causes it to have a higher cellular uptake into cisplatin-resistant cancer cells than nonconjugated platinum drugs.  The platinum(IV) prodrug that is delivered in the form of the Pt-PEG-GNRs conjugate is more inert than cisplatin in its interaction with the drug deactivation agents glutathione and metallothionein, which are found in high concns. in the cisplatin-resistant cells A549R.  Therefore, this Pt-PEG-GNRs conjugate can overcome cellular resistance assocd. with deactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfHlojtgqiorVg90H21EOLACvtfcHk0lisp_biH-43Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xns1WnsLs%253D&md5=b670c3d5584c74127e3afe30ac23ac9a</span></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1002%2Fanie.201201562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201201562%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DY.%2BZ.%26aulast%3DMao%26aufirst%3DC.%2BQ.%26aulast%3DChen%26aufirst%3DS.%2BM.%26aulast%3DMa%26aufirst%3DG.%2BL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%2BZ.%26atitle%3DCombating%2520the%2520drug%2520resistance%2520of%2520cisplatin%2520using%2520a%2520platinum%2520prodrug%2520based%2520delivery%2520system%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D6742%26epage%3D6747%26doi%3D10.1002%2Fanie.201201562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wexselblatt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yavin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, D.</span><span> </span><span class="NLM_article-title">Platinum(IV) prodrugs with haloacetato ligands in the axial positions can undergo hydrolysis under biologically relevant conditions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6059</span><span class="NLM_x">–</span> <span class="NLM_lpage">6062</span><span class="refDoi"> DOI: 10.1002/anie.201300640</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2Fanie.201300640" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6059-6062&author=E.+Wexselblattauthor=E.+Yavinauthor=D.+Gibson&title=Platinum%28IV%29+prodrugs+with+haloacetato+ligands+in+the+axial+positions+can+undergo+hydrolysis+under+biologically+relevant+conditions&doi=10.1002%2Fanie.201300640"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=10.1002%2Fanie.201300640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201300640%26sid%3Dliteratum%253Aachs%26aulast%3DWexselblatt%26aufirst%3DE.%26aulast%3DYavin%26aufirst%3DE.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DPlatinum%2528IV%2529%2520prodrugs%2520with%2520haloacetato%2520ligands%2520in%2520the%2520axial%2520positions%2520can%2520undergo%2520hydrolysis%2520under%2520biologically%2520relevant%2520conditions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D23%26spage%3D6059%26epage%3D6062%26doi%3D10.1002%2Fanie.201300640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Wong, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoong, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagusiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panczyk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ang, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorin, G.</span><span> </span><span class="NLM_article-title">Carbon nanotubes for delivery of small molecule drugs</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1964</span><span class="NLM_x">–</span> <span class="NLM_lpage">2015</span><span class="refDoi"> DOI: 10.1016/j.addr.2013.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.addr.2013.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=23954402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVSgs7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=1964-2015&author=B.+S.+Wongauthor=S.+L.+Yoongauthor=A.+Jagusiakauthor=T.+Panczykauthor=H.+K.+Hoauthor=W.+H.+Angauthor=G.+Pastorin&title=Carbon+nanotubes+for+delivery+of+small+molecule+drugs&doi=10.1016%2Fj.addr.2013.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10fR"><div class="casContent"><span class="casTitleNuber">10f</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon nanotubes for delivery of small molecule drugs</span></div><div class="casAuthors">Wong, Bin Sheng; Yoong, Sia Lee; Jagusiak, Anna; Panczyk, Tomasz; Ho, Han Kiat; Ang, Wee Han; Pastorin, Giorgia</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1964-2015</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the realm of drug delivery, carbon nanotubes (CNTs) have gained tremendous attention as promising nanocarriers, owing to their distinct characteristics, such as high surface area, enhanced cellular uptake and the possibility to be easily conjugated with many therapeutics, including both small mols. and biologics, displaying superior efficacy, enhanced specificity and diminished side effects.  While most CNT-based drug delivery system (DDS) had been engineered to combat cancers, there are also emerging reports that employ CNTs as either the main carrier or adjunct material for the delivery of various non-anticancer drugs.  In this review, the delivery of small mol. drugs is expounded, with special attention paid to the current progress of in vitro and in vivo research involving CNT-based DDSs, before finally concluding with some consideration on inevitable complications that hamper successful disease intervention with CNTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNp6_SqOer3LVg90H21EOLACvtfcHk0lhkOyXg7EdS0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVSgs7nM&md5=daae7a5a9b943877fa2385e87a77166c</span></div><a href="/servlet/linkout?suffix=cit10f&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2013.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2013.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DB.%2BS.%26aulast%3DYoong%26aufirst%3DS.%2BL.%26aulast%3DJagusiak%26aufirst%3DA.%26aulast%3DPanczyk%26aufirst%3DT.%26aulast%3DHo%26aufirst%3DH.%2BK.%26aulast%3DAng%26aufirst%3DW.%2BH.%26aulast%3DPastorin%26aufirst%3DG.%26atitle%3DCarbon%2520nanotubes%2520for%2520delivery%2520of%2520small%2520molecule%2520drugs%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2013%26volume%3D65%26spage%3D1964%26epage%3D2015%26doi%3D10.1016%2Fj.addr.2013.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Oberoi, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nukolova, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabanov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronich, T. K.</span><span> </span><span class="NLM_article-title">Nanocarriers for delivery of platinum anticancer drugs</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1667</span><span class="NLM_x">–</span> <span class="NLM_lpage">1685</span><span class="refDoi"> DOI: 10.1016/j.addr.2013.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2Fj.addr.2013.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=24113520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWmurbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=1667-1685&author=H.+S.+Oberoiauthor=N.+V.+Nukolovaauthor=A.+V.+Kabanovauthor=T.+K.+Bronich&title=Nanocarriers+for+delivery+of+platinum+anticancer+drugs&doi=10.1016%2Fj.addr.2013.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10gR"><div class="casContent"><span class="casTitleNuber">10g</span><div class="casTitle"><span class="NLM_cas:atitle">Nanocarriers for delivery of platinum anticancer drugs</span></div><div class="casAuthors">Oberoi, Hardeep S.; Nukolova, Natalia V.; Kabanov, Alexander V.; Bronich, Tatiana K.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">1667-1685</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Platinum based anticancer drugs have revolutionized cancer chemotherapy, and continue to be in widespread clin. use esp. for management of tumors of the ovary, testes, and the head and neck.  However, several dose limiting toxicities assocd. with platinum drug use, partial anti-tumor response in most patients, development of drug resistance, tumor relapse, and many other challenges have severely limited the patient quality of life.  These limitations have motivated an extensive research effort towards development of new strategies for improving platinum therapy.  Nanocarrier-based delivery of platinum compds. is one such area of intense research effort beginning to provide encouraging preclin. and clin. results and may allow the development of the next generation of platinum chemotherapy.  This review highlights current understanding on the pharmacol. and limitations of platinum compds. in clin. use, and provides a comprehensive anal. of various platinum-polymer complexes, micelles, dendrimers, liposomes and other nanoparticles currently under investigation for delivery of platinum drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9t-JIgD2CMrVg90H21EOLACvtfcHk0lhkOyXg7EdS0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWmurbO&md5=25ea0f4f9f5f2712c294c8f37bb541ce</span></div><a href="/servlet/linkout?suffix=cit10g&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2013.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2013.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DOberoi%26aufirst%3DH.%2BS.%26aulast%3DNukolova%26aufirst%3DN.%2BV.%26aulast%3DKabanov%26aufirst%3DA.%2BV.%26aulast%3DBronich%26aufirst%3DT.%2BK.%26atitle%3DNanocarriers%2520for%2520delivery%2520of%2520platinum%2520anticancer%2520drugs%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2013%26volume%3D65%26spage%3D1667%26epage%3D1685%26doi%3D10.1016%2Fj.addr.2013.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span> </span><span class="NLM_article-title">Human serum albumin conjugated nanoparticles for pH and redox-responsive delivery of a prodrug of cisplatin</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">16547</span><span class="NLM_x">–</span> <span class="NLM_lpage">16554</span><span class="refDoi"> DOI: 10.1002/chem.201502756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2Fchem.201502756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=26405808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFGktbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=16547-16554&author=H.+Shiauthor=Q.+Chengauthor=S.+Yuanauthor=X.+Dingauthor=Y.+Liu&title=Human+serum+albumin+conjugated+nanoparticles+for+pH+and+redox-responsive+delivery+of+a+prodrug+of+cisplatin&doi=10.1002%2Fchem.201502756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10hR"><div class="casContent"><span class="casTitleNuber">10h</span><div class="casTitle"><span class="NLM_cas:atitle">Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin</span></div><div class="casAuthors">Shi, Hongdong; Cheng, Qinqin; Yuan, Siming; Ding, Xin; Liu, Yangzhong</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16547-16554</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Platinum anticancer drugs are particularly in need of controlled drug delivery because of their severe side effects.  Platinum(IV) agents are designed as prodrugs to reduce the side effects of platinum(II) drugs; however, premature redn. could limit the effect as a prodrug.  In this work, a highly biocompatible, pH and redox dual-responsive delivery system is prepd. by using hybrid nanoparticles of human serum albumin (HSA) and calcium phosphate (CaP) for the PtIV prodrug of cisplatin.  This conjugate is very stable under extracellular conditions, so that it protects the platinum(IV) prodrug in HSA.  Upon reaching the acidic and hypoxic environment, the platinum drug is released in its active form and is able to bind to the target DNA.  The Pt-HSA/CaP hybrid inhibits the proliferation of various cancer cells more efficiently than cisplatin.  Different cell cycle arrests suggest different cellular responses of the PtIV prodrug in the CaP nanocarrier.  Interestingly, this delivery system demonstrates enhanced cytotoxicity to tumor cells, but not to normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhyedlE3uVpLVg90H21EOLACvtfcHk0lhkOyXg7EdS0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFGktbzK&md5=4f8d82979e4849bd314d625f9afd949f</span></div><a href="/servlet/linkout?suffix=cit10h&amp;dbid=16384&amp;doi=10.1002%2Fchem.201502756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201502756%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DQ.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DHuman%2520serum%2520albumin%2520conjugated%2520nanoparticles%2520for%2520pH%2520and%2520redox-responsive%2520delivery%2520of%2520a%2520prodrug%2520of%2520cisplatin%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2015%26volume%3D21%26spage%3D16547%26epage%3D16554%26doi%3D10.1002%2Fchem.201502756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Zheng, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suntharalingam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">8790</span><span class="NLM_x">–</span> <span class="NLM_lpage">8798</span><span class="refDoi"> DOI: 10.1021/ja5038269</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja5038269" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptl2itrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=8790-8798&author=Y.+R.+Zhengauthor=K.+Suntharalingamauthor=T.+C.+Johnstoneauthor=H.+Yooauthor=W.+Linauthor=J.+G.+Brooksauthor=S.+J.+Lippard&title=Pt%28IV%29+prodrugs+designed+to+bind+non-covalently+to+human+serum+albumin+for+drug+delivery&doi=10.1021%2Fja5038269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery</span></div><div class="casAuthors">Zheng, Yao-Rong; Suntharalingam, Kogularamanan; Johnstone, Timothy C.; Yoo, Hyunsuk; Lin, Wei; Brooks, Jamar G.; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8790-8798</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Albumin is the most abundant protein in human serum and drugs that are administered i.v. inevitably interact with it.  We present here a series of platinum(IV) prodrugs designed specifically to enhance interaction with human serum albumin (HSA) for drug delivery.  This goal is achieved by asym. functionalizing the axial ligands of the prodrug so as to mimic the overall features of a fatty acid.  Systematic variation of the length of the aliph. tail tunes the cellular uptake and, consequently, the cytotoxicity of cis,cis,trans-[Pt(NH3)2Cl2(O2CCH2CH2COOH)(OCONHR)], 4, where R is a linear alkyl group.  Investigation of an analog bearing a fluorophore conjugated to the succinate ligand confirmed that these compds. are reduced by biol. reductants with loss of the axial ligands.  Intracellular release of cisplatin from 4 was further confirmed by observing the characteristic effects of cisplatin on the cell cycle and morphol. following treatment with the prodrug.  The most potent member of series 4, for which R is a hexadecyl chain, interacts with HSA in a 1:1 stoichiometry to form the platinum-protein complex 7.  The interaction is non-covalent and extn. with octanol completely removes the prodrug from an aq. soln. of HSA.  Construct 7 is robust and can be isolated following fast protein liq. chromatog.  The nature of the tight interaction was investigated computationally, and these studies suggest that the prodrug is buried below the surface of the protein.  Consequently, complexation to HSA is able to reduce the rate of redn. of the prodrug by ascorbate.  The lead compd. from series 4 also exhibited significant stability in whole human blood, attributed to its interaction with HSA.  This favorable redox profile, in conjunction with the established nonimmunogenicity, biocompatibility, and enhanced tumor accumulation of HSA, produces a system that holds significant therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOojHJiVKj17Vg90H21EOLACvtfcHk0lh7h2LGgkjcfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptl2itrs%253D&md5=541fe9e155e3f4e2f8d6f61f3d81ee5a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fja5038269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja5038269%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BR.%26aulast%3DSuntharalingam%26aufirst%3DK.%26aulast%3DJohnstone%26aufirst%3DT.%2BC.%26aulast%3DYoo%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DW.%26aulast%3DBrooks%26aufirst%3DJ.%2BG.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DPt%2528IV%2529%2520prodrugs%2520designed%2520to%2520bind%2520non-covalently%2520to%2520human%2520serum%2520albumin%2520for%2520drug%2520delivery%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D8790%26epage%3D8798%26doi%3D10.1021%2Fja5038269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Leu, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chern, J. W.</span><span> </span><span class="NLM_article-title">Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1740</span><span class="NLM_x">–</span> <span class="NLM_lpage">1746</span><span class="refDoi"> DOI: 10.1021/jm701151c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701151c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislKqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1740-1746&author=Y.+L.+Leuauthor=C.+S.+Chenauthor=Y.+J.+Wuauthor=J.+W.+Chern&title=Benzyl+ether-linked+glucuronide+derivative+of+10-hydroxycamptothecin+designed+for+selective+camptothecin-based+anticancer+therapy&doi=10.1021%2Fjm701151c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Benzyl Ether-Linked Glucuronide Derivative of 10-Hydroxycamptothecin Designed for Selective Camptothecin-Based Anticancer Therapy</span></div><div class="casAuthors">Leu, Yu-Ling; Chen, Chien-Shu; Wu, Yih-Jang; Chern, Ji-Wang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1740-1746</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A β-glucuronidase-activated prodrug approach was applied to 10-hydroxycamptothecin, a Camptotheca alkaloid with promising antitumor activity but poor water soly.  A glucuronide prodrug of 10-hydroxycamptothecin I in which glucuronic acid is connected via a self-immolative 3-nitrobenzyl ether linker to the 10-OH group of 10-hydroxycamptothecin was synthesized.  I was 80 times more sol. than 10-hydroxycamptothecin in aq. soln. at pH 4.0 and was stable in human plasma.  I was 10- to 15-fold less toxic than the parent drug to four human tumor cell lines.  In the presence of β-glucuronidase, I could be activated to elicit similar cytotoxicity to the parent drug in tumor cells.  Enzyme kinetic studies showed that Escherichia coli β-glucuronidase had a quite low Km of 0.18 μM for I and exhibited 520 times higher catalytic efficiency for I than for a glucuronide prodrug of 9-aminocamptothecin.  Mol. modeling studies predicted that I would have a higher binding affinity to human β-glucuronidase than that glucuronide prodrug of 9-aminocamptothecin.  Prodrug I may be useful for selective cancer chemotherapy by a prodrug monotherapy (PMT) or antibody-directed enzyme prodrug therapy (ADEPT) strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcP5rY2HD4i7Vg90H21EOLACvtfcHk0lh7h2LGgkjcfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislKqt7k%253D&md5=93a025144bca4b097d7f5e9a8b2f0cea</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjm701151c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701151c%26sid%3Dliteratum%253Aachs%26aulast%3DLeu%26aufirst%3DY.%2BL.%26aulast%3DChen%26aufirst%3DC.%2BS.%26aulast%3DWu%26aufirst%3DY.%2BJ.%26aulast%3DChern%26aufirst%3DJ.%2BW.%26atitle%3DBenzyl%2520ether-linked%2520glucuronide%2520derivative%2520of%252010-hydroxycamptothecin%2520designed%2520for%2520selective%2520camptothecin-based%2520anticancer%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1740%26epage%3D1746%26doi%3D10.1021%2Fjm701151c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sudlow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birkett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, D. N.</span><span> </span><span class="NLM_article-title">Further characterization of specific drug binding sites on human serum albumin</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1052</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1004490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADyaE2sXjslCqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1976&pages=1052-1061&author=G.+Sudlowauthor=D.+J.+Birkettauthor=D.+N.+Wade&title=Further+characterization+of+specific+drug+binding+sites+on+human+serum+albumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Further characterization of specific drug binding sites on human serum albumin</span></div><div class="casAuthors">Sudlow, G.; Birkett, D. J.; Wade, D. N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1052-61</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The fluorescent probes, 5-dimethylaminonaphthalene-1-sulfonamide (I) [1431-39-6] and dansylsarcosine [1093-96-5] function as specific markers for 2 distinct binding sites for anionic drugs on human serum albumin (HSA).  The binding of drugs to site I or II was detected by measuring the displacement of these probes.  The results give an indication of some of the structural features required for binding at these sites.  Stearic acid [57-11-4] binding to HSA induced different conformational changes in the albumin at sites I and II, which were detected by changes in the fluorescence and/or strength of binding of probes specific for the 2 sites.  This provides further evidence for qual. differences between the 2 sites.  The specificity of the sites for particular drugs, even at high drug to albumin ratios, was established, and the specificity and characteristics of the 2 sites on human adult and neonatal sera were shown to be similar to those on cryst. HSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZMQN1NBrHM7Vg90H21EOLACvtfcHk0lh7h2LGgkjcfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXjslCqsA%253D%253D&md5=5286ae0da826f2764eb595b22361fe80</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSudlow%26aufirst%3DG.%26aulast%3DBirkett%26aufirst%3DD.%2BJ.%26aulast%3DWade%26aufirst%3DD.%2BN.%26atitle%3DFurther%2520characterization%2520of%2520specific%2520drug%2520binding%2520sites%2520on%2520human%2520serum%2520albumin%26jtitle%3DMol.%2520Pharmacol.%26date%3D1976%26volume%3D12%26spage%3D1052%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Deng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, N.</span><span> </span><span class="NLM_article-title">Crystal structure of the human glucose transporter GLUT1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">510</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span><span class="refDoi"> DOI: 10.1038/nature13306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1038%2Fnature13306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=24847886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFGitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=2014&pages=121-125&author=D.+Dengauthor=C.+Xuauthor=P.+Sunauthor=J.+Wuauthor=C.+Yanauthor=M.+Huauthor=N.+Yan&title=Crystal+structure+of+the+human+glucose+transporter+GLUT1&doi=10.1038%2Fnature13306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human glucose transporter GLUT1</span></div><div class="casAuthors">Deng, Dong; Xu, Chao; Sun, Pengcheng; Wu, Jianping; Yan, Chuangye; Hu, Mingxu; Yan, Nieng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">7503</span>),
    <span class="NLM_cas:pages">121-125</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The glucose transporter GLUT1 catalyzes facilitative diffusion of glucose into erythrocytes and is responsible for glucose supply to the brain and other organs.  Dysfunctional mutations may lead to GLUT1 deficiency syndrome, whereas overexpression of GLUT1 is a prognostic indicator for cancer.  Despite decades of investigation, the structure of GLUT1 remains unknown.  Here we report the crystal structure of human GLUT1 at 3.2 Å resoln.  The full-length protein, which has a canonical major facilitator superfamily fold, is captured in an inward-open conformation.  This structure allows accurate mapping and potential mechanistic interpretation of disease-assocd. mutations in GLUT1.  Structure-based anal. of these mutations provides an insight into the alternating access mechanism of GLUT1 and other members of the sugar porter subfamily.  Structural comparison of the uniporter GLUT1 with its bacterial homolog XylE, a proton-coupled xylose symporter, allows examn. of the transport mechanisms of both passive facilitators and active transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSeBmEBIMIurVg90H21EOLACvtfcHk0lh7h2LGgkjcfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFGitL8%253D&md5=b9426a934cddf7347fdc6c9073aa8636</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1038%2Fnature13306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13306%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DN.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520glucose%2520transporter%2520GLUT1%26jtitle%3DNature%26date%3D2014%26volume%3D510%26spage%3D121%26epage%3D125%26doi%3D10.1038%2Fnature13306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovejoy, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shima, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagpacan, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapuk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomini, K. M.</span><span> </span><span class="NLM_article-title">Organic cation transporters are determinants of oxaliplatin cytotoxicity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8847</span><span class="NLM_x">–</span> <span class="NLM_lpage">8857</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-0769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1158%2F0008-5472.CAN-06-0769" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8847-8857&author=S.+Zhangauthor=K.+S.+Lovejoyauthor=J.+E.+Shimaauthor=L.+L.+Lagpacanauthor=Y.+Shuauthor=A.+Lapukauthor=Y.+Chenauthor=T.+Komoriauthor=J.+W.+Grayauthor=X.+Chenauthor=S.+J.+Lippardauthor=K.+M.+Giacomini&title=Organic+cation+transporters+are+determinants+of+oxaliplatin+cytotoxicity&doi=10.1158%2F0008-5472.CAN-06-0769"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-0769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-0769%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DLovejoy%26aufirst%3DK.%2BS.%26aulast%3DShima%26aufirst%3DJ.%2BE.%26aulast%3DLagpacan%26aufirst%3DL.%2BL.%26aulast%3DShu%26aufirst%3DY.%26aulast%3DLapuk%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKomori%26aufirst%3DT.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26aulast%3DGiacomini%26aufirst%3DK.%2BM.%26atitle%3DOrganic%2520cation%2520transporters%2520are%2520determinants%2520of%2520oxaliplatin%2520cytotoxicity%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8847%26epage%3D8857%26doi%3D10.1158%2F0008-5472.CAN-06-0769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Burger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoumaro-Djayoon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boersma, A. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berns, E. M. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathijssen, R. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loos, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiemer, E. A. C.</span><span> </span><span class="NLM_article-title">Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">898</span><span class="NLM_x">–</span> <span class="NLM_lpage">908</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2009.00569.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1111%2Fj.1476-5381.2009.00569.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=20067471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtF2hsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2010&pages=898-908&author=H.+Burgerauthor=A.+Zoumaro-Djayoonauthor=A.+W.+M.+Boersmaauthor=J.+Hellemanauthor=E.+M.+J.+J.+Bernsauthor=R.+H.+J.+Mathijssenauthor=W.+J.+Loosauthor=E.+A.+C.+Wiemer&title=Differential+transport+of+platinum+compounds+by+the+human+organic+cation+transporter+hOCT2+%28hSLC22A2%29&doi=10.1111%2Fj.1476-5381.2009.00569.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)</span></div><div class="casAuthors">Burger, H.; Zoumaro-Djayoon, A.; Boersma, A. W. M.; Helleman, J.; Berns, E. M. J. J.; Mathijssen, R. H. J.; Loos, W. J.; Wiemer, E. A. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">898-908</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background: Solute carriers (SLCs), in particular org. cation transporters (OCTs), have been implicated in the cellular uptake of platinum-contg. anticancer compds.  The activity of these carriers may det. the pharmacokinetics and the severity of side effects, including neuro- and nephrotoxicity of platinum-based chemotherapy.  As decreased drug accumulation is a key mechanism of platinum resistance, SLCs may also contribute to the development of resistance.  Here, we define the role of hSLC22A2 (OCT2) in the cellular uptake of platinum compds.  Exptl. approach: Human embryonic kidney (HEK) 293 cells stably expressing the hSLC22A2 gene (HEK293/hSLC22A2) were used in platinum accumulation studies.  Following a 2 h exposure to various platinum compds. (100 μM), intracellular platinum levels were detd. by flameless at. absorption spectrometry.  Key results: HEK293/hSLC22A2 cells, compared with HEK293/Neo control cells, displayed significant increases in oxaliplatin (28.6-fold), Pt[DACH]Cl2 (20.6-fold), ormaplatin (8.1-fold), tetraplatin (4.5-fold), transplatin (3.7-fold) and cisplatin (1.3-fold), but not carboplatin.  SLC22A2-mediated transport could be inhibited by 1-methyl-4-phenylpyridinium.  Furthermore, hSLC22A2-mediated oxaliplatin and cisplatin accumulation was time- and concn.-dependent, but non-saturable.  Expression of hSLC22A2 in HEK293 cells resulted in enhanced sensitivity to oxaliplatin (12-fold) and cisplatin (1.8-fold).  Although, hSLC22A2 mRNA expression was frequently found in ovarian cancer cell lines, its expression in clin. ovarian cancer specimens (n = 80) was low and did not correlate with the treatment outcome of platinum-based regimens.  Conclusions and implications: The hSLC22A2 drug transporter is a crit. determinant in the uptake and cytotoxicity of various platinum compds., particularly oxaliplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Co2EGGOHCrVg90H21EOLACvtfcHk0lgTNEmzEzz-og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtF2hsL0%253D&md5=bde8b1e962d95d69d67b2f194c2ee266</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00569.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00569.x%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DH.%26aulast%3DZoumaro-Djayoon%26aufirst%3DA.%26aulast%3DBoersma%26aufirst%3DA.%2BW.%2BM.%26aulast%3DHelleman%26aufirst%3DJ.%26aulast%3DBerns%26aufirst%3DE.%2BM.%2BJ.%2BJ.%26aulast%3DMathijssen%26aufirst%3DR.%2BH.%2BJ.%26aulast%3DLoos%26aufirst%3DW.%2BJ.%26aulast%3DWiemer%26aufirst%3DE.%2BA.%2BC.%26atitle%3DDifferential%2520transport%2520of%2520platinum%2520compounds%2520by%2520the%2520human%2520organic%2520cation%2520transporter%2520hOCT2%2520%2528hSLC22A2%2529%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D159%26spage%3D898%26epage%3D908%26doi%3D10.1111%2Fj.1476-5381.2009.00569.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jamieson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Structure, recognition, and processing of cisplatin-DNA adducts</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2467</span><span class="NLM_x">–</span> <span class="NLM_lpage">2498</span><span class="refDoi"> DOI: 10.1021/cr980421n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr980421n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=1%3ACAS%3A528%3ADyaK1MXltV2lsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2467-2498&author=E.+R.+Jamiesonauthor=S.+J.+Lippard&title=Structure%2C+recognition%2C+and+processing+of+cisplatin-DNA+adducts&doi=10.1021%2Fcr980421n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, recognition, and processing of cisplatin-DNA adducts</span></div><div class="casAuthors">Jamieson, Elizabeth R.; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2467-2498</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 330 refs. on DNA, the biol. target of the anticancer drugs, and the effects of cisplatin adduct formation on DNA-dependent cellular functions and identification of the proteins that mediate the biol. response of cells to cisplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra6eC00RXB-bVg90H21EOLACvtfcHk0lgTNEmzEzz-og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltV2lsrg%253D&md5=ca3c75db0ad1446f3b28940ce36ac435</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fcr980421n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr980421n%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DE.%2BR.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DStructure%252C%2520recognition%252C%2520and%2520processing%2520of%2520cisplatin-DNA%2520adducts%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26spage%3D2467%26epage%3D2498%26doi%3D10.1021%2Fcr980421n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Warnke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kloft, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galanski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartinger, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keppler, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaehde, U.</span><span> </span><span class="NLM_article-title">Analysis of platinum adducts with DNA nucleotides and nucleosides by capillary electrophoresis coupled to ESI-MS: indications of guanosine 5′-monophosphate O6-N7 chelation</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1543</span><span class="NLM_x">–</span> <span class="NLM_lpage">1549</span><span class="refDoi"> DOI: 10.1002/cbic.200400015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1002%2Fcbic.200400015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1543-1549&author=U.+Warnkeauthor=C.+Rappelauthor=H.+Meierauthor=C.+Kloftauthor=M.+Galanskiauthor=C.+G.+Hartingerauthor=B.+K.+Kepplerauthor=U.+Jaehde&title=Analysis+of+platinum+adducts+with+DNA+nucleotides+and+nucleosides+by+capillary+electrophoresis+coupled+to+ESI-MS%3A+indications+of+guanosine+5%E2%80%B2-monophosphate+O6-N7+chelation&doi=10.1002%2Fcbic.200400015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200400015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200400015%26sid%3Dliteratum%253Aachs%26aulast%3DWarnke%26aufirst%3DU.%26aulast%3DRappel%26aufirst%3DC.%26aulast%3DMeier%26aufirst%3DH.%26aulast%3DKloft%26aufirst%3DC.%26aulast%3DGalanski%26aufirst%3DM.%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26aulast%3DJaehde%26aufirst%3DU.%26atitle%3DAnalysis%2520of%2520platinum%2520adducts%2520with%2520DNA%2520nucleotides%2520and%2520nucleosides%2520by%2520capillary%2520electrophoresis%2520coupled%2520to%2520ESI-MS%253A%2520indications%2520of%2520guanosine%25205%25E2%2580%25B2-monophosphate%2520O6-N7%2520chelation%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D1543%26epage%3D1549%26doi%3D10.1002%2Fcbic.200400015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">van der Veer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reedijk, J.</span><span> </span><span class="NLM_article-title">Reaction products from platinum(IV) amine compounds and 5′-GMP are mainly bis(5′-GMP)platinum(II) amine adducts</span> <span class="citation_source-journal">J. Inorg. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span><span class="refDoi"> DOI: 10.1016/0162-0134(86)80006-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;key=10.1016%2F0162-0134%2886%2980006-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1986&pages=137-142&author=J.+L.+van+der+Veerauthor=A.+R.+Petersauthor=J.+Reedijk&title=Reaction+products+from+platinum%28IV%29+amine+compounds+and+5%E2%80%B2-GMP+are+mainly+bis%285%E2%80%B2-GMP%29platinum%28II%29+amine+adducts&doi=10.1016%2F0162-0134%2886%2980006-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1016%2F0162-0134%2886%2980006-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0162-0134%252886%252980006-X%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BVeer%26aufirst%3DJ.%2BL.%26aulast%3DPeters%26aufirst%3DA.%2BR.%26aulast%3DReedijk%26aufirst%3DJ.%26atitle%3DReaction%2520products%2520from%2520platinum%2528IV%2529%2520amine%2520compounds%2520and%25205%25E2%2580%25B2-GMP%2520are%2520mainly%2520bis%25285%25E2%2580%25B2-GMP%2529platinum%2528II%2529%2520amine%2520adducts%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D1986%26volume%3D26%26spage%3D137%26epage%3D142%26doi%3D10.1016%2F0162-0134%2886%2980006-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PYP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PYP','PDB','4PYP'); return false;">PDB: 4PYP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E7H" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E7H','PDB','1E7H'); return false;">PDB: 1E7H</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i54"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00433">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_78734"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00433">10.1021/acs.jmedchem.7b00433</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Full experimental details, NMR data, and bioassay information (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_001.csv">CSV</a>)</p></li><li><p class="inline">Docking of <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E7H">1E7H</a> (HSA) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Docking of <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PYP">4PYP</a> (GLUT1) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_003.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_001.csv">jm7b00433_si_001.csv (1.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_002.pdb">jm7b00433_si_002.pdb (420.98 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_003.pdb">jm7b00433_si_003.pdb (591.6 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00433/suppl_file/jm7b00433_si_004.pdf">jm7b00433_si_004.pdf (2.36 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00433&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00433%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00433" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ab650ce5a3c40","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
